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1. Introduction 
1.1 Regulation of enzymatic activity 
Organisms need to preserve metabolic homeostasis although manifold biotic and abiotic environmental 
factors affect them to a different extent. Therefore, regulation of certain biochemical processes within the 
organism is mandatory. Key players in this regard are enzymes since they govern all biological reactions in 
the cell. Tight control is necessary to provide that enzymes are active at the right time and the right place. 
Two major modes of enzyme regulation are typically described in text books:   
The amount of an enzyme can be controlled on different levels through its synthesis or degradation. On the 
gene level synthesis of the enzyme is either regulated by transcription of the gene [1] or by translation of 
the corresponding messenger RNA [2]. Degradation of proteins is typically initiated by ubiquitination [3]. 
This response to a stimulus is less immediate but with longer a duration. 
The activity of an enzyme can be regulated and typically allows fast answer of the organism to the particular 
stimulus. Regulation includes numerous principles whereat binding of inhibitors and covalent 
modifications are the most common ones. Although a great number of posttranslational modifications are 
described in the literature, nearly all principles constitute reversible alterations of a pre-existing enzyme 
(also called pre-enzyme). Here, the pre-enzyme represents the non-active enzyme which becomes 
activated after modification. Noteworthy, inverted cases are also known where the existing enzyme 
resembles the active form which is turned off due to the modification. Activation is often initiated by a 
conformational transition which finally leads to a change of enzymatic activity. Due to the multitude of 
principles only a selected number of activity modulations are discussed here in more detail (figure 1): 
A: Allosteric control. An effector of an enzyme can bind to an allosteric site which is different in shape 
and position compared to the active site. A prominent kind of allosteric control is the feedback 
mechanism where the end product of a multistep pathway inhibits an enzyme that catalyzes the 
first reaction of this pathway [4]. 
B: Covalent modifications. Covalent modifications cover phosphorylation, acetylation, glycosylation, 
myristoylation, palmitoylation and can be reversible or irreversible. Only two examples are 
described in more detail. 
Myristoylation of a pre-enzyme is performed by N-myristoyltransferase which covalently attaches a 
myristoyl moiety to an N-terminal Gly of the protein. The process is irreversible and mediates 
membrane binding of the enzyme or interaction with other proteins [5]. 
Proteases can activate pre-enzymes (here also termed zymogens) via proteolytic cleavage of a 
polypeptide part [6]. To turn off the irreversibly activated enzyme further enzymes are mandatory. 
C: Protein-protein interactions. Many enzymes need other proteins like regulatory subunits for functional 
activity [7]. Also the formation of catalytically active homooligomers for example dimerization of 
membrane-bound receptors is known [8]. 
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D: Localization in a different environment. Enzymes need defined milieus like an optimal pH or oxidative 
environment for their functionality. The optimal milieu can either contribute to a functional 
active site or to the global structure [9]. 
 
figure 1: Regulation modes of enzymes. The non-active enzyme (orange) is converted to the active form (blue), which is able 
to react with the substrate (red). Different activation modes are A: allosteric activation, B: covalent modifications, C: protein-
protein interactions, D: localization in a different environment. 
 
Often enzymes are regulated by multiple modes to adapt perfectly on different metabolic conditions. For 
instance enzymes which become covalently modified with a myristoyl anchor subsequently change their 
localization to the hydrophobic environment of a lipid bilayer [10] [11].    
In this thesis the regulation of the peripheral membrane protein pyruvate oxidase from E. coli (EcPOX) is 
analyzed in detail. EcPOX is a metabolic enzyme which is localized in the cytosol and only recruited to the 
membrane in response to a certain stimulus [12]. Association of EcPOX to the lipid bilayer converts this 
enzyme from a fairly unreactive to a powerful catalyst by enhancing the catalytic efficiency by several 
orders of magnitude [13]. Aim of this thesis is to elucidate the molecular mechanism which controls 
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1.2 Pyruvate oxidase from E.coli 
Pyruvate oxidase from E. coli (EC 1.2.2.2, EcPOX) is a peripheral membrane protein which was first 
found in the soluble fraction of E. coli lysate by Hager in 1957 [14]. The enzyme is a homotetramer with a 
subunit size of 62 kDa and requires one thiamine diphosphate (ThDP) and one flavin adenine 
dinucleotide (FAD) as cofactors per monomer for catalysis [15] [16]. EcPOX catalyzes the oxidative 
decarboxylation of pyruvate yielding acetate and carbon dioxide. During this reaction two electrons arise 
which are initially stored at the flavin cofactor. Subsequently, both electrons are used to reduce 
ubiquinone-8 (Q8), a membrane-bound electron carrier of the respiratory chain [17]. According to the 
localization the overall reaction catalyzed by pyruvate oxidase can be divided into two parts:  
cytosol:   EcPOX-ThDP-FAD + pyruvate + H2O → EcPOX-ThDP-FADH2 + CO2 + acetate 
membrane:                  EcPOX-ThDP-FADH2 + Q8  →  EcPOX-ThDP-FAD + Q8H2 
Pyruvate binding and conversion can take place in the cytoplasm. However, the reduced enzyme must be 
attached to the membrane in order to transfer electrons to Q8. Therefore, EcPOX was described as 
peripheral membrane protein which is mainly found in the cytosol [18] [17]. 
1.2.1 The catalytic cycle of EcPOX 
The detailed reaction mechanism of EcPOX is similar to other thiamine enzymes and follows the 
descriptions of Breslow and Schellenberger (figure 2) [19] [20]. The thiamine cofactor is bound in its 
typical V-conformation  [21] which ensures deprotonation of the C2-atom of the thiazolium ring as 
prerequisite for catalysis [22]. Therefore, a co-catalytic function of the N1’- and N4’-atom of the 
aminopyrimidine ring in combination with a conserved Glu (Glu50 in EcPOX), which acts as acid/base 
catalyst for proton abstraction, can be supposed. The resulting ylide moiety at the C2-atom can attack the 
substrate pyruvate in a nucleophilic forming lactyl-ThDP (L-ThDP), which is decarboxylated yielding the 
resonance-stabilized hydroxyethyl-ThDP (HE-ThDP) intermediate. Starting from HE-ThDP the catalytic 
pathway is subdivided: two electrons are transferred from HE-ThDP to the flavin cofactor and acetyl-
ThDP (Ac-ThDP) is formed. This is further hydrolyzed resulting in the product acetate and regenerated 
ThDP. For complete regeneration of the enzyme the reduced flavin cofactor needs to be oxidized. 
Therefore, EcPOX, which was hitherto localized in the cytoplasm, is recruited to the membrane where it 
transfers both electrons to the final acceptor Q8. 
EcPOX catalysis can be described as ping-pong mechanism with pyruvate and water as substrates and 
carbon dioxide and acetate as corresponding products [23]. According to the redox state of the flavin 
cofactor the catalytic cycle can be divided into two half-reactions [24]. The reductive half-reaction includes 
all processes yielding the reduced flavin and refer to formation of L-ThDP, decarboxylation, and 
formation of Ac-ThDP with concomitant flavin reduction (yellow half-cycle in figure 2). Contrary, the 
part of the catalytic cycle which leads to reoxidation of the flavin cofactor by Q8 constitutes the oxidative 
half-reaction (white half-cycle in figure 2).     
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figure 2: Catalytic cycle of EcPOX. 1: activation of ThDP, 2: covalent binding of pyruvate, 3: decarboxylation of lactyl-ThDP, 
4: electron transfer to FAD, 5: hydrolysis of acetyl-ThDP, 6: FAD reoxidation by membrane-bound Q8. Further explanations are 
given in the text. (R1 = aminopyrimidine moiety, R2 = diphosphate anchor) 
 
1.2.2 The physiological function of EcPOX 
Typically, E. coli cells gain energy via the pivotal pyruvate dehydrogenase (PDH) complex which utilizes 
pyruvate to produce acetyl-CoA and NADH [25]. Acetyl-CoA can be feed in the citric acid cycle or used 
to generate fatty acids or steroids. The product NADH, which resembles reducing equivalents, serves as 
electron donor for the respiratory chain. In this regard, the reaction catalyzed by EcPOX seems to be non-
essential and wasteful, because EcPOX converts pyruvate only to low-energy acetate and reducing 
equivalents. Other enzymes like acetokinase, phosphotransacetylase or acetyle-CoA synthetase are 
required to produce acetyl-CoA in ATP-dependent reactions [26]. Thus, the physiological role of EcPOX 
remained enigmatic for a long time. 
In 1994 Chang et al. demonstrated that EcPOX is expressed in the early stationary phase and during 
anaerobic growth [27]. Since in both cases the PDH complex functions poorly they speculated that 
EcPOX serves as a backup system to provide acetyl-CoA. This assumption was further supported by 
Abdel-Hamid and coworkers [28] who showed that in PDH-deficient E. coli strains EcPOX takes over the 
function of the PDH complex and supports acetate-independent growth. Additionally, expression of the 
poxB gene (encoding for EcPOX) and activity of the corresponding acetyl-CoA producing enzymes was 
increased in these E.coli strains. Moreover, in an EcPOX-deficient E. coli strain less carbon units were 











































































































the conclusion that EcPOX contributes to aerobic growth [28], but the question remained open how this 
is achieved.   
1.2.3 Activation of EcPOX 
When Hager first described the thiamine-dependent enzyme pyruvate oxidase from E.coli in 1957 he also 
reported that a manifold increase in activity was observed if the protein is incubated with trypsin [14]. 
Similar results were observed by Williams et al., who added surfactants like SDS and lipid extracts to the 
enzyme [15]. Both effects were later termed activation and remained a subject of interest during the last 50 
years. 
Proteolytic and amphiphile-mediated activation are attributed to the C-terminal part of EcPOX 
Recny et al. showed that the proteolytic digestion of EcPOX leading to activation is related to removal of 
the last 23 amino acids of the C-terminus, which “locks” the enzyme irreversibly in the activated state [29]. 
Interestingly, the resulting EcPOX Δ23 deletion variant shows a severely reduced affinity for lipids and 
detergents [18]. Therefore, it was proposed that the 23 C-terminal amino acids act as membrane anchor 
and promote the attachment of EcPOX to the lipid bilayer. The anchor was later called alpha-peptide due 
to the truncation by alpha-chymotrypsin [29]. Additionally, it was deciphered that two C-termini are 
mandatory for functional membrane binding of an EcPOX tetramer [30] [31]. 
Since detergent-stimulated EcPOX shows similar catalytic parameters like Δ23 it was suggested that also in 
amphiphile-mediated activation the C-terminus is involved [13]. Proteolytic digestion of EcPOX in the 
presence of detergents reveals no proposed truncation to Δ23 [13] which gives evidence that a direct 
interaction of the detergent with the Δ23 cleavage site and thus with the membrane anchor can be 
observed [13]. Further, while the full-length enzyme is activated by 80 different amphiphiles, activity of 
EcPOX Δ23 is not further enhanced in the presence of any detergent [27]. These findings foster the idea 
that proteolytic and amphiphile-mediated activation are attributed to interactions with the C-terminal 
membrane anchor of EcPOX. The crucial role of the C-terminal part for the physiological function of 
EcPOX was also demonstrated in vivo. E.coli strains expressing the truncated pyruvate oxidase show no 
oxidase activity [32] and cannot restore acetate-independent growth contrary to the full-length 
protein [28]. 
Both, proteolytic and amphiphile-mediated activation were equally applied in the past as substitute for the 
native membrane binding process [33] [32]. However, it turned out that the presence of pyruvate is 
mandatory for EcPOX activation. Proteolysis of EcPOX in the absence of pyruvate leads to inactivation 
of the enzyme [18] and a similar effect is observed for amphiphilic stimulations [34]. Therefore, it was 
assumed that pyruvate-triggered reduction of the flavin cofactor induces a conformational change which 
leads to exposition of the membrane anchor [35].  
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Model of EcPOX activation 
A model of EcPOX activation and concomitant structural changes was proposed by Neumann and 
Weidner et al. [35] (figure 3). Resting state EcPOX is localized in the cytosol and shows poor basal activity 
(Km = 90 mM, kcat = 7 s-1). The C-terminal membrane anchor is attached to the protein surface which 
prevents membrane binding. Elevated concentrations of the substrate pyruvate lead to reduction of the 
flavin cofactor and trigger a conformational change which comprises exposure of the membrane anchor. 
After association to the membrane in vivo the enzyme is activated characterized by a 30fold increased kcat 
and a 8fold decreased Km (Km = 12 mM, kcat = 200 s-1). 
 
figure 3: Activation model of EcPOX. EcPOX is localized in the cytosol with a protein-bound membrane anchor. Elevated 
concentrations of pyruvate trigger membrane anchor exposure. Subsequently, EcPOX is either activated in vivo by membrane 
association or in vitro by limited proteolysis or amphiphiles. In all cases catalytic efficiency is manifold enhanced. Since the 
interaction mode with amphiphiles is unclear so far contacts of monomers or amphiphilic micelles with the membrane anchor are 
indicated. Catalytic constants for amphiphile-mediated activation were determined in the presence of 100 µM SDS. Figure was 
taken from Neumann and Weidner et al. [35] and modified. 
Similar effects are observed in vitro if reduced EcPOX is subjected to limited proteolysis which causes C-
terminal truncation of the enzyme leading to irreversibly activated EcPOX Δ23. Also amphiphiles like 
detergents and lipids are able to increase the activity to a similar activation level as observed in vivo.  
Although the detailed interaction mechanism of amphiphilic molecules with EcPOX is still unclear [34] 
[13] [36], these substances are apparently applied to mimic the native membrane.  
One of the central conclusions that can be drawn from the model of Neumann and Weidner et al. is that 
the membrane anchor undergoes a conformational transition due to pyruvate conversion, which promotes 
release of the membrane anchor. Additionally, in all three activation modes the exposed membrane 
anchor is either stabilized by the membrane and mimics thereof or removed due to proteolytic digestion. 
Which step of EcPOX catalysis constitutes the initial signal for displacement of the membrane anchor was 
further investigated by limited proteolysis [29] [18] [35]. 
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1.2.4 Limited proteolysis of EcPOX 
Limited proteolysis of EcPOX is an artificial process exclusively observed in vitro and has no relevance for 
EcPOX functionality in vivo [32]. However, it is often used to investigate the activation of EcPOX since 
proteolytically truncated enzyme and lipid-activated EcPOX show similar catalytic enhancements [18]. 
With the help of substrate surrogates, cofactor analogs and artificial reduction by sodium dithionite the 
step of the catalytic mechanism, which controls fundamental membrane anchor release, was identified. 
Flavin reduction is the initial signal for membrane anchor exposure 
Proteolytic digestion of EcPOX was detailed investigated in the past [29] [18] [35] [37]. All findings are 
summarized in a figure from Neumann and Weidner et al. who analyzed EcPOX fragments derived from 
proteolytic cleavage by gel electrophoresis (figure 4 A) [35].  
It was demonstrated that in the absence of pyruvate EcPOX is cleaved at its C-terminal end into a non-
active Δ101 variant and the beta-peptide (101 amino acids). Contrary, incubation with pyruvate prior to 
protease addition leads to the formation of catalytically activated EcPOX Δ23 and the C-terminal alpha-
peptide (23 amino acids).  
 
figure 4: A: SDS-PAGE analysis of proteolytic digestion of EcPOX. 3 mg/mL (51 µM active sites) EcPOX wt were 
subjected to proteolytic digestion (+) with alpha-chymotrypsin (20 µg/ml): in the absence of substrate (resting state), in the 
presence of pyruvate (200 mM), after reaction with 20 mM MAP, reconstituted with 100 µM thiamin thiazolone diphosphate, 
after artificial reduction with 290 µM sodium dithionite under anaerobic conditions. B: Structures of ThDP intermediates of 
the catalytic cycle of EcPOX and mimics thereof. L-ThDP and its related substrate surrogate-ThDP complex 
phosphonolactyl-ThDP. HE-ThDP and the corresponding ThDP analog thiamine thiazolone. R1 and R2 represent the 
aminopyrimidine ring and diphsophate anchor, respectively. Figure A was taken from Neumann and Weidner et al. [35] and 
modified. 
The first step of the catalytic cycle can de simulated by incubation of EcPOX with the pyruvate analogue 
methyl acetyl-phosphonate (MAP) (figure 4 B). Similar to pyruvate MAP covalently binds to ThDP 
yielding a phosphonolactyl-ThDP adduct which mimics the pre-decarboxylation intermediate L-ThDP. 
Since the phosphonate moiety of MAP cannot be cleaved off in contrast to the carboxylic function of 
pyruvate MAP is a potent, covalent and competitive inhibitor. After addition of MAP and alpha-
chymotrypsin EcPOX remains in the uncleaved form indicating that both cleavage sites leading to EcPOX 

































































intermediate) was used instead of thiamine to simulate the post-decarboxylation intermediate (figure 4 B). 
In this case, both cleavage sites are also inaccessible. 
Remarkably, artificial reduction of the flavin by sodium dithionite is sufficient to induce a conformational 
change which leads to exposure of the activating Δ23 cleavage site even in the absence of reactions at the 
thiamine cofactor. However, also slight amounts of EcPOX Δ101 can be detected which implies that 
protection of the inactivating restriction site is not complete in the artificially reduced enzyme. 
A minimal model comprises three conformations of EcPOX  
Combining the obtained results, a minimal model of three different EcPOX conformations can be created 
(figure 5).  
 In the resting state (R) the alpha-peptide is bound to the protein which results in protection of 
the Δ23 cleavage site (EcPOX Y549-M550). Contrary, the Δ101 restriction site (EcPOX K471-
A472) is accessible and the beta-peptide can be truncated by the protease.  
 The substrate-bound state (SB) resembles the formation of covalent ThDP intermediates, while 
the flavin cofactor is still in the oxidized state. These intermediates induce a first structural 
change leading to protection of both cleavage sites and thus to attachment of both alpha- and 
beta-peptide segments.  
 The substrate-reduced state (SR) is induced by electron transfer to FAD which initiates a second 
conformational switch. In this state the beta-peptide part is protein-bound resulting in an 
inaccessible Δ101 cleavage site, whereas the exposed alpha-peptide part leads to accessibility of 
the Δ23 cleavage site.  
Although these three conformations of EcPOX can be fairly characterized by proteolysis studies, the 
underlying molecular mechanism which controls the conformational changes is still unknown. Especially 
amino acid residues which sense the different structural states or which are involved in their 
interconversion were unknown. New insights into the activation mechanism gave the crystal structures of 




figure 5: Minimal model of EcPOX conformations. In the resting state (R) the Δ101 cleavage site is accessible whereas the 
Δ23 restriction site is protected. The substrate-bound state (SB) is induced by formation of covalent ThDP-intermediates, 
while FAD remains unaffected. Both protease cleavage sites are protected. The substrate-reduced state (SR) is formed due to 
reduction of FAD. While the Δ101 cleavage site remains inaccessible, the Δ23 restriction site is exposed. The functional tetramer 
of EcPOX is simplified illustrated as monomer for better visualization. Note that the alpha-peptide is displayed separately from 
the beta-peptide, although the alpha-peptide resembles the C-terminal part of the beta-peptide.     
1.2.5 X-ray structures of EcPOX 
In 2008 Neumann and Weidner et al. succeeded in solving the crystal structure of pyruvate oxidase from 
E. coli [35]. Since it is a peripheral membrane protein it was remarkable that full-length enzyme could be 
crystallized with the complete membrane anchor in absence of any hydrophobic or amphiphilic additives. 
Additionally, the structure of the proteolytically activated form EcPOX Δ23, which typically mimics the 
membrane-bound state of EcPOX, was determined. This allowed a direct comparison and gave new 
insights into the mechanism of EcPOX activation. 
The global structure of EcPOX consists of 4 domains 
The resting-state enzyme crystallized in tetragonal space group P43212 with half of the tetramer per 
asymmetric unit (figure 6 A). The cofactors thiamine diphosphate and FAD are located at the subunit 
interface of a catalytically active dimer implying that the resulting active sites are composed of amino acid 
residues originating also from two subunits. All residues are resolved and only a loop of 12 amino acids 
(residues 466-478) shows poor density indicating higher flexibility of this part.  
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figure 6: Structure of full-length EcPOX. A: Structure of the tetramer. Cofactors are shown in stick representation and 
highlight the position of the active sites at the subunit interface. The catalytic active dimers (α1-α2 and α3-α4) are colored in 
orange and green. B: Domain structure of an EcPOX monomer. The four domains are displayed in different colors. Cofactors 
ThDP and FAD are presented in stick format. Figures were taken from Neumann and Weidner et al. [35]. 
A monomeric structure consists of 3 domains (figure 6 B) also found on other thiamine enzymes [38] [21]. 
The Pyr domain (residues 2-172) harbors the pyrimidine moiety of the ThDP cofactor, whereas the PP-
binding domain (residues 358-530) is responsible for binding of the diphosphate anchor of thiamine with 
the help of a bivalent magnesium ion. The FAD domain (residues 188-323) mediates binding of the flavin 
cofactor. Interestingly, a fourth domain (531-572) is exclusively found in EcPOX which was termed the C-
terminal membrane binding region.  
The proteolytically activated enzyme crystallizes in orthorhombic space group P212121 containing three 
functional tetramers in the asymmetric unit. However, the structure is very similar compared to the 
enzyme in the resting state. Only slight positional deviations are detected within the active site. The 
dominant difference is found in the C-terminal membrane binding region. This part is only defined up to 
Lys539 in EcPOX Δ23, although the protease truncates the C-terminus only at Tyr549 implying a less 
stabilized terminus. Additionally, several residues starting from Glu531 that were previously organized in a 
beta-sheet in full-length EcPOX are now rearranged resulting in an undefined structure (figure 7). Similar 
to the full-length enzyme the loop from residue 466-477 is found to be highly flexible. 
The active site of EcPOX favors decarboxylation and electron transfer to FAD 
The identical active site of the full-length EcPOX is constructed similar to other enzymes of the thiamine 
family. The cofactor ThDP is bound in its typical V-conformation ensuring spatial orientation of the 
reactive C2-atom of the thiazolium ring to the pyrimidine 4’-amino function acting as acid/base 
catalyst [22] [21]. The flavin cofactor is located in close proximity (approximately 12 Å) to the carbon-2 
atom of ThDP. The isoalloxazine ring of FAD is bent by 15°, which is suggested to favor the electron 
transfer reaction since the distortion destabilizes the oxidized form of the flavin [39]. A similar 
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observation can be made for other flavoenzymes like pyruvate oxidase from Lactobacillus plantarum 
(LpPOX) [39] or glucose oxidase from aspergillus niger [40]. Additionally, mainly hydrophobic residues are 
located in the active site which facilitates decarboxylation [41]. 
 
figure 7: Active site accessibility of full-length EcPOX and EcPOX Δ23. The position of the active site is highlighted by the 
cofactors ThDP (yellow) and FAD (green) in stick representation. A: full-length EcPOX (pdb: 3EY9). The linker region (residues 
531-549) of the lipid binding domain is depicted in blue and the alpha-peptide (residues 550-572) is presented in red cartoon 
format. B: EcPOX Δ23. The residual linker domain (residues 531-539) after proteolytic processing is shown in blue. 
EcPOX Δ23 shows improved accessibility to the active site and can accelerate electron transfer  
The main difference between the structure of the full-length protein and the activated form Δ23 is the 
accessibility of the catalytic center (figure 7). In the resting state, the active site is blocked by a helix 
(residues 536-544), which is part of the lipid binding domain. Due to truncation this helix is disordered in 
EcPOX Δ23 which provides improved access to the thiamine and flavin cofactor. This observation 
explains the 8fold decreased Km for pyruvate due to proteolytic activation (full-length EcPOX: 
Km = 90 mM, Δ23 = 12 mM) [35] which clearly indicates an increased affinity for the substrate of the 
proteolytically activated form. Thus, the membrane binding region is proposed to act as autoinhibitory 
domain in the resting state of the enzyme [35]. 
Comparison of active site residues of both enzyme species reveals no significant positional differences of 
central amino acid residues or both cofactors. The only prominent discrepancy is that Phe465, which is 
located in close proximity to both cofactors  in the resting state (approximately 11 Å to C2-atom of 
ThDP), undergoes a conformational transition upon activation (figure 8). It swings between ThDP and 
FAD (approximately 6 Å to C2-atom of ThDP) and is suggested to facilitate electron transfer from 
thiamine to the flavin, which is drastically increased in the proteolytically activated variant (full-length 
EcPOX: 3s-1, EcPOX Δ23: approximately 400 s-1) [42]. This assumption is further supported by structural 
analysis of related thiamine-dependent flavoenzymes. In constitutively activated pyruvate oxidase from 
Lactobacillus plantarum side chain Phe479 occupies the same position like activated Phe465 in EcPOX. 
Remarkably, acetohydroxyacid synthase from yeast contains no corresponding residue at this location and 












Phe465 concomitant with an improved electron transfer could also explain the increased catalytic activity 
upon activation (full-length EcPOX: kcat = 7 s-1, EcPOX Δ23: kcat = 200 s-1) [35].  
figure 8: Structural transition of EcPOX upon proteolytic 
activation. The resting state of EcPOX is depicted in green 
whereas the structure of EcPOX Δ23 is illustrated in yellow. 
The cofactors ThDP and FAD are highlighted as yellow 
sticks. Upon proteolytic activation the linker region of the 
lipid binding domain is rearranged leading to unfolding of the 
helix (green) and beta-strand motif (gray). Further, F465 is 
repositioned and swings between both cofactors to facilitate 
electron transfer from ThDP to FAD. Figure was taken from 
Neumann and Weidner et al. [35]. 
 
 
The full-length enzyme stabilizes the membrane anchor via numerous interactions 
As stated earlier, the C-terminal lipid binding domain of EcPOX is a unique structural element within 
thiamine enzymes. It can be divided into a linker region (residues 531-549), which mainly covers the active 
site, and the alpha-peptide (residues 550-572), which was identified to be the membrane anchor [18] [13, 
35]. In the crystal structure of the resting-state enzyme the membrane binding domain is completely 
traced. Remarkably, the entire domain is attached to the protein surface. At the protein surface of full-
length EcPOX a four-stranded half barrel structure is formed by beta-strands derived from the PP- and 
membrane binding domain (residues 531-534, 552-555, 560-565, and 467-469) (figure 9). Additionally, an 
alpha-helix composed of residues 536-544 can be observed, which is responsible for inaccessibility of the 
active center. The last 8 amino acids of the C-terminus do not show a defined secondary structure.  
Besides the stabilization by the half-barrel motif several interactions support the attachment of the lipid 
binding domain to the protein surface (figure 9). Gln537 of the N-terminal helix forms a hydrogen bond 
with Glu564. Further, a kink in the middle of the alpha-peptide is stabilized by an intramolecular hydrogen 
bond between Asp560 and Ser556. Additionally, the protein core interacts by two prominent salt bridges 
with the center of the membrane anchor (Asp348-Arg558) and the C-terminal edge (Asp328-Arg572).  
All interactions are evenly distributed over the entire membrane binding domain, which ensures 
comprehensive stabilization in the resting state. However, due to the release of the membrane anchor in 
response to flavin reduction it is assumed that the anchor undergoes a structural reorganization to 
facilitate subsequent membrane binding. The conformation of the alpha-peptide competent to bind the 
membrane was recently investigated by Neumann and Weidner [35] [45].  
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figure 9: Structure of the C-terminal lipid 
binding domain of full-length EcPOX. A: 
The lipid binding domain is attached to the 
protein surface of EcPOX (gray) and is 
displayed in cartoon format. The 4-stranded 
half-barrel motif is highlighted in blue and the 
alpha-helix of the linker is depicted in pink. 
The cofactors ThDP and FAD are shown as 
yellow and green spheres. Three prominent 
electrostatic interactions and one hydrogen 
bond, which stabilize the membrane anchor 
to the protein surface, are indicated as red 
dashed lines. B: Primary sequence and 
secondary structure assignments of the lipid 
binding domain. Beta-strands are presented as 
blue arrows whereas the alpha-helix is 
highlighted as red zigzag. Hydrogen bonds 
and salt bridges of selected residues are 





1.2.6 Structural analysis of the membrane anchor of EcPOX 
The crystal structure of the resting-state enzyme reveals that the protein-bound form of the membrane 
anchor (residues 550-572) shows two beta-strand elements and loop structures (figure 9) [35]. However, it 
remains to be analyzed how the single peptide can mediate membrane binding of EcPOX. Since analysis 
of the primary amino acid sequence predicts an amphipathic helix conformation for the alpha-peptide part 
it was suggested that the helical structure resembles the membrane-associated form of the alpha-
peptide [29].  
This assumption was further proved by Neumann and Weidner who demonstrated that the isolated alpha-
peptide adopts a random-like structure if dissolved in buffer (helix content 0 %), but forms an alpha-helix 
in the presence of SDS micelles (helix content 33 %) [35] [45]. Further studies of the isolated alpha-
peptide by liquid-state nuclear magnetic resonance (NMR) spectroscopy supported the previous 
findings [45]. Here, the structure of the peptide was solved on a molecular level in the presence of 
deuterated SDS micelles, which can be used to mimic a membrane [46].  
The alpha-peptide shows a characteristic asymmetric structure typical for amphipathic helices (figure 10). 
Polar and negatively charged residues are located at one half of the helical axis whereas hydrophobic 
amino acids and positively charged side chains contribute to the opposite site. Since the surface of SDS 
micelles consists of negatively charged sulfate groups it was supposed that the peptide binds to the 
micelles with the hydrophobic and positively charged face [45]. Noteworthy, the helix is marginally 
extended and the helical axis is slightly bended. These effects can be related to the high surface curvature 
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figure 10: Structure of the isolated alpha-peptide in the presence of deuterated SDS micelles. 1 mM of the alpha-peptide 
was incubated with 150 mM deuterated SDS and analyzed by liquid-state NMR. Yellow color highlights positively charged and 
hydrophobic residues of one helix site; green color represent negatively charged and hydrophobic amino acids of the opposite 
face. Figure was taken from Weidner [45]. 
In summary, the membrane anchor of EcPOX can adopt at least two different conformations. The 
protein-bound form is characterized by beta-strands and loop structures, whereas the membrane-bound 
peptide (in the presence of SDS micelles) can form an amphipathic helix.  
Reversible membrane binding via amphipathic helices is not only observed for EcPOX, but it is a 
common principle of peripheral membrane proteins. 
1.2.7 Membrane binding via amphipathic helices 
Amphitropic membrane proteins can localize in two compartments 
In 1988 Burn described amphitropic proteins to be a new class of membrane proteins [49]. In contrast to 
traditional integral membrane proteins, localization of amphitropic or peripheral membrane proteins is not 
restricted to the lipid bilayer since these proteins are also found in the aqueous compartment. Their ability 
to associate to the membrane is reversible and a subject of regulation [50]. Several peripheral membrane 
proteins are localized in the aqueous compartment and undergo a conformational transition, which 
promotes membrane binding [51] [52]. Once attached to the lipid bilayer their catalytic function is often 
accelerated [53], they assemble with other proteins [54] or have access to lipophilic substrates [55].  
Amphipathic helices as membrane binding mediators 
A common feature of peripheral proteins to associate to the membrane is via amphipathic helices. These 
helices are characterized by a structural asymmetry with one lipophilic face containing mostly hydrophobic 
residues and an opposite face harboring polar amino acids [56]. The resulting electrostatic asymmetry 
allows parallel partition into the bilayer where the hydrophobic part of the helix penetrates the membrane 
and the polar surface of the helix can interact with lipid head groups and the aqueous 
compartment [56] [57].  
Membrane binding of amphipathic helices requires electrostatic and hydrophobic interactions with the 
lipids and can be described as a two-step process [50]. First, electrostatic interactions are mandatory to 
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attract the protein from the bulk solvent and bring it in spatial vicinity to the bilayer surface. Positively 
charged amino acids contribute to this process [58] [59] which explains the preference of amphipathic 
helices to bind to anionic phospholipids [56]. The second step includes the integration of the helix into the 
membrane by hydrophobic contacts [60]. For most peripheral membrane proteins the hydrophobic part is 
dominant over the electrostatic and thus the driving force for membrane insertion  [56]. 
Interestingly, some amphipathic helices also contain negatively charged amino acids which would lead to 
unfavored electrostatic repulsion with the negatively charged lipid head groups if the helix is inserted deep 
enough into the membrane. The detailed function of these residues is questionable so far, but it was 
reported that they might serve as charge sensor to mediate selectivity [58] [61]. Additionally one can 
speculate that they are involved in the dissociation process of the helix to ensure reversibility.   
Often lipid molecules do not only provide a hydrophobic surface, but they are actively involved in the 
pivotal structural change of amphipathic helices. Many of these helices are unstructured in an aqueous 
compartment and undergo a disorder-order transition due to contact with membranes. Therefore, lipids 
are supposed to either stabilize the amphipathic structure [57] [62] or can actively catalyze the folding 
process [63]. 
1.2.8 The electron transfer to Q8 – a challenging task 
The catalytic cycle of EcPOX is completed by a final two-electron transfer from the reduced flavin 
cofactor to Q8 [17]. However, this redox reaction includes not only simple shuffling of reducing 
equivalents between donor (FADH2) and acceptor (Q8), but also translocation of the hitherto cytosolic 
enzyme to the cell membrane to provide access to Q8. This is ensured by the alpha-peptide which forms 
an amphipathic helix in the presence of lipids [35] [45] (chapter 1.2.6). Embedding of this helix into the 
lipid bilayer shortens the distance between active site-flavin and Q8. However, detailed insights how the 
electron transfer reaction proceeds after membrane binding are still missing. According to Forneris and 
Mattevi two strategies of substrate-binding modes can be discussed for EcPOX [64]. 
Enigma of enzymatic reactions combining hydrophobic and hydrophilic substrates 
Forneris and Mattevi described the challenge to enzymes to convert substrates originating from opposite 
compartments [64]. They mainly focused on different concepts of enzymes which combine catalysis of 
hydrophilic water with lipophilic substrates dissolved in the cellular membrane. Two interaction modes 
described by Forneris and Mattevi can also be supposed for EcPOX (figure 11): 
A: Desorb-and-modify. The active site of the protein is located in the aqueous compartment and the 
lipophilic substrate is extracted from the bilayer by hydrophobic tunnels or cavities. The 
mechanism of substrate desorption is poorly understood but often the membrane binding 
mediator of the enzyme is involved. 
B: Working at the interface. The catalytic center is precisely located at the membrane surface allowing 
both hydrophobic and hydrophilic substrates to stay in their original environment during catalysis. 
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figure 11: Catalytic strategies 
used by enzymes to convert 
hydrophobic and hydrophilic 
substrates. A: Desorb-and-
modify. B: Working at the 
interface. Detailed descriptions 
are given in the text. Figure was 
taken from Forneris and 
Mattevi [64]. 
 
Influence of the substrate-interaction mode on the electron transfer of EcPOX 
Based on the two possible concepts for the interaction of cytosolic EcPOX with lipophilic ubiquinone, the 
mechanism of electron transfer to Q8 could also be determined. According to desorb-and-modify, the 
benzoquinone moiety of Q8 could stick partially out of the membrane to enter the active site, whereas the 
isoprenoid tail is still in contact with the lipid bilayer. Interaction of FADH2 with Q8 could support a 
direct electron transfer via tunneling which can be roughly described as a single transfer step 
(figure 12) [65]. Since electron tunneling rates decrease exponentially with the distance of both redox 
centers, this mechanism becomes unlikely if an edge-to-edge distance of  14 Å between flavin and the 
ubiquinone head group is exceeded [66] [67]. The second opportunity, working at the interface, would require 
ubiquinone to stay in the membrane. Here, hopping of electrons from FADH2 to Q8 has to take place 
since the active site is not directly located at the membrane-cytosol interface. Hopping can be simplified 
illustrated as multiple electron transfer steps (or hops) between donors and acceptors  (figure 12) [65]. 
One or more intermediates are involved that transiently stabilize electrons. Therefore, the protein matrix 
could provide temporary electron storage places. Given that both electrons transfer mechanism from the 
reduced flavin to Q8 can occur in EcPOX further analysis is required to understand this puzzling process. 
figure 12: Scheme of possible electron transfer 
mechanisms for EcPOX. A: Electron tunneling. 
Electrons are directly transferred from FADH2 to 
Q8. B: Electron hopping. Electrons are transferred 
by multiple steps from FADH2 to Q8. X resembles 




















1.2.9 EcPOX and its reactivity towards oxygen 
Since the final catalytic step in EcPOX is the electron transfer from reduced flavin to Q8 and not to 
oxygen the name “pyruvate oxidase” is misleading. Oxygen can replace the electron acceptor Q8 just in a 
minor side reaction in EcPOX [45]. Thus, EcPOX shares characteristic features of dehydrogensases [68].  
Classification of flavoenzymes 
Flavoenzymes are ubiquitously distributed and involved in versatile processes like electron transfers [69], 
dehydrogenations [70], halogenations [71], and even protein folding [72]. According to their reactivity 
towards oxygen or electron acceptors three groups of flavoenzymes can be distinguished [68] (figure 13): 
A: Dehydrogenases react slowly or not at all with oxygen and typically regenerate the reduced flavin 
cofactor by electron transfer to small molecules like ubiquinones.  
B: Oxidases catalyze rapid electron transfer to oxygen yielding hydrogen peroxide as product.  
C: Monooxygenases also show fast reaction with oxygen and formation of a stable C4a-peroxyflavin-
intermediate. Subsequently, monooxygenases incorporate one oxygen atom into the substrate. 
 
figure 13: Classification of flavoenzymes according to their reactivity towards oxygen. Prior to oxygen reaction the flavin 
cofactor is reduced during catalysis. Subsequently, dehydrogenases do not react with oxygen but rather reoxidize their flavin using 
small electron acceptors like ubiquinones (Q). Oxidases utilize oxygen for flavin regeneration yielding hydrogen peroxide. 
Monooxygenases form a (hydro)peroxyflavin-intermediate with oxygen and subsequently insert one oxygen atom into the 
substrate leading to water as second product. The N5- and C4a-atom involved in flavin redox reactions are colored red and blue. 
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Does Tyr278 regulate oxygen reactivity in EcPOX? 
According to the previously discussed flavoenzyme groups EcPOX can be classified as dehydrogenase 
which utilizes small electron acceptors like quinones for flavin regeneration. Interestingly, pyruvate 
oxidase from Lactobacillus plantarum (LpPOX), which is closely related to EcPOX, is a functional oxidase 
[73]. LpPOX is also a thiamine-dependent flavoenzyme and utilizes pyruvate as substrate in a similar 
reaction to EcPOX (figure 14 A and figure 41) [74]. However, the energy-conserving step in LpPOX is the 
formation of high-energy acetyl phosphate. The two arising reducing equivalents are only transferred to 
oxygen yielding hydrogen peroxide as waste product [75]. The product acetyl phosphate is further utilized 
by substrate-level phosphorylation to generate ATP since Lactobilli contain no respiratory chain in contrast 
to Enterobacteria [76]. 
Since both enzymes have similar catalytic sites the question arises how each enzyme promotes its 
individual catalytic reaction in a similar constructed environment. Comparison of the catalytic centers 
reveals that a central difference is observed near the reactive N5- and C4a-atom of the flavin cofactor. 
While EcPOX contains Tyr278 at this position, Phe289 is found in LpPOX (figure 14 B). One can 
speculate that Tyr278 suppresses oxidase activity in EcPOX since it is positioned to effectively shield the 
N5-position of the flavin cofactor against oxygen attack. This idea is supported by other reports about 
flavoenzymes which showed that particularly the local environment and access to the reactive N5-locus 
controls reactivity with oxygen [77] [78].  
 
figure 14: Comparison of EcPOX and LpPOX. A: Net reactions of EcPOX and LpPOX. Both enzymes catalyze the oxidative 
decarboxylation of pyruvate. However, they differ in the energy-conserving step which is the reduction of Q8 for EcPOX and the 
formation of acetyl phosphate for LpPOX. B: Selected amino acids near flavin N5- and C4a-atom of LpPOX and EcPOX. 
Structures of EcPOX wt (pdb: 3EY9) and LpPOX wt (unpublished high-resolution structure at 1.09 Å, friendly provided by Dr. 





pyruvate +  Q8 +  H2O     → CO2 +  acetate +  Q8H2
LpPOX:   




Aim of this thesis is to elucidate the molecular mechanism which controls activation and membrane 
binding of the peripheral membrane protein pyruvate oxidase from E. coli (EcPOX). Activation of EcPOX 
is initiated by reduction of the flavin cofactor at elevated concentrations of pyruvate. This induces 
cytosolic exposure of the hitherto protein-associated membrane anchor and triggers membrane binding. 
Association to the lipid bilayer promotes accessibility to Q8 and accelerates the catalytic activity of EcPOX 
by several orders of magnitude. To analyze the activation and subsequent membrane binding process of 
EcPOX four main topics are addressed in this thesis: 
1. How is the initial signal for membrane anchor release perceived and how is this information 
transferred from the reduced flavin cofactor at the active site to the membrane anchor at the 
protein surface? 
This question should be answered by a detailed structural and mechanistic analysis of the protein variants 
Y278F, F465A, Y549A and F260A (figure 15 A). Tyr278 could sense the redox state via a hydrogen bond 
to the redox-active N5-atom of the flavin. Phe465 swings between both cofactors due to proteolytic 
activation and facilitates electron transfer to FAD. In cooperation with Tyr549 Phe465 is suggested to 
initiate membrane anchor exposure since the activated conformation of Phe465 would clash with Tyr549. 
This might lead to repulsion of Tyr549 out of the active site and subsequent destabilization of the entire 
membrane anchor. A similar function can be supposed for Phe260 which shows an alternative 
conformation after proteolytic digestion. Interconversion between both orientations would collide with 
Ile554 and Leu565 of the membrane anchor which might promote membrane anchor release 
(figure 15 A).   
2. How is the membrane anchor stabilized at the protein surface and in the membrane-bound form?  
To study this topic the following variants should be generated: 3x (D328A, D348A, Q537A), F260A, 
I554A/G, L565A/G, W570A/G and the double mutant 2G (I554G, L565G). While the triple mutant 3x 
lacks electrostatic interactions and hydrogen bonds to the membrane anchor (figure 15 B), the other 
variants show decreased hydrophobic contacts (figure 15 C and D). Note that amino acid exchanges of 
EcPOX 3x and F260A change the protein part, while I554A/G, L565A/G, 2G and W570G alter the 
primary sequence of the membrane anchor itself.  
Additionally, the structural determination of the isolated membrane anchor (alpha-peptide) in the presence 
of different membrane mimics and compositions should be examined by far-UV CD spectroscopy and 
NMR spectroscopy. 
3. How are the electrons transferred from the reduced flavin cofactor to membrane-dissolved Q8? 
A direct interaction of Q8 with the active site of EcPOX should be elucidated by X-ray crystallography of 
an EcPOX Δ23:ubiquinone complex. 
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4. How can the protein matrix of EcPOX suppress unfavored electron transfer to oxygen? 
Tyr278 is predicted to prevent oxygen reactivity of EcPOX by its interaction with the reactive N5- and 
C4a-locus of FAD. Reciprocal mutations of EcPOX (Y278F) and LpPOX (F289Y), an enzyme which 
utilizes oxygen as substrate, should prove this hypothesis (figure 14). 
 
 
figure 15: Active site rearrangements during proteolysis and potential interactions of the membrane anchor with the 
protein surface of EcPOX. The entire membrane binding domain is represented as colored cartoon where beta-strands are 
shown in blue and the alpha-helix is depicted in red. The cofactors ThDP and FAD are either presented as yellow and green lines 
(A) or shown as gray spheres (B-D) and highlight the active site. Conformational changes due to proteolytic activation are 
indicated by red arrows.  
A: Active site rearrangements due to proteolytic activation. Amino acids potentially involved in the signal transfer process are 
shown as green (resting-state EcPOX) and blue (Δ23) sticks. A hydrogen bond between Y278 and N5-flavin is indicated as red 
dashed line. B: Membrane anchor stabilization at the protein. The alpha-peptide is stabilized at the protein by two salt bridges 
(D328-R572 and D348-R558) and one hydrogen bond (E564-Q537) indicated as red dashed lines. Central amino acids of the 
protein surface are shown as green sticks whereas interaction partners of the membrane anchor are presented as green lines. C: 
Potential hydrophobic interactions of the membrane anchor with the protein surface. Central amino acids are shown as green 
(resting-state EcPOX) and blue (Δ23) sticks. D: The pocket which stabilizes W570 (green sticks) at the protein surface is 
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3. Materials and Methods 
Media, buffers, and solutions were prepared with double-deionized water. All chemicals used in this thesis 
were assigned to be of highest purity. 
3.1 Chemicals 
acetic acid     Carl Roth GmbH & Co. KG, Karlsruhe 
acetonitrile (HPLC gradient grade)  Fischer Scientific UK Ltd., Loughborough 
acrylamide (30 %) 37.5:1    Carl Roth GmbH & Co. KG, Karlsruhe 
agar-agar     AppliChem GmbH, Darmstadt 
albumin fraction V    AppliChem GmbH, Darmstadt 
ammonium chloride    Carl Roth GmbH & Co. KG, Karlsruhe 
15N-ammonium chloride (99 %)   Euriso-Top, Saint-Aubin Cedex 
ammonium peroxodisulfate   Carl Roth GmbH & Co. KG, Karlsruhe 
ammonium sulfate    Carl Roth GmbH & Co. KG, Karlsruhe 
ampicillin     AppliChem GmbH, Darmstadt 
aprotinin     AppliChem GmbH, Darmstadt 
beta-mercaptoethanol    Carl Roth GmbH & Co. KG, Karlsruhe 
BME vitamins 100x solution   Sigma-Aldrich Chemie GmbH, Munich 
bromophenol blue    AppliChem GmbH, Darmstadt 
BugBuster master mix    Merck KGaA, Darmstadt 
calcium chloride dihydrate   Carl Roth GmbH & Co. KG, Karlsruhe 
coomassie brilliant blue G250   AppliChem GmbH, Darmstadt 
2,6-dichlorphenolindophenol   Merck KGaA, Darmstadt 
dithiothreitol      AppliChem GmbH, Darmstadt 
n-dodecyl phosphocholine (DPC)  Avanti Polar Lipids, USA 
ethylene glycol     Sigma-Aldrich Chemie GmbH, Munich 
flavin adenine dinucleotide (FAD)  Sigma-Aldrich Chemie GmbH, Munich 
flavin mononucleotide (FMN)   Sigma-Aldrich Chemie GmbH, Munich 
D(+)-glucose     AppliChem GmbH, Darmstadt 
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13C- D(+)-glucose (99 %)   Euriso-Top, Saint-Aubin Cedex 
glycerole     AppliChem GmbH, Darmstadt 
hexylene glycol (MPD)    Sigma-Aldrich Chemie GmbH, Munich 
imidazole     AppliChem GmbH, Darmstadt 
isopropyl β-D-thiogalactopyranoside (IPTG) AppliChem GmbH, Darmstadt   
kanamycine sulfate    Carl Roth GmbH & Co. KG, Karlsruhe 
D(+)-lactose     AppliChem GmbH, Darmstadt 
magnesium sulfate (heptahydrate)  Carl Roth GmbH & Co. KG, Karlsruhe 
methanol     Sigma-Aldrich Chemie GmbH, Munich 
polyethylene glycole 2000 (PEG 2000)  Merck KGaA, Darmstadt 
potassium dihydrogen phosphate  Carl Roth GmbH & Co. KG, Karlsruhe 
potassium hexacyanoferrate (III)   Riedel de Haën, Seelze 
potassium pyruvate    Sigma-Aldrich Chemie GmbH, Munich 
protamine sulfate    Sigma-Aldrich Chemie GmbH, Munich 
sodium chloride     Carl Roth GmbH & Co. KG, Karlsruhe 
sodium dihydrogen phosphate dihydrate  Carl Roth GmbH & Co. KG, Karlsruhe 
sodium dodecyl sulfate (SDS)   AppliChem GmbH, Darmstadt 
sodium hydroxide    AppliChem GmbH, Darmstadt 
streptomycin sulfate    AppliChem GmbH, Darmstadt 
tetramethylethylenediamine (TEMED)  Carl Roth GmbH & Co. KG, Karlsruhe 
thiamine diphosphate    Sigma-Aldrich Chemie GmbH, Munich 
thiamine hydrochloride    AppliChem GmbH, Darmstadt 
trifluoroacetic acid (HPLC grade) (TFA)  AppliChem GmbH, Darmstadt 
2,2,2-trifluoroethanol    Carl Roth GmbH & Co. KG, Karlsruhe 
tryptone     AppliChem GmbH, Darmstadt 
ubiquinone-0, ubiquinone-1, ubiquinone-2 Sigma-Aldrich Chemie GmbH, Munich 
yeast extracts     AppliChem GmbH, Darmstadt 
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3.2 Proteins and Enzymes 
alpha-chymotrypsin (from bovine pancreas, AppliChem GmbH, Darmstadt 
1600 U/mg) 
DNase I (5811 U/mg)    AppliChem GmbH, Darmstadt 
Dpn I (10 U/µL)    Fermentas, St. Leon-Rot 
glucose oxidase (from Aspergillus niger,  Sigma-Aldrich Chemie GmbH, Munich 
17300 U/g) 
lysozyme (25000 U/mg)    AppliChem GmbH, Darmstadt 
Phusion F-530S (2 U/µL)   Thermo Scientific GmbH, Schwerte 
SUMO-protease (16.1 µM)   friendly provided by Dr. Stefan Lüdtke 
 
3.3 Devices 
Centrifuges:      Universal 320R  Hettich AG, Bach, Switzerland 
                         AvantiJ-30I Beckmann Coulter GmbH, Krefeld 
                         AvantiJ-20XPI  Beckmann Coulter GmbH, Krefeld 
                         Biofuge Pico UniEquip GmbH, Martinsried 
Chirascan  CD spectrometer Applied Photophysics Ltd., UK 
Electrophorese device, EV 231   Consort nv, Belgium 
Electroporator, MicroPulser electroporator  Bio-Rad Laboratories GmbH, Munich 
FPLC-Systems: ÄKTAprime plus, ÄKTApurifier  GE Healthcare 
HPLC-System: DG-2080-54 4-line degasser,  
                        LC-Net II/ADC,  
                        PU-2086 Plus intelligent prep. Pump, 
                        UV-2077 4-λ Plus intelligent UV-Vis 
                        detector 
Jasco, Gross-Umstadt 
                        Rheodyne 7725(i) manuel sample injector IDEX Health & Science, USA 
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Incubation shaker, Unitron  Infors AG, Bottmingen, Switzerland 
ITC-System, ITC200  GE Healthcare 
Lyophilizer Lyovac GT3  Lyotech, Griesheim 
Microfluidizer, M-110S Small Volume Pneumatic  Microfluidics (Division of MFIC Corp.), USA 
Nanodrop 2000  Thermo scientific 
pH electrode   Mettler Toledo, Gießen 
SX.20 Stopped-flow spectrometer  Applied Photophysics Ltd., UK 
Thermoblock, Digital Dry Bath 3721D   Fisher Bioblock Scientific, UK 
Thermocycler, TProfessional Standard 96 well Gradient Whatman BiometraR, Göttingen 
X-ray: MM-007 rotating-anode generator,  
          Micromax 007- HF X-stream 2000,  
          R-AXIS IV++ imaging-plate system 
Rikagu Corp., USA 
UV-Vis Spectrometer, V-650  Jasco GmbH, Groß-Umstadt 
 
3.4 Commodities and Columns 
Columns:  HiLoad Superdex 200 (16/60, 120 mL), 
                 HiLoad Q-Sepharose (26/10, 50 mL), 
                 HisTrap FF (5 mL), 
                 HiTrap Desalting (5 mL)  
                 Nucleosil C18 120-5, 250 x 2 mm, 
                 Nucleosil C18 120-5, 250 x 4 mm 




Macherey & Nagel, Düren 
 
Crystallization cover plates, 18 mm  VWR International GmbH, Darmstadt 
Crystallization plates (24 well), costar  Corning, Inc., USA 
Vivaspin 20 MWCO 50 and 10 Sartorius, Göttingen 
Vivaspin 20 diafiltration cups Sartorius, Göttingen 
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3.5 E. coli strains  
The following E. coli strains were used for plasmid amplification or protein expression (table 1). E. coli 
strain C600 contained an additional plasmid pFDX500Δdra, which encodes for the lac-repressor with an 
additional kanamycin resistance [79]. 
table 1: E. coli strains used in this thesis. 
E. coli strains genotype source 
E. coli ZK126 F- W3110 tna2 ββα Δlac U169 Prof. Dr. R. Kolter, USA 
E. coli BL 21 (DE3) F- ompT gal dcm lon hsdSB (rB- mB-) λ(DE3 [lacI lacUV5-T7 gene 1 ind1 
sam7 nin5]) 
Novagen, USA 
E. coli XL-1 blue F’endA1 gyrA96(nalR) thi-1 recA1 lac glnV44  [::Tn10 pro AB+ lacIq 
Δ(lacZ)M15] hsdR17(rK- mK+) 
Stratagene, USA 
E. coli C600 F- glpR200(glpc) thiE1 thr-1 leuB6(Am) lacY1 glnV44(AS) rfbC1 
fhuA21 λ-  
Stratagene, USA 
3.6 Plasmids 
The following plasmids were used for protein expression as well as templates for site-directed mutagenesis 
(table 2). The poxB gene encoding for EcPOX wt was located on the pYYC102 plasmid. LpPOX was 
expressed or mutated using the vector pBP 200. Expression of the isolated alpha-peptide was performed 
as SUMO (small ubiquitin-like modifier) fusion construct using the pET SUMO-alpha plasmid.  
table 2: Vectors used in this thesis. 
plasmid characteristics resistance source 
pYYC102 poxB gene encodes for EcPOX 
expression 
ampicillinR friendly provided by Prof. Dr. John E. 
Cronan, USA 
pET SUMO-alpha expression of SUMO-alpha fusion 
construct 
kanamycinR friendly provided by Dr. Annett Weidner, 
Martin-Luther-University Halle-Wittenberg 
[45] 
pBP 200 Expression of LpPOX ampicillinR friendly provided by Dr. Danilo Meyer, 
Georg-August-University Göttingen [80] 
3.7 Site-directed mutagenesis 
To introduce specific amino acid exchanges within the sequence of EcPOX and LpPOX, site-directed 
mutagenesis was used. Variants were generated according to the QuikChange-Kit (Stratagene, USA) with 
oligonucleotides containing the mutated nucleotides (table 3, synthesized at Sigma Aldrich). Based on the 
native sequence mutations were introduced using polymerase chain reaction following the protocol of the 
Phusion F-530S polymerase (Thermo Scientific, Schwerte). Double and triple variants were generated 
starting with a single or double mutated plasmid as template. Plasmid pYYC102 F465A encoding for the 
variant EcPOX F465A was friendly provided by Dr. Annett Weidner (Martin-Luther-University Halle-
Wittenberg [45]). 
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table 3: Oligonucleotides used in this thesis. Underlined codons resemble the substituted amino acids. 
oligonucleotide sequence 5’ → 3’ 
EcPOX D328A forward GGAAGAAAAAGCCGCTCGCAAGTTTCTG 
EcPOX D328A reverse CAGAAACTTGCGAGCGGCTTTTTCTTCC 
EcPOX D348A forward CGCAAAGGGCTGGACGCTTTAGCTAAACC 
EcPOX D348A reverse GGTTTAGCTAAAGCGTCCAGCCCTTTGCG 
EcPOX Q537A forward GTTAGCCATTCCACCGGCGATCAAACTCG 
EcPOX Q537A reverse CGAGTTTGATCGCCGGTGGAATGGCTAAC 
EcPOX F260A forward CGGCTTCTCGTCAGGTGCCCATACCATGATG 
EcPOX F260A reverse CATCATGGTATGGGCACCTGACGAGAAGCCG 
EcPOX L565A forward GGTGATGAAGTGATCGAAGCGGCGAAAACAAAC 
EcPOX L565A reverse GTTTGTTTTCGCCGCTTCGATCACTTCATCACC 
EcPOX L565G forward GGTGATGAAGTGATCGAAGGGGCGAAAACAAAC 
EcPOX L565G reverse GTTTGTTTTCGCCCCTTCGATCACTTCATCACC 
EcPOX I554A forward ATGCTGCGCGCAGCCATCAGCGGACG 
EcPOX I554A reverse CGTCCGCTGATGGCTGCGCGCAGCAT 
EcPOX I554G forward ATGCTGCGCGCAGGCATCAGCGGACG 
EcPOX I554G reverse CGTCCGCTGATGCCTGCGCGCAGCAT 
EcPOX Y549A forward GGCCAAAGGTTTCAGCCTGGCGATGCTGC 
EcPOX Y549A reverse GCAGCATCGCCAGGCTGAAACCTTTGGCC 
EcPOX W570G forward CGAAAACAAACGGGCTAAGGTAGAGC 
EcPOX W570G reverse GCTCTACCTTAGCCCGTTTGTTTTCG 
EcPOX Y278F forward CACGCAATTTCCCTTCCGCGCCTTC 
EcPOX Y278F reverse GAAGGCGCGGAAGGGAAATTGCGTG 
LpPOX F289Y forward GGTAATAATTATCCGTATGCAGAAGTTTCCAAAGC 
LpPOX F289Y reverse GCTTTGGAAACTTCTGCATACGGATAATTATTACC 
EcPOX sequencing 1 reverse GCCGTTGATTAAGTGCAGGT 
EcPOX sequencing 2 forward GTCTTAATCGCATGGGCACCAT 
EcPOX sequencing 3 forward TGCGCGGTAAAGAACATGTC 
EcPOX sequencing 4 forward TCTCAGTAGTGCAGATGAAA 
LpPOX seq 1369-1389 forward TTGGCGACGCAAGTTCAATAC 
LpPOX seq 866-885 forward TTGCAGAAGTTTCCAAAGCG 
LpPOX seq 567-589 forward TCAAACGCCGTTATTACCAGAAC 
LpPOX seq 251-273 forward GACCTGGTGGCACTCATCTTATG 
LpPOX seq 505-522 reverse CCATGGTAAATCGACTGG 
SUMO-alpha sequence reverse AGCTAGTTATTGCTCAGCGG 
 
After the mutagenesis reaction the template plasmid was digested using Dpn I (10 U/µl, overnight at 
room temperature). The PCR product was transformed into competent E. coli XL-1 blue cells via 
electroporation [81]. Clones containing the mutated plasmid were selected on LB-agar plates 
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supplemented with the corresponding antibiotics. Plasmid DNA was isolated from an overnight culture of 
transfected E. coli XL-1 blue cells using the Qiaprep Spin Miniprep Kit (Qiagen, Hilden). Successful 
introduction of mutations was verified by DNA sequencing at SEQLAB (SEQLAB Sequence-
Laboratories GmbH, Göttingen). Plasmids with the correct mutations were finally transformed into 
electrocompetent E. coli cells (E. coli ZK126 cells for EcPOX, E.coli C600 cells for LpPOX). 
3.8 Expression of EcPOX 
EcPOX wt and variants were expressed in E. coli ZK126 cells with the plasmid pYYC102 as already 
described [82]. Using this plasmid protein expression was auto-induced by rpoS gene encoded σS-factor, a 
growth factor which is expressed in the early stationary phase. Therefore, an overnight pre-culture was 
used to inoculate 6 x 1 L LB-media (10 g/L tryptone, 5 g/L yeast extract, 5 g/L NaCl, 100 mg/L 
ampicillin) to an OD600 of 0.1. Cells were grown at 37 °C and 200 rpm and harvested by centrifugation 
(4000 x g, 4 °C, 30 min) after 16-20 hours. The cells were flash-frozen with liquid nitrogen and stored 
at - 20 °C. 20-30 g cells were obtained from 6 L media. 
3.9 Purification of EcPOX 
EcPOX wt and variants were purified according to an already established protocol [82] with slight 
modification. Usually, 10 g cells were resuspended in 30 mL low salt buffer (20 mM KH2PO4 pH 6.5) 
supplemented with 100 µM FAD and disrupted by three passages through a microfluidizer. Cell debris 
was removed by centrifugation (70000 x g, 8 °C, 30 min). 0.5 % (w/v) streptomycin sulfate was added to 
the supernatant and incubated for 30 min at 4 °C to precipitate nucleic acids. After a second 
centrifugation step (70000 x g, 8 °C, 30 min) the supernatant was subjected to a heat precipitation step 
(3 min at 65 °C). Afterwards, the solution was cooled immediately and centrifuged (70000 x g, 8 °C, 
30 min). The supernatant was loaded onto a Q-Sepharose anion exchange column, which was equilibrated 
with low salt buffer before. Unbound proteins were removed by a washing step of 30 % high salt buffer 
(300 mM KH2PO4 pH 6.5). EcPOX was eluted from the Q-Sepharose by a linear gradient of 30-100 % 
high salt buffer over six column volumes. Fractions containing EcPOX were analyzed by SDS-PAGE and 
combined. Homogenous protein fractions were concentrated up to 30-50 mg/mL with a Vivaspin 
concentrator (molecular weight cut off 50 kDa) and stored at -20 °C. Fractions containing impure EcPOX 
were also concentrated and afterwards loaded onto a HiTrap Superdex-200 gel filtration column pre-
equilibrated with high salt buffer. The protein was eluted with high salt buffer and analyzed by SDS-
PAGE. Fractions containing pure EcPOX were concentrated like described before and stored at -20 °C. 
The overall amount of pure EcPOX wt and variants was typically 30-50 mg/L media. 
3.10 Expression of LpPOX 
LpPOX wt and variants were expressed in E.coli C600 cells relying on an already established protocol [83]. 
Briefly, an overnight culture was used to inoculate 6 x 0.7 L TBY-media ( 10 g/L tryptone, 5 g/L yeast 
extract, 100 mM KH2PO4, 100 µM MgSO4, 100 mg/L ampicillin, 50 mg/L kanamycin sulfate) 
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supplemented with the cofactor precursors thiamine hydrochloride (37 mg/L) and flavin mononucleotide 
(30 mg/L), which should increase the expression of LpPOX. Cells were cultivated at 28 °C and 200 rpm. 
Expression was induced by the addition of 15 g/L lactose and cells were harvested by centrifugation (4000 
x g, 4 °C, 30 min) after 16-20 hours. Typically, 6 g cells were obtained per L media. 
3.11 Purification of LpPOX 
According to Wille et al. [83] 25 g of cells were resuspended in 40 mL low salt buffer (20 mM KH2PO4 pH 
6.0, 1 mM MgSO4, 100 µM ThDP) supplemented with 20 µM FAD and disrupted by 3 passages through a 
microfliudizer. Cell debris was removed by centrifugation (70000 x g, 8 °C, 30 min). Streptomycin sulfate 
(0.8 % (w/v)) was added to the supernatant, which was subsequently incubated for 30 min at 4 °C with 
constant stirring. Precipitated nucleic acids were removed by centrifugation (70000 x g, 8 °C, 30 min). The 
supernatant was subjected to a fractionated ammonium sulfate precipitation between 23-33 % (w/v). The 
resulting pellet was dissolved in low salt buffer and dialyzed over night at 4 °C against low salt buffer. The 
obtained protein solution was then loaded onto a Q-Sepharose anion exchange column, which was 
previously equilibrated with low salt buffer. Unbound proteins were removed from the column with low 
salt buffer. LpPOX was eluted with a linear gradient from 0-100 % high salt buffer (150 mM KH2PO4 pH 
6.0, 1 mM MgSO4, 100 µM ThDP) with 3 column volumes. Fractions containing LpPOX were analyzed 
by SDS-PAGE and combined. The protein was concentrated by a Vivaspin concentrator (molecular 
weight cut off 30 kDa) up to a volume of 2 mL. The obtained protein concentrate was subsequently 
loaded onto a HiTrap Superdex-200 gel filtration column, pre-equilibrated with buffer containing 200 mM 
KH2PO4 pH 6.0, 1 mM MgSO4, 100 µm ThDP. LpPOX was eluted with the same buffer and fractions 
were analyzed by SDS-PAGE. Fractions containing LpPOX were combined and concentrated up to 10-30 
mg/mL. The final concentrate of LpPOX was flash-frozen with liquid nitrogen and stored at -20 °C. 25 g 
cells led finally to 36 mg of LpPOX. 
3.12 Expression of non-labeled SUMO-alpha fusion construct 
The SUMO-alpha fusion construct was expressed in E. coli BL21 (DE3) cells containing the plasmid pET 
SUMO-alpha. A pre-culture was used to inoculate 6 x 1 L LB-media (10 g/L tryptone, 5 g/L yeast extract, 
5 g/L NaCl, 50 mg/L kanamycin sulfate) to an OD600 of 0.1. Cells were grown at 37 °C and 200 rpm until 
an OD600 of 1 was reached. Expression of the SUMO-fusion protein was induced by the addition of 1 
mM IPTG. After 4 hours cells were harvested (4000 x g, 4 °C, 30 min), flash-frozen with liquid nitrogen 
and stored at -20 °C. Typically, 20 g cells were obtained out of 6 L media. 
3.13 Purification of non-labeled SUMO-alpha fusion construct 
20 g of cells containing SUMO-alpha fusion protein were resuspended in 60 mL low imidazole buffer (50 
mM KH2PO4 pH 7.2, 300 mM NaCl, 20 mM imidazole) supplemented with 10 mg lysozyme, 5 µg/mL 
DNase I and 10 mM MgSO4. Cells were disrupted by 3 passages through a microfluidizer and cell debris 
was removed by centrifugation (70000 x g, 8 °C, 30 min). Afterwards, the supernatant was loaded onto a 
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His-Trap column (5 mL), which was pre-equilibrated with low imidazole buffer. Unbound protein was 
removed from the column with 50 mL low imidazole buffer. SUMO-alpha was eluted from the column by 
a linear gradient of 0-100 % high imidazole buffer (50 mM KH2PO4 pH 7.2, 300 mM NaCl, 250 mM 
imidazole) over 10 column volumes. Elution fractions were analyzed by SDS-PAGE and fractions 
containing SUMO-alpha were combined. For further digestion of the SUMO-alpha fusion construct with 
the SUMO-protease imidazole needed to be removed. Therefore, SUMO-alpha was concentrated to a 
volume of 1 mL with a Vivaspin concentrator (molecular weight cut off 10 kDa). Buffer was exchanged to 
desalting buffer (50 mM KH2PO4 pH 7.2, 300 mM NaCl) directly in the concentrators using Vivaspin 
diafiltration cups. The obtained concentrate of SUMO-alpha was either directly digested or flash-frozen 
and stored at -20 °C. Typically, 50 mg of the SUMO-alpha fusion construct were obtained out of 6 L 
media. 
3.14 Expression of 13C- and 15N-labeled SUMO-alpha fusion construct 
Heavy-atom labeled SUMO-alpha was expressed according to the protocol of Marley et al. [84]. Due to 
multiple steps performed during expression particular attention was paid to sterile conditions. A pre-
culture was prepared to inoculate 10 x 0.5 L LB-media (10 g/L tryptone, 5 g/L yeast extract, 5 g/L NaCl, 
50 mg/L kanamycine sulfate) to an OD600 of 0.1. Cells were grown at 37 °C and 200 rpm in baffled flasks 
up to an OD of 0.7-1. Cells were harvested by centrifugation (4000 x g, 4 °C, 20 min) and gently 
resuspended in 250 mL of M9 salts (15 g/L KH2PO4, 37.3 g/L NaH2PO4 * 2 H2O, 2.5 g/L NaCl) to 
wash the cells. Washing solution was removed by centrifugation (2000 x g, 4 °C, 20 min) and the 
pelletized cells were gently resuspended in 1.25 L M9 minimal media (supplemented with 50 mg/L 
kanamycin sulfate) containing the labeled nutrients 15N-ammonium chloride and 13C-glucose. Complete 
composition of the M9 minimal media is listed in table 4. The resuspended cells were then split into 5 x 1 
L baffled flasks (5 x 250 mL cultivation volume) and further grown at 37 °C and 200 rpm. After one hour, 
which allowed clearance of unlabeled nutrients and recovery of the cells, SUMO-alpha expression was 
induced by the addition of 0.8 mM IPTG. After 4 hours cells were harvested (4000 x g, 4 °C, 30 min), 
flash-frozen with liquid nitrogen and stored at -20 °C. Approximately 2.5 g cells were obtain per 250 mL 
M9 minimal media. 
table 4: Final composition of M9 minimal media containing labeled nutrients. 
substance concentration in M9 minimal media 
15N-ammonium chloride 0.25 g/250 mL 
13C-glucose 1 g/250 mL 
M9 salts:    KH2PO4 0.75 g/250 mL 
                   NaH2PO4 * 2 H2O 1.9 g /250 mL 
                   NaCl 0.125 g/250 mL 
BME vitamins 100 x 1 x 
MgSO4 * 7 H2O 0.124 g/250 mL 
CaCl2 * 2 H2O 3.7 mg/250 mL 
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3.15 Purification of labeled SUMO-alpha fusion construct 
Due to the low yield of SUMO-alpha and the amount needed for further experiments the purification 
procedure was slightly modified compared with unlabeled protein. 2.5 g cells were resuspended in 13 mL 
BugBuster master mix and gently stirred for 20 min at room temperature. BugBuster master mix is a 
detergent mix supplemented with lysozyme which offers gentle lysis of the cells. Additionally, benzonase 
nuclease is included to digest DNA simultaneously during resuspension. After incubation with the mix 20 
mL low imidazole buffer (50 mM KH2PO4 pH 7.2, 300 mM NaCl, 20 mM imidazole) was added and cell 
debris was removed by centrifugation (70000 x g, 8 °C, 30 min). The supernatant was loaded onto a His-
Trap column (5 mL) which was previously equilibrated with low imidazole buffer. Unbound proteins as 
well as the BugBuster master mix were removed by washing the column with 50 mL low imidazole buffer. 
The labeled SUMO-alpha construct was eluted by a linear gradient from 0-100 % high imidazole buffer 
(50 mM KH2PO4 pH 7.2, 300 mM NaCl, 250 mM imidazole) over 10 column volumes. Eluted fractions 
were analyzed by SDS-PAGE and fractions containing the SUMO-alpha fusion construct were combined. 
For the following digestion with the SUMO-protease SUMO-alpha was concentrated to a volume of 1 mL 
using Vivaspin concentrator (molecular weight cut off 10 kDa) and buffer was exchanged to desalting 
buffer (50 mM KH2PO4 pH 7.2, 300 mM NaCl) containing no imidazole. Therefore, Vivaspin diafiltration 
cups were used which allowed direct buffer exchange in the concentrator. The obtained concentrate 
contained ~30 mg SUMO-alpha from 250 mL M9 minimal media. It was then subjected to the digestion 
reaction with SUMO-protease like described for the non-labeled SUMO-alpha fusion construct. 
3.16 SUMO-alpha digestion  
The protein concentration of the SUMO-alpha fusion construct (non-labeled and labeled) was determined 
by Bradford assay [85] prior to digestion. For the digestion approach the concentration of SUMO-alpha 
was set to 10-15 mg/mL by dilution with digestion buffer (50 mM KH2PO4 pH 7.2). SUMO-protease 
(16.1 µM in 50 % (v/v) glycerol, 25 mM Tris-HCl pH 8.0, 250 mM NaCl, 0.5 mM dithiothreitol, 0.1 % 
(v/v) IGEPAL, friendly provided by Dr. Stefan Lüdtke) was added in a 1:2000 molar ratio to SUMO-
alpha and the approach was incubated at 4 °C overnight. To separate the SUMO-protein from the alpha-
peptide the digestion approach was applied to a 1 mL His-Trap column, which was pre-equilibrated with 
desalting buffer (50 mM KH2PO4 pH 7.2, 300 mM NaCl). The alpha-peptide, which could not bind to the 
column any longer, was in the flow-through or further eluted from the column with desalting buffer. 
However, the SUMO-protein as well as the SUMO-protease attached to the column due to a 
polyhistidine-tag and are washed from the His-Trap column with high imidazole buffer (50 mM KH2PO4 
pH 7.2, 300 mM NaCl, 250 mM imidazole). The flow-through and fractions containing the alpha-peptide 
were combined, stored on ice or flash-frozen with liquid nitrogen and stored at -20 °C. 
3.17 Alpha-peptide purification 
After crude extraction of the alpha-peptide by a His-Trap column (chapter 3.16), which followed the 
digestion reaction, further purification was performed by reversed-phase HPLC (RP-HPLC). Initially, an 
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analytical C18 column (Nucleosil 120-5, 250 x 2 mm) was used with a solvent system A and B (table 5). 
100 µL of the combined alpha-peptide fractions was loaded on the column pre-equilibrated with 5 % 
solvent B and a flow rate of 0.4 mL/min. The alpha-peptide was eluted with a stepwise gradient from 5-
100 % solvent B (table 6) with 0.4 mL/min and monitored at 220 and 280 nm. Peaks with different 
retention times were identified by mass spectrometry (chapter 3.19). 
table 5: Composition of solvents used for reversed phase HPLC. 
solvent composition 
A 99.9 % H2O, 0.1 % TFA 
B 10 % H2O, 89.9 % acetonitrile, 0.1 % TFA 
 
For preparative purification of the alpha-peptide an optimized procedure was used. 1.5 mL of the crude 
alpha-peptide was loaded on a semi-preparative C18 column (Nucleosil 120-5, 250 x 4 mm, friendly 
provided by Professor Ivo Feußner) using a 2 mL loop. The column was previously equilibrated with 5 % 
solvent B with a flow rate of 1 mL/min. The alpha-peptide or shorter fragments were eluted from the 
column with an optimized gradient (table 6) from 5-100 % solvent B and a flow rate of 1 mL/min. 
Elution was monitored at 220 and 280 nm and fractionized. The alpha-peptide content of the fractions 
was analyzed by analytical RP-HPLC using the previously assigned retention times. Fractions containing 
the pure alpha-peptide were combined and acetonitrile was removed by evaporation using a stream of 
nitrogen. The aqueous solution was than flash-frozen with liquid nitrogen and water was removed by 
lyophilization to dryness. The peptides were stored as solid powders at -20 °C. Approximately 1 mg of 
non-labeled peptide was obtained from 1 L LB-media and 1.3 mg of labeled alpha-peptide from 250 mL 
M9 minimal media.  
table 6: HPLC gradients used for analytical and preparative purification of the alpha-peptide. 
analytical gradient preparative gradient 
time (min) solvent B (%) time (min) solvent B (%) 
0 5 0 5 
10 30 5 35 
30 41 20 41 
40 100 21 100 
50 100 31 100 
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3.18 Determination of protein concentration 
3.18.1 EcPOX 
Concentration of EcPOX was determined spectroscopically at 438 nm with the NanoDrop 2000 since at 
this wavelength the protein-bound flavin cofactor has its absorbance maximum. An extinction coefficient 
of 13721 M-1cm-1 was used for EcPOX wt, Δ23 and all variants, which was determined by Dr. Annett 
Weidner specifically for EcPOX [45]. A molecular weight of 62 kDa and 59.4 kDa was used for full-length 
EcPOX and EcPOX Δ23, respectively.  
3.18.2 LpPOX 
At 280 nm the concentration of LpPOX was determined by a NanoDrop 2000. At this wavelength the 
extinction coefficient of the holo-enzyme (including enzyme-bound ThDP- and FAD-cofactor) was 
calculated to be 108900 M-1cm-1 [74]. A molecular weight of 66 kDa was used for LpPOX wt and variants. 
3.18.3 SUMO-alpha 
To determine the concentration of the SUMO-alpha fusion construct Bradford assay was used [85]. Prior 
to this a calibration line with albumin fraction V was recorded. The molecular weight of 16.0 kDa 
included 2.6 kDa of the isolated alpha-peptide and 13.4 kDa of the SUMO-protein. 
3.18.4 Alpha-peptide 
Concentration of the isolated alpha-peptide was determined spectroscopically at 280 nm using the 
NanoDrop 2000. Due to the fact that the alpha-peptide contained only one optically active Trp residue 
(sequence is displayed bellowed), the extinction coefficient for Trp was used (ε280 nm = 5500 M-1cm-1) [86]. 
The molecular weight of the isolated alpha-peptide was calculated with 4 molecules of TFA as counter 
ions additionally to the alpha-peptide mass, which are residual artifacts from RP-HPLC purification.  
Amino acid sequence of the alpha-peptide (corresponds to EcPOX 550-572): 
H-Met-Leu-Arg-Ala-Ile-Ile-Ser-Gly-Arg-Gly-Asp-Glu-Val-Ile-Glu-Leu-Ala-Lys-Thr-Asn-Trp-Leu-Arg-OH 
3.19 Mass spectrometry of the isolated alpha-peptide 
Mass spectrometry analysis of the alpha-peptide and variants was performed, by Dr. Holm Frauendorf (at 
the Institute of Organic and Biomolecular Chemistry in the Department Zentrale Analytik und 
Massenspektrometrie, Göttingen). Typically, peaks with the appropriate retention time were collected 
from an analytical HPLC run. Peptide samples contained 30-40 % acetonitrile in water supplemented with 
0.1 % TFA. Peptide masses were determined by electro spray ionization and an APEX IV (FTICR-MS) 
instrument (Bruker). Measured masses were deconvoluted prior to analysis. 
To analyze the amount of incorporated 15N- and 13C-atoms into the labeled alpha-peptide the calculated 
molecular weights of non-labeled (C116H197N35O33S: 2639 g/mol) and completely labeled alpha-peptide 
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(13C116H19715N35O33S: 2790 g/mol) were compared. The difference of both masses (151 g/mol) 
corresponded to heavy-atom enrichment of 100 %. 
3.20 Q0 steady-state assay 
Enzymatic activity of EcPOX was monitored at 20 °C on a Jasco spectrometer by the loss of absorbance 
of coenzyme Q0 at 408 nm. A 10 mM stock solution of Q0 was prepared with water and stored at room 
temperature. The molar extinction coefficient of oxidized Q0 was determined by UV-Vis spectroscopy to 
be ε408 = 722.5 M-1cm-1. Sodium dithionite-reduced Q0 showed no absorbance in this range (figure 16).  
 
figure 16: UV-Vis spectra of oxidized and reduced 
ubiquinone-0. 500 µm oxidized Q0 were reduced with 1 mM 






For the Q0 steady-state assay EcPOX (0,81 µM full-length EcPOX, 32 nM EcPOX Δ23) was pre-
incubated for 2 min at 20 °C in buffer containing 100 mM KH2PO4 pH 6.0, 10 mM MgSO4 and 200 µM 
ThDP supplemented with 200 mM pyruvate in a 1 mL cuvette. Subsequently, the reaction was started by 
the addition of 500 µM Q0 and Q0 reduction was monitored. Equation 1 was used to determine the 
specific activity: 
equation 1 As = 
   min   V
εQ0
   d   V    c
  
  
As = specific activity (U/mg) 
Δ  min = change in Q0-absorbance per minute 
V = volume of the cuvette (µL) 
    = extinction coefficient of Q0 (ε408 = 722.5 M
-1cm-1) 
d = path length of the cuvette (cm) 
VE = volume of EcPOX solution added to the cuvette (µL) 
c = EcPOX concentration of the stock solution 
3.21 Flavin reduction of EcPOX and LpPOX 
Pyruvate-triggered reduction of the flavin cofactor was carried out with a SX.20 stopped-flow 
spectrophotometer relying on Tittmann et al. [73]. Change in flavin absorbance of EcPOX was observed at 
wavelenght (nm)
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438 nm with a path length of 1 cm and at 20 °C with a photomultiplier or photodiode array. For aerobic 
reactions 2 mg/mL EcPOX were pre-incubated for 2 min in reaction buffer (100 mM KH2PO4 pH 6.0, 
10 mM MgSO4 and 200 µM ThDP) in one stopped-flow syringe. The second syringe contained 200 mM 
pyruvate dissolved in reaction buffer. FAD reduction was initiated by rapid mixing of EcPOX and 
pyruvate in 1+1 ratio. Anaerobic measurements in the absence of oxygen were performed under the same 
conditions, but β-D-glucose (4 mg/mL) and glucose oxidase (GOX, 2.6 µg/mL) were added to both the 
substrate and enzyme solution, respectively. Both solutions were incubated for 2 min at 20 °C in the 
stopped-flow device prior to the experiments. The oxygen-consuming reaction of GOX consists of two 
steps:                        
  β-D-glucose + GOX-FAD   →   γ-D-gluconolactone + GOX-FADH2 
                        GOX-FADH2 + O2   →   GOX-FAD + H2O2 
To compare EcPOX and LpPOX variants the same experiment was performed for LpPOX using similar 
conditions. 2 mg/mL LpPOX were incubated for 2 min at 25 °C in 200 mM KH2PO4 pH 6.0, 1 mM 
MgSO4, 100 µm ThDP and subsequently mixed with 100 mM pyruvate in the same buffer. Absorbance of 
protein-bound flavin of LpPOX was monitored at 457 nm. For anaerobic measurements β-D-glucose and 
GOX were added to enzyme and substrate solution as already described.  
All progress curves were normalized by correlating the overall amplitude to 100 % oxidized FAD. For 
aerobic measurements the position of the FAD:FADH2 steady state was determined. To analyze anaerobic 
curves a single exponential equation was used for EcPOX (equation 2) and a double-exponential equation 
was applied to decipher the rate constant of FAD reduction for LpPOX (equation 3).  
equation 2  y = a   e- r d   t    c  y = FAD signal at 438 nm 
a = amplitude of FAD reduction 
kred = rate constant of FAD reduction (s-1) 
t = time (s) 
c = offset (corresponds to FADH2 absorbance) 
 
equation 3 y = a1   e 
– r d   t   a2   e
 – la    t   c y = FAD signal at 457 nm 
a1 = amplitude of FAD reduction 
kred = rate constant of FAD reduction (s-1) 
a2 = amplitude of lag phase 
klag = rate constant of lag phase (s-1) 
t = time (s) 
c = offset (corresponds to FADH2 absorbance) 
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3.22 Proteolytic activation of EcPOX 
3.22.1 Analytical proteolysis of EcPOX 
The protease alpha-chymotrypsin was used to irreversibly activate EcPOX wt and variants by mild limited 
proteolysis according to an already established protocol [35]. A 1 mg/mL stock solution of lyophilized 
alpha-chymotrypsin (1500 U/mg) was prepared in 1 mM hydrochloric acid. Aliquots were flash-frozen, 
stored at -20 °C and only used once.  In a typical experiment, 3 mg/mL of EcPOX were pre-incubated for 
10 min at room temperature in 100 mM KH2PO4 pH 6.0, 1 mM MgSO4 and 200 µM ThDP 
supplemented with 200 mM pyruvate, which led to the reduction of enzyme-bound FAD and Δ23 
cleavage site exposure. To investigate the effect of substrate analogs, 20 mM MAP were added instead of 
pyruvate. Subsequently, 10 µg/mL alpha-chymotrypsin were added to initiate limited proteolysis. The 
digestion reaction was either monitored by SDS-PAGE or by activity assay. For analyses by SDS-PAGE 
10 µL of the digestion reaction were mixed after defined time points with 200 µL gel sample buffer (0.1 M 
Tris pH 6.8, 25 % (v/v) glycerol, 2 % (w/v) SDS, 0.02% (v/v) bromophenol blue, 2.5 % (v/v) β-
mercaptoethanol) and immediately heated to 95 °C for 5 min. 0.5 µg EcPOX were loaded on a 10 % SDS 
gel. Simultaneously, the activation process was monitored using the Q0 steady-state assay. 10 µL of the 
proteolysis mixture were rapidly diluted into 140 µL reaction buffer including 200 mM pyruvate. 10 µL of 
this dilution were transferred to a 1 mL reaction assay containing 200 mM pyruvate. Activity 
measurements were immediately initiated by the addition of 500 µM Q0.  
The half-life of the digestion reactions was determined to be the time when 50 % of the full-length 
enzyme is cleaved to Δ23. Based on a single-exponential approximation the obtained half-life was used to 
calculate the rate constant kact according to equation 4. Data of the activity assay were analyzed using a 






kcat = rate constant of proteolytic activation (min-1) 
t1/2 = half-life of the proteolytic activation 
 
equation 5 y = a   e  act   t   c y = specific activity (U/mg) 
a = amplitude of the specific activity 
t = alpha-chymotrypsin incubation time 
c = offset (corresponds to resting-state activity of EcPOX) 
kact = rate constant of activation process (min-1) 
 
A critical point was the construction of the assay. It was assumed that the rate constant kact exclusively 
dependents on the equilibrium of protein-bound and cytosol-exposed membrane anchor. This would 
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mean that chymotrypsin digestion is rather fast and transition from closed to the open form is the rate 
limiting step. Thus, the rate constant should be independent of the chymotrypsin concentration. However, 
if higher amounts of chymotrypsin were added, the half-life was decreased for the wt enzyme. Therefore, 
the measured rate constant kact needed to be related to the applied protease concentration used in the 
assay. To avoid an influence of the protease concentration EcPOX wt and all variants were examined 
under standard conditions to compare the individual rate constants and the effect of the introduced 
mutations on the activation process. 
3.22.2 Preparative proteolysis of EcPOX 
To generate higher amounts of proteolytic activated EcPOX a modified digestion assay was used. 
3 mg/mL of EcPOX were pre-incubated for 10 min at room temperature in 100 mM KH2PO4 pH 6.0, 1 
mM MgSO4 and 200 µM ThDP with 200 mM sodium pyruvate. The proteolysis reaction was started by 
the addition of 15 µg/mL alpha-chymotrypsin and incubated for 40 min at room temperature. The 
digestion reaction was stopped by the addition of 150 µg/mL aprotinin (40fold molar excess to alpha-
chymotrypsin). The protease and smaller peptide fragments as well as pyruvate were removed by a HiTrap 
Superdex-200 gel filtration column. The digestion reaction was applied to the column, which was 
previously equilibrated with 100 mM KH2PO4 pH 6.0, 10 mM MgSO4 and 1 mM ThDP, and eluted with 
the same buffer. Fractions containing EcPOX Δ23 were analyzed by SDS-PAGE and further concentrated 
to 20-50 mg/mL. Due to decreased stability EcPOX Δ23 was only stored on ice and not flash-frozen.  
3.22.3 Limited proteolysis under turnover conditions 
Limited proteolysis under steady-state conditions was performed slightly different than the analytical 
approaches. In prior studies appropriate concentrations of EcPOX and Q0 were identified which ensured 
a sufficient amount of EcPOX to be loaded on the gel as well as an adequate period of time to monitor Q0 
consumption. In the digestion reaction 0.186 mg/mL of EcPOX were pre-incubated for 10 min at room 
temperature in 100 mM KH2PO4 pH 6.0, 1 mM MgSO4 and 200 µM ThDP supplemented with 200 mM 
pyruvate. The steady-state reaction was started by the addition of 10.4 mM Q0. Within 30 s the steady 
state phase was reached and 20 µg/mL alpha-chymotrypsin were added to initiate the proteolytic cleavage. 
Q0 consumption was monitored at 500 nm (ε500 = 123 M-1cm-1). Simultaneously, gel samples were 
prepared after defined time points to document the digestion pattern of EcPOX. 40 µL of the reaction 
were mixed with 10 µL gel sample buffer (0.1 M Tris pH 6.8, 25 % (v/v) glycerol, 2 % (w/v) SDS, 0.02 % 
8v/v) bromophenol blue, 2.5 % (v/v) β-mercaptoethanol) and immediately heated to 95 °C for 5 min. 0.5 
µg EcPOX were loaded on a 10 % SDS-PAGE. As reference experiments the same reactions were 
performed either in the absence of pyruvate or Q0. 
3.23 SDS-mediated activation of EcPOX 
As previously described EcPOX can be activated by amphiphiles like SDS similar to mild limited 
proteolysis [34]. To study the SDS-mediated activation a modified Q0 steady-state assay was used. 
Measurements were performed using a SX.20 stopped-flow spectrophotometer at 20 °C and a path length 
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of 1 cm. 10 µg/mL EcPOX were pre-incubated in buffer (containing 100 mM KH2PO4 pH 6.0, 10 mM 
MgSO4 and 200 µM ThDP) supplemented with 200 mM pyruvate for 2 minutes at room temperature. 
Afterwards, a given SDS amount was added and the mixture was rapidly loaded into one syringe of the 
stopped-flow device. The second syringe contained 1 mM Q0 dissolved in the same buffer including 
200 mM pyruvate and SDS. Four shots were performed as quickly as possible to equilibrate the system. 
After distinct delay times Q0 and EcPOX were mixed in 1+1 ratio and Q0 reduction was monitored at 
408 nm. Typically, 1 minute passed between SDS addition and the first measurement. The start activity 
was determined using a linear fit of the first 5 seconds and equation 1. To compare the different variants 
the final activity obtained at saturating concentrations of SDS was adjusted to 100 %. 
3.24 Thermic stability determined by CD spectroscopy 
Thermic stability of different EcPOX variants was determined by far-UV CD spectroscopy using a 
Chirascan CD spectrometer. The secondary structure of active EcPOX variants at 20 °C was determined 
from 190-260 nm and compared with the unfolded structure at 95 °C. Due to the fact that the highest 
difference occurred at 208 nm, this wavelength was chosen to record the temperature dependent 
unfolding of the protein. For the reaction 0.1 mg/mL EcPOX was incubated in 100 mM KH2PO4 pH 6.0, 
10 mM MgSO4 and 200 µM ThDP in a 1 mm cuvette. A linear gradient from 20-95 °C was used with the 
following settings: step 0.5 °C, heating rate 2 °C/min, tolerance 0.2 °C, record time 12 s/point. 
The transition of the melting curve, which corresponds to the apparent melting temperature (Tm), was 
determined using equation 6 according to Pace [87]. This equation describes the reversible unfolding of 
proteins, which is inaccurate for such irreversible denatured proteins like EcPOX, due to the fact that Tm 
is influenced by different parameters like the heating rate. However, the equation of Pace was used as 
approximation to determine an apparent melting temperature, since all variants were examined under the 
same conditions. Therefore, a qualitative comparison of the different EcPOX variants was feasible. 
equation 6   y= 
(y
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y = CD signal at 208 nm (mdeg) 
T = temperature (K) 
Tm = melting temperature (here the apparent melting temperature in K) 
R = universal gas constant (8.315 JK-1mol-1) 
ΔHm = change of the enthalpy at Tm 
yf, mf = parameters of the baseline of the folded protein 
yu, mu = parameters of the baseline of the unfolded protein 
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3.25 Crystallization of EcPOX 
EcPOX wt and different variants were crystallized relying on an already established protocol [82]. Briefly, 
prior to crystallization all EcPOX variants were rebuffered into crystallization buffer (20 mM KH2PO4 pH 
6.0, 10 mM MgSO4, 10 mM ThDP) using a HiTrap Desalting column. Yellow fractions containing 
EcPOX were enriched using a Vivaspin concentrator (molecular weight cut off 30 kDa) up to a 
concentration of 20 mg/mL. Crystallization experiments were set up using 24-well hanging drop plates 
with varying concentrations of EcPOX in the droplets after mixing. 
Crystals of full-length EcPOX were set up at room temperature by mixing 2 µL of protein (5-20 mg/mL) 
with 2 µL of the reservoir solution. The reservoir contained 0.2-0.8 % (w/v) PEG 2000 and 0.05 % (w/v) 
protamine sulfate (always freshly prepared) dissolved in 80 mM KH2PO4 pH 6.0. The protein droplets 
were incubated over 500 µL of the reservoir and yellow crystals appeared within 2-5 days at 6 °C in 
darkness. Prior to flash-cooling the crystals were cryo-protected by subsequent incubation in three cryo-
solutions with increasing amounts of ethylene glycol (5, 15 and 30 % (v/v) mixed with the reservoir 
solution. The crystal was incubated for 10 s in 5 % ethylene glycol, followed by 3 min in 15 % ethylene 
glycol and finally a short soaking step for a few seconds in 30 % ethylene glycol before flash-cooling.  
EcPOX Δ23 was crystallized in the dark at 20 °C. The reservoir mixture contained 20-28 % (v/v) MPD 
and 100 mM MES-NaOH pH 6.2. 2 µL of this reservoir were mixed with 2 µL of EcPOX (5-20 mg/mL) 
and crystallization was initiated by streak seeding. Therefore, an old EcPOX Δ23 crystal was crashed and 
diluted with crystallization buffer prior to seeding. The protein droplets were equilibrated against 500 µL 
of the reservoir solution and crystals were observed after a few weeks. Due to large amounts of MPD no 
further cryo-protection was necessary and crystals could be directly flash-cooled in a liquid-nitrogen.  
Crystal structures of EcPOX Δ23 in complex with Q0 were obtained by co-crystallization. Therefore, the 
protein was transferred into crystallization buffer and subsequently incubated with Q0 (2-50 molar 
equivalents) for one hour at 4 °C. Crystals were set up by streak seeding and flash-cooled as described 
above. Q0-soaking trials were performed with EcPOX Δ23 crystals obtained as already described which 
were incubated in soaking solutions containing 5-20 mM Q0 in 40 mM MES-NaOH pH 6.2 supplemented 
with 20-30 % (v/v) MPD. Soaking was performed in the dark at 20 °C for 1-24 hours. Prior to data 
collection crystals were flash-cooled in a liquid nitrogen without further cryo-protection. 
3.26 Crystallization of LpPOX 
LpPOX variants were crystallized like wt according to a procedure described previously [88]. Crystals were 
set up at room temperature by mixing 2 µL of the reservoir with 2 µL LpPOX (12-15 mg/mL in 200 mM 
KH2PO4 pH 6.0, 1 mM MgSO4, 100 µm ThDP). The reservoir solution contained 1.5-1.7 M ammonium 
sulfate in 200 mM KH2PO4 pH 6.0, 1 mM MgSO4 and 100 µm ThDP. Crystals were grown within 1 
month at 6 °C in the dark. The obtained crystals were cryo-soaked in 115 mM KH2PO4 pH 5.8, 1.3 M 
ammonium sulfate and 25 % (v/v) glycerol for a few seconds before flash-cooling in a liquid nitrogen. 
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3.27 Data collection and processing of EcPOX and LpPOX crystals 
X-ray diffraction data sets were collected at different synchrotron sources (Swiss Light Source (SLS) in 
Villingen, Helmholtz-Zentrum Berlin für Materialien und Energie (HZB) and Deutsches Elektronen 
Synchrotron Hamburg Petra III (DESY)) or with an in-house source at the Department for Molecular 
Structural Biology, Göttingen at cryogenic temperatures (table 7). Data were mainly collected by Dr. Piotr 
Neumann (Deparment for Molecular Structural Biology, Göttingen) and Dr. Stefan Lüdtke (former 
Deparment of Bioanalytics, Göttingen). 
 Data were processed and scaled with XDS [89] performed by Dr. Piotr Neumann (Department for 
Molecular Structural Biology, Göttingen) or Dr. Stefan Lüdtke (former Department of Bioanalytics, 
Göttingen). To solve the structures of different variants initial rigid body refinements were performed 
using the corresponding wt structures as primary models (EcPOX: pdb 3EY9 [35], LpPOX: pdb 4FEG 
[90]). Subsequently, alternating cycles of model building and refinement were performed using COOT, 
Refmac and PHENIX [91] [92] [93]. Simulated annealing omit maps calculated using CNS [94] were 
generated for variant EcPOX I554G by Dr. Piotr Neumann (Department for Molecular Structural 
Biology, Göttingen).  
table 7: Beamlines and resolution of data sets collected at different synchrotrons. 
X-ray structure beamline resolution (Å) 
EcPOX Y278F HZB 14.1 2.96 
EcPOX D328A, D348A, Q537A SLS PX II 3.20 
EcPOX F260A HZB 14.1 3.08 
EcPOX Y549A HZB 14.1 2.79 
EcPOX I554A DESY P14 3.02 
EcPOX I554G DESY P14 2.90 
EcPOX L565A HZB 14.1 3.24 
EcPOX Δ23:Q0 in-house 3.20 
LpPOX F289Y HZB 14.1 1.43 
 
3.28 Secondary structure of the alpha-peptide determined by CD spectroscopy 
The secondary structure of the alpha-peptide was determined by far-UV CD spectroscopy with a 
Chirascan CD spectrometer. 0.1 mg/mL of the peptide was incubated in 50 mM NaH2PO4 pH 6.0 at 20 
°C in a 1 mm cuvette. The effect of detergent micelles was studied by addition of 50 mM SDS (CMC = 
1.9 mM) or 50 mM DPC (CMC = 1.3 mM). As positive control the peptide solution was supplemented 
with 50 % (v/v) trifluoroethanol, which is known to induce helical structures [95]. The following settings 
were used for all measurements: 190 – 250 nm, step: 0.5 nm, record time 1 s/point, 3 repeats. To 
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determine the percentage of secondary structure elements spectra were corrected for baseline and buffer 
and deconvoluted with the program CDNN [96]. 
3.29 Structure determination of the alpha-peptide by NMR spectroscopy 
The molecular structure of micelles-bound alpha-peptide was determined by solution-state NMR 
spectroscopy by Dr. Piotr Wysoczanski and Prof. Dr. Markus Zweckstetter (Department of Structure 
determinations of Proteins using NMR, Max-Plack-Institute for biophysical chemistry, Göttingen). 
Therefore, 13C- and 15N-labelled peptide was investigated in the presence of deuterated DPC micelles. 
1mM of the labeled peptide was incubated with 50 mM D-DPC in 50 mM potassium phosphate pH 6.0 
(supplemented with 10 % D2O) for several hours on ice.  
The NMR spectra of the free peptide and peptide bound to DPC micelles were measured on 700 MHz 
NMR spectrometer equipped with room temperature 5 mm HCN, Z-gradient probe. The sample was 
placed in 3 mm tube and all measurements were taken at 298 K. Following experiments were run in order 
to assign the chemical shifts of backbone atoms and CB: 1H, 15N HSQC, HNCO, HNCA, HNCACB, 
HNHA. HNHA was also used to extract 3J HN-HA values. Also, 1H, 15N HSQC was measured for the 
free peptide. 
Spectra were processed using NMRpipe [97] and assigned using ccpn analysis 2.2.1 [98]. Secondary 
chemical shifts were calculated according to [99] and 3J HN-HA values were fitted to Karplus equations 
to extract the phi dihedral angle values [100]. 
Protein backbone atoms chemical shifts are sensitive to the secondary structure of a protein and thus 
provide a reliable method to detect the conformational preferences. By calculating secondary chemical 
shifts (difference between the measured chemical shift and the value expected from a random coil) one 
can extract relative likelihood of a given residue to occupy ramachandran space corresponding to an 
alpha-helix, a random coil or a beta-sheet. Additionally, 3J HN-HA values are modulated by the dihedral 
angle formed by H-N-Ca-Ha atoms thus providing an even more direct measure of a protein secondary 
structure.  TALOS [101] and SSP were used [102] to get a global likelihood of the secondary structure and 
TALOS to predict the S2 order parameter [103]. 
3.30 Determination of critical micelle concentration of SDS and DPC 
The critical micelle concentration (CMC) of the surfactants SDS and n-Dodecyl phosphocholine (DPC) 
was determined under different conditions by isothermal titration calorimetry (ITC) relying on already 
published procedures [104]  [105].  
The CMC of the surfactants was determined in water and in phosphate buffer containing 50 mM 
NaH2PO4 pH 6.0. SDS stock solutions (50 – 100 mM) were prepared by weighing a specific SDS amount 
and dissolving it in water or in the appropriate buffer. DPC was used as powder and also weighed and 
dissolved in either water (75 mM DPC) or 50 mM NaH2PO4 pH 6.0 (50 mM DPC). 
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Measurements were performed with an ITC200 at 20 °C. All experiments were repeated 3 times and the 
average of the CMC value was calculated. The reference cell of the ITC device contained water, whereas 
the measuring cell was either filled with water or the corresponding buffer. The ITC syringe was loaded 
with the detergent stock solution, which was stepwise titrated into the measuring cell. The following 
settings were used for all experiments: 
cell temperature: 20 °C injections: 
stirring speed:  1000 rpm      1:                   0.2 µL, spacing 90 s 
reference power: 5-7      2-50:              0.5 µM, spacing 120 s 
response:  high filter period:   5 s 
 
Data were baseline-corrected and analyzed according to [106]. The results are shown in the appendix 
(chapter 8.1).   





4.1 Analysis of the information transfer from the active site to the membrane 
anchor and stabilization of the protein-bound membrane anchor at the 
protein surface 
4.1.1 Q0 steady-state assay 
Q0 acts as water-soluble substitute for the native substrate Q8 
To analyze the activity of EcPOX wt and variants a new steady-state assay was established. In former 
activity assays cofactor-reconstituted enzyme transferred pyruvate-derived electrons to artificial electron 
acceptors like ferricyanide or 2,6-dichlorophenolindophenol [15]. Reduction of these acceptors was 
followed by UV-Vis spectroscopy. However, these electron acceptors show severe structural differences 
compared with the native substrate Q8 (figure 17). Further, properties of electron acceptance vary 
significantly. While in the native reaction two electrons are completely transferred to one Q8 molecule, 
only one electron can be accepted by ferricyanide. Additionally, it is possible that artificial electron 
acceptors, once passed the active site, can uptake reducing equivalents not only from the reduced flavin 
cofactor, but already from HE-ThDP intermediate [107].  
In the new approach Q0 was used as final electron acceptor. Q0 is a water-soluble analogue of the native 
substrate Q8, which lacks the 8 isoprenoid units necessary for membrane anchoring. Since the 
benzoquinone head groups of Q8 and Q0, which are considered to facilitate substrate binding to the active 
site, are identical one can assume that electron transfer proceed in a similar way for both ubiquinones. 
Comparison of the catalytic constants using ferricyanide and Q0 as electron acceptors revealed no 
significant differences (data not shown). Therefore, the Q0 steady-state assay was used for further 
applications instead of ferricyanide or 2,6-dichlorophenolindophenol. Prior to activity measurements of 
different EcPOX variants the Q0 amount required for saturation was determined. For EcPOX wt and all 
mutants a final concentration of 500 µM Q0 was sufficient in the assay (full-length EcPOX and Δ23: 




figure 17: Overview of different terminal electron acceptors converted by EcPOX. The following electron acceptors are 
used by EcPOX in vivo or in vitro. A: Q8. B: Q0. C: 2,6-dichlorophenolindophenol. D: ferricyanide. Redox reactions are indicated by 
addition of electrons and protons. 
 
Pyruvate dependence of the steady-state activity follows Michaelis-Menten kinetics 
The steady-state activity of EcPOX wt and variants was studied by Q0 steady-state assay. The catalytic 
parameters were calculated using the Michaelis-Menten equation 7, which is based on the following 
reaction scheme: 
                     E = enzyme, S = substrate (pyruvate)  
                     ES= enzyme-substrate complex, P = product 
 
equation 7  v = 
Vmax    S 
     S 
  
  
v = specific activity (U/mg) 
Vmax = maximum activity (U/mg) 
[S] = pyruvate concentration (mM) 
Km = Michaelis constant (mM) 
According to this scheme, the enzyme reacts with substrate to an ES-complex which either can be 
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Michaelis constant Km is derived from the rate constants of several processes (equation 8). It consists of 
the dissociation constant of the ES-complex (k-1/k1) and the overall rate constant k2, which reflects all 
steps following ES formation.  
equation 8                                  
  = 
 -1    2
 1
  
Km = Michaelis constant 
k-1 = rate constant of ES-complex degradation 
k1 = rate constant of ES-complex formation 
k2 = rate constant of product formation 
However, the catalyzed reaction of EcPOX includes more steps than formation of an ES-complex and 
product generation. Thus, the determined values can only been seen as approximation of the overall 
reaction and cannot be assigned to specific rate constants or single catalytic steps. In this regard a 
decreased Km value of a variant should not automatically be interpreted as increased affinity for the 
substrate pyruvate, since the smaller Michaelis constant could only reflect a decelerated rate constant k2, 
while association of the ES-complex is not affected. 
steady-state activity of EcPOX variants 
EcPOX wt and activated enzyme forms:  
As previously described in the literature EcPOX wt exhibits a kcat of 6.6 ± 0.2 s-1, whereas the 
proteolytically activated Δ23 variant or the addition of 100 µM SDS to the wt enzyme lead to 25-30fold 
increase in catalytic activity and simultaneously to a 3-6fold decreased Km  [18] [108] (figure 18 and table 8). 
 
 
figure 18: Steady-state activity of EcPOX wt and selected variants in dependence of pyruvate concentration. A: Progress 
curves of Q0 conversion by EcPOX wt at different pyruvate concentrations (5-200 mM). B: Pyruvate dependence of selected 
EcPOX variants. Data (dots) were fitted according to Michaelis-Menten equation (lines). Obtained catalytic parameters for all 
variants are listed in table 8. 
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Putative signal transfer variants F465A, Y278F, Y549A and F260A: 
Wt-like activities were observed for variants F260A and Y278F (figure 18 and table 8). Surprisingly, 
mutant EcPOX Y549A showed a 10fold increased kcat which implies a partially activated enzyme already in 
the resting state. F465A is the only variant with significantly reduced activity (kcat = 0.1 ± 0.01 s-1) 
indicating a vital role of this residue for the catalytic mechanism.  
Potential alpha-peptide binding variants 3x, I554A/G, L565A/G, 2G, W570G:  
Variants supposed to be involved in hydrophobic membrane anchor binding (L565A/G, I554A/G, 
W570G) show an increased kcat similar to fully activated enzyme already in the resting state (figure 18 and 
table 8). These results implicate that semi-activated variants are generated due to removal of hydrophobic 
methyl units in the variants. Remarkably, the double mutant EcPOX 2G is completely activated showing a 
catalytic efficiency similar to activated Δ23. Contrary, variant EcPOX 3x (lacking electrostatic contacts and 
hydrogen bonds for alpha-peptide attachment) exhibits wt-like activity. 
 
table 8: Steady-state constants of EcPOX variants. Parameters were calculated from data of the Q0 steady-state assay using 











(M-1 * s-1) 
wt 99.1 (± 6.8)  6.4 (± 0.2) 6.6 (± 0.2) 67 
wt + 100 µM SDS 30.7 (± 2.4) 141.0 (± 3.3) 145.7 (± 3.4) 4746 
wt Δ23 14.6 (± 0.9) 187.7 (± 2.8) 185.8 (± 2.7) 12726 
F465A 48.3 (± 6.0) 0.1 (± 0.01) 0.1 (± 0.01) 2 
Y278F 69.9 (± 9.5) 2.9 (± 0.1) 3.0 (± 0.1) 43 
Y549A 52.5 (± 4.6) 56.3 (± 1.5) 58.2 (± 1.6) 1109 
F260A 68.8 (± 3.5) 11.4 (± 0.2) 11.8 (± 0.2) 172 
D328A, D348A, Q537A (EcPOX 3x) 114.0 (± 7.0) 5.7 (± 0.1) 5.9 (± 0.2) 52 
L565A 188.0 (± 20.4) 41.4 (± 2.3) 42.8 (± 2.4) 228 
L565G 94.6 (± 9.7) 78.7 (± 3.2) 81.3 (± 3.3) 860 
I554A 232.7 (± 16.6) 50.5 (± 2.0) 52.2 (± 2.1) 224 
I554G 115.6 (± 14.9) 120.8 (± 6.6) 124.8 (± 6.8) 1080 
L565G, I554G (EcPOX 2G) 15.6 (± 1.9) 92.4 (± 2.5) 95.5 (± 2.6) 6122 
W570G 117.5 (± 8.1) 23.7 (± 0.7) 24.5 (± 0.7) 209 
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In conclusion, results obtained from the activity assay indicate that variants with decreased hydrophobic 
contacts between the alpha-peptide and the protein surface (L565A/G, I554A/G, 2G, W570G) show 
Δ23-like behavior. It can be speculated that these variants mimic the proteolytically activated enzyme with 
improved active site accessibility and at least with a partially released membrane anchor. 
4.1.2 Flavin reduction at anaerobic conditions 
The reductive half-reaction of EcPOX 
In the absence of any terminal electron acceptor the catalytic cycle of EcPOX is incomplete (figure 19). 
Pyruvate can undergo just one cycle yielding acetate, but the flavin cofactor cannot be regenerated and 
remains in the reduced form FADH2. Subsequently, a second pyruvate molecule can only be converted to 
HE-ThDP since no oxidized flavin cofactor is available to accept further electrons which is a prerequisite 
for HE-ThDP depletion. Hence, two equivalents of pyruvate are utilized, whereas only single-turnover of 
FAD can be observed. This simplified catalytic cycle is called reductive half-reaction [24] and resembles 
pre-steady-state conditions of EcPOX. In contrast to the Q0 steady-state assay, where overall rate 
constants are determined, the catalytic constants derived from this approach can be attributed only to 
steps yielding the reduced flavin cofactor. 
figure 19: Reductive half-
reaction of EcPOX. Activa-
tion of ThDP yields the 
reactive ylide form (1). Cova-
lent pyruvate binding leads to 
L-ThDP (2) followed by 
decarboxylation (3). The re-
sulting HE-ThDP intermedi-
ate can transfer two elec-
trons to the flavin cofactor 
(4). In the absence of any 
electron acceptor flavin rege-
neration does not occur and 
the catalytic cycle stops at 
this stage. Acetate hydrolysis 
and subsequent binding of a 
second pyruvate molecule are 
neglected for clarity. (R1 = 
aminopyrimidine moiety, 
R2 = diphosphate anchor) 
Pre-steady-state conditions allow determination of the flavin reduction rate  
In the pre-steady-state assay, EcPOX was rapidly mixed with pyruvate using a stopped-flow device and 
flavin reduction was detected at 438 nm. Anaerobic conditions were applied since molecular oxygen can 
reoxidize the previously reduced flavin cofactor [45] [109]. The loss of absorbance at 438 nm corresponds 
to formation of completely reduced FADH2 from FAD induced by pyruvate. The resulting progress 
curves of selected EcPOX variants at standard conditions are displayed in figure 20 and were compared to 
























































































figure 20: Pyruvate-induced flavin reduction of EcPOX wt and variants. A: Spectra of oxidized and pyruvate-reduced 
EcPOX wt. 2 mg/mL EcPOX wt (red) were reduced (black) with 100 mM pyruvate. B: Kinetics of EcPOX flavin reduction at 
anaerobic conditions. 2 mg/mL of EcPOX were rapidly mixed with 200 mM pyruvate in the absence of oxygen or other electron 
acceptors. Flavin reduction was monitored at 438 nm and 20 °C with a stopped-flow device. Progress curves were converted to 
relative amount of oxidized flavin. The rate constant of the first phase kred was determined by a single-exponential equation (fit 
not shown). Rate constants of all EcPOX variants are listed in table 9. Inset: FAD reduction within the first 2 seconds.  
The pre-steady-state curve of EcPOX wt shows two different phases. The first phase corresponds to 
nearly 90 % of the overall amplitude and is finished after approximately 5 seconds. This phase is 
interpreted as pyruvate-triggered flavin reduction and can be analyzed by a single-exponential equation 
yielding the rate constant kred which includes the microscopic rate constants of pyruvate binding, L-ThDP 
decarboxylation and flavin reduction. The second phase is rather slow and even not finished after 1000 s 
when the measurement was stopped (data not shown). Amplitude and rate constant of this phase are 
independent of the pyruvate concentration. The molecular origin of this phase is unclear but it seems 
possible that a less-active enzyme species exists in solution, which could be reduced rather slowly.  
Flavin reduction rate of EcPOX variants 
EcPOX wt and prot olytically activat d Δ23: 
In contrast to EcPOX wt proteolytically activated enzyme exhibits a 400fold increased kred (EcPOX wt: kred 
= 1.9 ± 0.001 s-1, Δ23: kred = 848 ± 78 s-1) which is already indicated in the steady-state assay.  
Putative signal transfer variants F465A, Y278F, Y549A and F260A: 
Similar flavin reduction rate like for EcPOX wt is detected for variant Y278F. In this regard it can be 
concluded that all steps leading to reduced FAD are not influenced and catalytic processes starting from 
FADH2 are mainly affected in this variant.  
Remarkably, F465A is the only variant that shows an impaired flavin reduction with a 100fold decreased 
kred. This implies that pyruvate binding, decarboxylation or electron shuffling to FAD are disturbed in 
F465A. The low kred value is also reflected in poor catalytic activity monitored in the steady-state assay.  
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table 9: Flavin reduction rate of EcPOX variants. kred was determined from progress curves shown in figure 20 by a single-
exponential equation (equation 2) under saturating concentrations of pyruvate (100 mM). Progress curves of flavin reduction for 
individual EcPOX variants are displayed in the appendix (chapter 8.5). (n. d. = not determined) 
EcPOX variant kred  (s-1) 
wt 1.9 (± 0.001) 
wt Δ23 848 (± 78) 
F465A 0.02 (± 0.00002) 
Y278F 2.1 (± 0.002) 
Y549A 37.9 (± 0.13) 
F260A 4.6 (±0.003) 
D328A, D348A, Q537A (EcPOX 3x) n. d. 
L565A 5.2 (± 0.007) 
L565G 16.3 (± 0.043) 
I554A 4.4 (± 0.017) 
I554G 4.6 (± 0.007) 
L565G, I554G (EcPOX 2G) n. d. 
W570G 2.2 (± 0.003) 
A 2.5fold increased kred relative to the wt enzyme is detected for variant EcPOX F260A. Due to the 
position of Phe260 on the protein surface a catalytic function during flavin reduction can be excluded. It 
seems more likely that a partially released membrane anchor improves active site accessibility leading to 
enhanced substrate binding. Since covalent binding of pyruvate yielding L-ThDP was reported to be the 
rate-limiting step in EcPOX [45], acceleration of this process would consequently lead to an increased kred. 
Noteworthy, EcPOX Y549A shows a 20fold increased kred of 37.9 ± 0.13 s-1. Although Tyr549 is located 
in close proximity to the flavin and thiamine cofactors it seems unlikely that the substituted Ala can 
improve electron transfer compared to Tyr549. One could speculate that Phe465 already switch to the 
activated position in variant Y549A and facilitates electron shuffling like observed in EcPOX Δ23. 
However, the flavin reduction rate is still 20fold slower with respect to the proteolytically activated 
enzyme. On the other hand, the increased kred could be explained by improved active site accessibility 
already suggested for variant F260A which is provided by partial release of the membrane anchor from 
the protein surface. 
Potential alpha-peptide binding variants I554A/G, L565A/G, W570G:  
Variants supposed to be involved in hydrophobic membrane anchor binding (L565A/G, I554A/G, 
W570G) show accelerated flavin reduction. However, the obtained rate constants are still 50fold slower 
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compared to the proteolytically activated enzyme (variants: kred = 2.2 – 16.3 s-1). Thus, it is questionable 
that these minor changes are caused by a reorganized active site with Phe465 already occupying its 
activated position to promote electron transfer to FAD. A reasonable explanation for the slightly 
increased reduction rates in these variants could be again improved substrate binding caused by increased 
accessibility of the active site. 
Analyses of anaerobic flavin reduction was not only mandatory to decipher the electron transfer within 
the active site of EcPOX but also necessary for further membrane binding studies. Proper flavin reduction 
is a prerequisite for membrane anchor exposition. The latter step can be monitored for instance by limited 
proteolysis experiments (chapter 4.1.4) or SDS-mediated activation of EcPOX (chapter 4.1.5). 
4.1.3 Flavin reduction under steady-state conditions  
Flavin reoxidation by molecular oxygen is an artificial side reaction 
EcPOX is an enzyme involved in energy metabolism of the bacterial cell. It converts energy-rich pyruvate 
to low energetic products acetate and carbon dioxide. Additionally, during this reaction arise two electrons 
which are initially stored at the flavin cofactor. The final energy conserving steps are the transfer of the 
two reducing equivalents into the membrane to Q8, which subsequently feeds energy rich electrons into 
the respiratory chain. Most important for energy conservation within EcPOX is the absence of electron 
acceptors since reduction of unpreferred low energetic products would lead to a waste of energy. 
In vitro, an artificial energy-wasting reaction can be observed for EcPOX: the reoxidation of the reduced 
flavin cofactor by molecular oxygen yielding the final product hydrogen peroxide. This process is 
described as artificial oxidative half-reaction in thesis, since the native oxidative half-reaction corresponds 
to flavin reoxidation by Q8. In contrast to electron transfer from HE-ThDP to ferricyanide, the artificial 
oxidative half-reaction was reported to be rather slow [42] [45]. Poor oxygen reactivity of EcPOX is not 
astonishing since the enzyme is a dehydrogenase rather than a functional oxidase (see chapter 1.2.9). This 
implicates, that the active site is constructed in a way to prevent such an artificial reaction.  
Steady-state conditions allow determination of the flavin reoxidation rate 
The rate constant of the artificial oxidative half-reaction kreoxi was indirectly determined using a modified 
assay of the reductive half-reaction (chapter 4.1.2). In this steady-state assay EcPOX was mixed with 
pyruvate dissolved in air-saturated buffer solution. Again the flavin cofactor was used as intrinsic probe 
and decrease in absorbance was monitored at 438 nm, which corresponds to FAD reduction.  
Initial loss of absorbance is caused by pyruvate-triggered reduction of FAD in the pre-steady-state phase 
(figure 21) as observed in the reductive half-reaction (chapter 4.1.2). Subsequently, in a counteracting 
process the previously reduced FADH2 is reoxidized by molecular oxygen observed as increase in 
absorbance due to formation of oxidized flavin. A steady state of FAD and FADH2 is established after 10 
seconds for EcPOX wt (figure 21). However, this phase only takes a few seconds and ends due to oxygen 
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depletion, which also causes the slow loss of absorbance until the measurement finishes. Once oxygen is 
completely converted, EcPOX catalysis stops at HE-ThDP intermediate. 
figure 21: Pyruvate-induced flavin reduction of EcPOX 
wt and Δ23 at aerobic conditions. 2 mg/mL of EcPOX 
were rapidly mixed with 200 mM pyruvate in the presence 
of oxygen. Flavin reduction was monitored at 438 nm and 
20°C. Progress curves were converted to relative amount 
of oxidized flavin. The position of the steady state is 
indicated with an arrow. Inset: FAD reduction of the first 
30 seconds. Dashed lines highlight the amount of oxidized 
FAD in the steady state (EcPOX wt: 22 % FADox, Δ23: 
21 % FADox). 
 
 
Since net rates of reduction (kred) and reoxidation (kreoxi) are equal during steady state, equilibrium of 
oxidized and reduced flavin is established. The position of this equilibrium in combination with the 
previously determined kred of the reductive half-reaction (chapter 4.1.2 table 9) can be used to calculate the 
reoxidation rate according to equation 9 and equation 10. As described for the rate constant kred, kreoxi is 
also a mixed constant which reflects not only the electron transfer from FADH2 but also oxygen binding 
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   FAD = amount of oxidized FAD in equilibrium (%) 
FADH2 = amount of reduced FAD in equilibrium (%) 
kred = rate constant of reductive half reaction (s-1) 
kreoxi = rate constant of FADH2 reoxidation (s-1) by 
oxygen 
equation 10  r o i= 
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Flavin reoxidation rate of EcPOX variants 
EcPOX wt and prot olytically activat d Δ23: 
The different resting-state activities of full-length EcPOX and EcPOX Δ23 are also reflected in the rate 
constants of flavin reduction and reoxidation. While the wt enzyme shows slow reduction of the flavin 
cofactor in the pre-steady state (kred = 1.9 ± 0.001 s-1) and poor reoxidation by molecular oxygen (kreoxi = 
0.54 ± 0.0003 s-1), the proteolytic activated Δ23 variant can accelerate both processes approximately 
400fold (kred = 848 ± 78 s-1, kreoxi = 225 ± 21 s-1) (figure 21 and table 10).  
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The observed enhancements due to proteolytic truncation are presumably caused by both a more 
accessible active site, which improves substrate binding (this was reported to be the rate-limiting step in 
EcPOX catalysis [45]), and repositioning of the residue Phe465 that can accelerate the electron transfer 
between both cofactors in EcPOX Δ23. A similar effect of significantly increased flavin reoxidation upon 
proteolytic processing was described for xanthine oxidoreductase [110]. This enzyme is expressed as 
dehydrogenase showing poor reoxidation, but is activated to a functional oxidase due to proteolytic 
digestion. Here, the increased reoxidation rate is attributed to rearrangement of loop Gln423-Lys433 
closing the active site after proteolysis, which suppresses access of other electron acceptors than oxygen. 
Consequently, ubiquitous oxygen is utilized for cofactor regeneration yielding enzymatic oxidase activity.  
In connection with the physiological function the different reoxidation rates of full-length EcPOX and 
Δ23 seem to be astonishing on the first view since one would expect poor artificial flavin reoxidation also 
in activated EcPOX. One interpretation could be that inhibition of artificial reoxidation plays only a minor 
role in catalysis of EcPOX Δ23. The pyruvate-reduced full-length enzyme needs to inhibit unfavored 
reoxidation in the cytosol until it is recruited to the membrane and interacts with the electron acceptor Q8. 
Otherwise, energy is not conserved by EcPOX. Once attached to the membrane, fast electron transfer to 
Q8 seems to be beneficial. This membrane-bound state is resembled by the activated variant Δ23, which 
favors an accessible active site concomitant with accelerated electron transfer. Suppression of reoxidation 
by oxygen in this state seems to be less importance.  
Although the physiological relevance of different reoxidation rates of full-length EcPOX and activated 
Δ23 is still unclear, the reoxidation rate can be used as parameter to classify the examined variants. 
Putative signal transfer variants F465A, Y278F, Y549A and F260A: 
As stated earlier, EcPOX has to prevent electron transfer to oxygen while localized in the cytosol to 
conserve energy. Since shuffling of the electrons starts from FADH2, it seems reasonable that the enzyme 
matrix suppresses oxygen reactivity already near the flavin cofactor. One predestined candidate for 
shielding the flavin against oxygen could be Tyr278. The crystal structure of the resting-state enzyme 
implies that this residue is positioned in 3.2 Å vicinity to the redox active N5- and C4a-atom of the flavin 
and forms a hydrogen bond to flavin-N5 (figure 22 and figure 14). However, the relevance of this 
hydrogen bond needs to be examined.  
 
figure 22: Redox reaction of the flavin 
cofactor and interactions of the 
isoalloxazine ring with Tyr278. The redox 
active centers N5 and C4a are highlighted in 
blue and red color, respectively. The 
potential hydrogen bond between Tyr278 
and N5-atom as well as the interaction with 
































The amount of oxidized FAD in equilibrium is shifted for EcPOX Y278F by 12 % towards the oxidized 
species with respect to the wt enzyme (EcPOX wt: 23 % FAD, Y278F: 35 % FAD) leading to kreoxi of 
0.54 ± 0.0003 s-1 and 1.11 ± 0.001 s-1 for EcPOX wt and Y278F, respectively (figure 23 and table 10). 
Since flavin reduction is not affected in Y278F (chapter 4.1.2), the 2fold increased reoxidation rate can be 
directly related to events starting from the reduced flavin cofactor. Due to the fact that no structural 
changes are observed for the variant compared to EcPOX wt (chapter 4.1.7), it is reasonable to assume 
that oxygen migration to the active site or product release are identical for wt enzyme and Y278F. Thus, 
the increased kreoxi can be attributed to a participation of Tyr278 in the reoxidation process. One can 
propose that the hydroxyl function of Tyr278 is involved in suppression of unfavored electron transfer to 
molecular oxygen. This hypothesis was further investigated with pyruvate oxidase from Lactobacillus 
plantarum, an enzyme which can be classified as real oxidase (chapter 4.4). 
figure 23: Pyruvate-induced flavin reduction of EcPOX 
wt and Y278F at aerobic conditions. 2 mg/mL of EcPOX 
were rapidly mixed with 200 mM pyruvate in the presence of 
oxygen. Flavin reduction was monitored at 438 nm and 20°C. 
Progress curves were converted to relative amount of 
oxidized flavin. The position of the steady state is indicated by 
an arrow. Inset: FAD reduction of the first 40 seconds. 
Dashed lines highlight the amount of oxidized FAD in the 




As already observed for flavin reduction, variant F260A shows slightly accelerated flavin reoxidation. 
However, a 1.5fold increased kreoxi is most likely caused by a more accessible active site which improves 
oxygen migration within the enzyme.  
Surprisingly, a 10fold increased kreoxi can be detected for variant EcPOX Y549A with respect to the wt 
enzyme. This increase of the flavin reoxidation rate in combination with a 20fold accelerated flavin 
reduction rate is most likely related to increased accessibility of the catalytic center. Improved accessibility 
could be provided by release of the membrane anchor from the protein surface.   
Reoxidation of the flavin cofactor in variant F465A was demanding to investigate since analysis of the 
reductive half-reaction already revealed disturbed electron transfer to FAD (chapter 4.1.2). Although the 
progress curve of the steady-state assay showed a decrease of oxidized FAD, no steady state was 
established after subsequent reoxidation within the measuring time of 1000 seconds (chapter 8.5). 
Therefore, it was not possible to calculate kreoxi. It can be suggested that in variant F465A flavin reduction 
and reoxidation are severely impaired which underlines the pivotal role of Phe465 in EcPOX catalysis. 
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Potential alpha-peptide binding variants I554A/G, L565A/G, W570G:  
The reoxidation rates of semi-activated variants, which are potentially involved in hydrophobic membrane 
anchor binding, are analyzed from another point of view. Here the difference between the full-length 
variants and EcPOX wt Δ23 are of great importance. Nearly all variants showed accelerated flavin 
reduction in combination with an at least 2fold increased reoxidation rate. However, these results indicate 
that the variants are still wt-like enzymes and are less similar to EcPOX Δ23. As already discussed for 
flavin reduction (chapter 4.1.2), the slight changes observed are most likely caused by increased 
accessibility of the active site due to a partly released membrane anchor which enhances oxygen migration 
into the active site.  
table 10: Overview of rate constants for the reductive and oxidative half-reaction for EcPOX variants. kred was determined 
by a single-exponential equation from progress curves of the reductive half-reaction (table 9). kreoxi was calculated from progress 
curves of flavin reduction at steady-state conditions using equation 10. Individual progress curves for all examined EcPOX 
variants are displayed in the appendix (chapter 8.5). (n. d. = not determined, a = no steady state was established) 
EcPOX variant kred (s-1) kreoxi (s-1) FAD : FADH2 (%) 
wt 1.9 (± 0.001) 0.54 (± 0.0003) 22 : 78 
wt Δ23 848 (± 78) 225 (± 21) 21 : 79 
F465A 0.02 (± 0.00002) - a - a 
Y278F 2.1 (± 0.002) 1.11 (± 0.001 ) 35 : 65 
Y549A 37.9 (± 0.13) 7.22 (± 0.025) 16 : 84 
F260A 4.6 (± 0.003) 0.88 (± 0.0006) 16 : 84 
D328A, D348A, Q537A (EcPOX 3x) n. d. n. d. n. d. 
L565A 5.2 (± 0.007) 1.30 (± 0.002) 20 : 80 
L565G 16.3 (± 0.043) 3.34 (± 0.009) 17 : 83 
I554A 4.4 (± 0.017) 1.31 (± 0.005) 23 : 77 
I554G 4.6 (± 0.007) 1.01 (± 0.002) 18 : 82 
L565G, I554G (EcPOX 2G) n. d. n. d. n. d.  
W570G 2.2 (± 0.003) 0.42 (± 0.0006) 16 : 84 
4.1.4 EcPOX activation by limited proteolysis 
Limited proteolysis of EcPOX is an artificial process exclusively observed in vitro which has no relevance 
for EcPOX functionality in vivo [32]. However, it was often used in the past as substitute for membrane 
binding studies of EcPOX since proteolytically activated enzyme and membrane-bound EcPOX show 
similar catalytic parameters [18]. In both cases the increased catalytic activity is attributed to removal of 
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the membrane anchor from the protein surface. This anchor is either truncated, as observed during 
proteolysis reaction, or stabilized by lipids of the membrane.  
Extension of the minimal model of three different EcPOX conformations 
As detailed described in the introduction (chapter 1.2.4) proteolysis studies of EcPOX allow creation of a 
minimal model comprising three different enzyme conformations (figure 5). In the resting-state enzyme 
(R-state) the activating Δ23 cleavage site is protected, while a non-activating restriction locus leading to 
EcPOX Δ101 is exposed. Pyruvate binding, resembled by the substrate-bound state (SB-state), induces a 
first conformational change resulting in protection of both cleavage sites. Solely the electron transfer 
reaction yielding reduced FADH2 in the substrate-reduced state (SR-state) leads to exposure of the Δ23 
restriction site coupled to release of the membrane anchor and thus to the formation of activated EcPOX 
Δ23.  
Although the previously created minimal model describes fairly the three different EcPOX conformations 
it lacks one aspect. One can assumed, that the substrate-bound enzyme (Δ101 and Δ23 protected) is not 
directly converted to the substrate-reduced state (Δ101 protected and Δ23 accessible) due to flavin 
reduction. It seems more likely that electrons are transferred to FAD but the conformational change 
proceeds afterwards. Thus, a new enzyme conformation needs to be introduced: a substrate-reduced 
enzyme in which the Δ23 and Δ101 cleavage sites are still protected, while FAD is already reduced (figure 
24). This conformation is now called SR II. Accordingly, S  III resembles the state where the Δ23 
cleavage site is exposed and membrane anchor is released due to the second structural rearrangement. In 
this regard equilibrium of SR II and SR III is established if no stabilizers like lipids or proteases are 
present which fix species SR III. The position of the equilibrium is of central importance for EcPOX 
functionality since SR III is the only conformation capable for efficient membrane binding in vivo or 
proteolytic activation in vitro (figure 24).  
In the following section alteration of the SR II:SR III equilibrium due to amino acid substitution in the 
different variants will be detailed discussed and compared to the wt enzyme. One can assume that 
equilibrium is shifted towards species SR III in enzyme variants showing decreased membrane anchor 
stabilization and partial release. Analysis if the SR II:SR III position was performed by limited proteolysis 
and monitored with two methods: SDS-PAGE and Q0 activity assay. 
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figure 24: Supposed model of proteolytic EcPOX activation. In the resting state (R) the Δ101 cleavage site is accessible 
whereas the Δ23 restriction site is protected. The substrate-bound state (SB) is induced by formation of covalent ThDP-
intermediates, while FAD remains unaffected. Both protease cleavage sites are protected. The substrate-reduced state (SR) is 
formed due to pyruvate-induced reduction of FAD. Equilibrium of two forms is established: SR II represents an enzyme species 
where the flavin cofactor is already reduced, but the Δ23 cleavage site is still protected. SR III resembles the enzyme after the 
second conformational change with an exposed Δ23 cleavage site and a released membrane anchor. Only state III is competent to 
produce activated EcPOX Δ23 upon proteolytic digestion. The functional tetramer of EcPOX is simplified illustrated as monomer 
for better visualization. Note that the alpha-peptide is displayed separately from the beta-peptide, although the alpha-peptide 
resembles the C-terminal part of the beta-peptide.     
Determination of the position of the SR II:SR III equilibrium by SDS-PAGE 
Limited proteolysis was used to investigate the activation process and to locate the position of the 
SR II:SR III equilibrium. While enzyme state SR II should remain uncleaved during the proteolysis 
reaction, SR III can be digested to activated EcPOX Δ23 (figure 24). Thus, the position of SR II:SR III 
equilibrium was determined indirectly via Δ23 formation exclusively generated from SR III. Since SR III is 
continuously removed from equilibrium due to digestion, the full-length enzyme is completely converted 
over time to EcPOX Δ23.  
SDS-PAGE can be applied to detect the formation of EcPOX Δ23 [35]. Here, the enzyme was reduced 
with pyruvate followed by addition of alpha-chymotrypsin to initiate the digestion reaction. Gel samples 
were taken after distinct time points and analyzed by SDS-PAGE. The position of the SR II:SR III 
equilibrium of different variants with respect to the wt enzyme was compared using the half-life (t1/2) of 
the digestion reaction. The half-life, which corresponds to the time where 50 % of the full-length protein 
is cleaved to Δ23, was used to calculate the rate constant kact of the activation process assuming single-
exponential formation of Δ23 (equation 4). In this regard, a higher kact (derived from a smaller t1/2) 
resembles an increased amount of SR III in equilibrium with respect to the wt enzyme.   
To investigate whether amino acid substitutions in the variant also alter other conformational changes 
than the SR II→SR III transition the digestion reactions was also performed with the resting-state enzyme 
(R-state). In an additional digestion approach MAP was added instead of pyruvate to generate the 
protease
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phosphonolactyl-ThDP intermediate. Generation of this pre-decarboxylation mimic induces the first 
conformational change from the R-state to the SB-state.  
As example proteolysis reactions of EcPOX wt and variant I554G, which is supposed to be involved in 
membrane anchor stabilization, are shown exemplary in figure 25 and table 11. Digestion patterns of 
other variants are presented in the appendix (chapter 8.6) and all rate constants of proteolytic activation 
are summarized in table 11. 
 
figure 25: Proteolytic digestion of EcPOX wt and I554G monitored by SDS-PAGE. A: + pyruvate. 48.4 µM of EcPOX 
was reduced with 200 mM pyruvate for 10 min at room temperature and 0.4 µM alpha-chymotrypsin was added to initiate 
digestion reaction. Gel samples were prepared after distinct time points and 0.6 µg of proteolyzed EcPOX were analyzed by SDS-
PAGE. B: - pyruvate. EcPOX was treated similar to A, but pyruvate was omitted. C: + MAP. EcPOX was treated similar to A, 
but 20 mM MAP was added as substitute for pyruvate. The different protein bands are indicated as followed: FL = full-length 
protein, Δ23 = EcPOX Δ550-572, Δ101 = EcPOX Δ471-572. Half-life of the digestion reaction (t1/2), where half of the full-
length protein is cleaved to Δ23, is highlighted (). 
EcPOX wt shows an activation rate of 0.14 min-1 (t1/2 = 5 min) in the presence of pyruvate. As already 
stated above, without any substrate the wt enzyme is cleaved into Δ101, whereas the addition of MAP 
prevents the proteolysis reaction. Remarkably, variant I554G shows a 2.5fold increased kact = 0.35 min-1 
(t1/2 = 2 min) if the enzyme is reduced with pyruvate. Surprisingly, also in the presence of MAP or without 
substrate Δ23 generation is detected.  
Determination of the SR II:SR III equilibrium by activity assay 
As second method the Q0 activity assay was applied to determine the amount of SR III in equilibrium. 
Here, increase in activity due to formation of Δ23 from S  III was used. Since Δ23 exhibits a 30-fold 
accelerated activity compared to the full-length form of the wt enzyme (full-length wt: kcat = 6.6 ± 0.2 s-1, 
Δ23: kcat = 185.8 ± 2.7 s-1, chapter 4.1.1) the increase in activity can be directly correlated to the amount of 
generated Δ23. Due to the fact that incubation of enzyme state S  II with protease would not lead to 
truncation of EcPOX it was assumed that catalytic activity of SR II is similar to the resting-state protein 
(R-state). 
The proteolysis reaction is performed identical to proteolysis visualized by SDS-PAGE but progress of 
digestion is monitored by Q0 steady-state assay. Increase in catalytic activity is displayed in dependence of 
EcPOX wt
0     2  3      4      5     6       7     8      10    15   20    40    60   120   0  min   
0     10    20     40    60   120    0  min   
- pyruvate + MAP
+ pyruvate
t1/2 (Δ23) = 5 min








t1/2 (Δ23) = ~15 min
0    0.6   0.8   1.5    2    2.5     3      4      5     7     10    20    60   120  0  min   









- pyruvate + MAP
+ pyruvate
t1/2 (Δ23) = 2 min








incubation time with alpha-chymotrypsin (figure 26). The rate constant kact of this assay is determined by a 
single-exponential equation (equation 5) and should correspond to kact derived from SDS-PAGE analysis. 
Again activation of EcPOX wt in comparison to variant I554G is shown exemplary (figure 26). Activation 
of other variants is displayed in the appendix (chapter 8.6) and summarized in table 11.  
 
figure 26: Proteolytic activation of EcPOX wt and I554G 
monitored by Q0 steady-state assay. Proteolytic digestion 
was performed similar to the SDS-PAGE experiment and 
activated enzyme was examined by Q0 steady-state assay after 
distinct time points. Increase in activity (dots) due to Δ23 
formation was analyzed by a single exponential equation 




The rate constants of activation obtained by Q0 steady-state assay are in good agreement to kact determined 
by SDS-PAGE (table 11). I554G is converted 5fold faster to the corresponding Δ23 variant than wt. As 
already observed in steady-state kinetics, the resting-state activity (in this regard the activity prior to alpha-
chymotrypsin addition) was higher than in the wt enzyme.  
Proteolytic activation of EcPOX variants 
Putative signal transfer variants F465A, Y278F, Y549A and F260A: 
EcPOX F465A is not activated by addition of alpha-chymotrypsin. Only traces of Δ23 are detected by 
SDS-PAGE if F465A is digested in the presence of pyruvate. The majority of the protein is rapidly 
cleaved to inactivate EcPOX Δ101. This result is not astonishing, since no complete flavin reduction is 
observed (chapter 4.1.2) which is a prerequisite for the structural transition S  II→S  III. Additionally, in 
the presence of MAP also Δ101 is formed which implies that the conformational transition  →SB 
(leading to protection of the Δ101 cleavage site due to substrate binding) is altered. This finding is further 
supported by the observation that formation of Δ101 from the resting state protein is enhanced. Thus, a 
central role of Phe465 in the structural reorganization induced by covalent substrate binding and in the 
electron transfer process from HE-ThDP to FAD is feasible.  
Wt-like behavior is observed for variant EcPOX F260A with similar activation rates derived from both 
assays. Also proteolysis of the resting state and substrate-bound state shows no deviations to EcPOX wt. 
Thus, residue Phe260 seems to neither participate in the signal transfer nor in release of membrane anchor 
prior to membrane binding. 
Contrary results are observed for EcPOX Y278F. The half-life of pyruvate-reduced enzyme is 4fold 
increased with respect to the wt enzyme (EcPOX wt: t1/2 = 5 min, Y278F: t1/2 = 20 min). Since all steps 
chymotrypsin incubation time (min)





















EcPOX wt:       kact = 0.16 min
-1 (Astart = 5.3 U/mg)
EcPOX I554G: kact = 0.81 min
-1 (Astart = 74.3 U/mg)
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leading to reduced flavin are not affected (chapter 4.1.2), the SR II:SR III equilibrium seems to be shifted 
towards the SR II form with a shielded Δ23 cleavage site. However, Tyr278 is an active site residue and is 
not involved in membrane anchor stabilization at the protein surface. Thus, information transfer from the 
active site to the membrane anchor seems disturbed in the variant Y278F. This residue could act as initial 
sensor for perception of the reduced flavin. 
Limited proteolytic digestion of variant Y549A was also performed although the primary cleavage site of 
Δ23 (EcPOX Y549-M550) is altered in this mutant. However, it was reported that other proteases like 
trypsin (preferred cleavage C-terminal to Lys or Arg) and even proteases with broader specificity like 
subtilisin or proteinase K exclusively process the full-length enzyme of EcPOX to Δ23 after pyruvate 
addition [18]. Therefore, the presence of Tyr549 at the primary cleavage site seems to be of less 
importance. Proteolysis of Y549A in the presence of pyruvate shows no significant deviations to the wt 
enzyme. Pyruvate-reduced enzyme is completely digested to Δ23 with a t1/2 of 5 minutes. Remarkably, a 
slight amount of Δ23 is formed in the absence of pyruvate or in the presence of MAP. This is also 
observed for several variants potentially involved in membrane anchor stabilization by hydrophobic 
interactions and is detailed described later. In summary, this observation is explained by an already 
released membrane anchor in the resting state or substrate-bound state. 
table 11: Half-lives and kact of proteolytic activation derived from SDS-PAGE and Q0 activity assay for EcPOX variants. 
The half-life t1/2 corresponds to formation of Δ23 from pyruvate-reduced enzyme monitored by SDS-PAGE. t1/2 was used to 
calculate kact from SDS-PAGE (equation 4). kact determined by Q0 activity assay was calculated using a single-exponential equation 
5. t1/2 determined by SDS-PAGE – pyruvate corresponds to the half-life of Δ23 formation where pyruvate was omitted from the 
digestion approach. (- = no Δ23 formation was detected) 







by Q0 assay  
(min-1) 
t1/2 determined by 
SDS-PAGE 
- pyruvate (min) 
wt 5 0.14 0.16 (± 0.01) - 
F465A - - - - 
Y278F 20 0.04 0.06 (± 0.002) - 
Y549A 5 0.14 0.16 (± 0.04) >>120 
F260A 5 0.14 0.19 (± 0.02) - 
D328A, D348A, Q537A (EcPOX 3x) 5 0.14 n. d. - 
L565A 2.5 0.28 0.51 (± 0.04) ~120 
L565G 2 0.35 0.42 (± 0.04) 10 
I554A 3 0.23 0.52 (± 0.03) >120 
I554G 2 0.35 0.81 (± 0.06) ~30 
L565G, I554G (EcPOX 2G) ~0.75 0.92 0.69 (± 0.13) <<10 
W570G ~1.75 0.40 0.29 (± 0.02) >120 
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Potential alpha-peptide binding variants 3x, I554A/G, L565A/G, 2G, W570G: 
Wt-like behavior is observed for variant EcPOX 3x lacking electrostatic interactions for stabilization of 
the membrane anchor. Thus, it is suggested that the SRII:SR III equilibrium is similar positioned as in 
EcPOX wt and that the conformational transition S  II→S  III is not altered. Therefore, participation of 
residues Asp328, Asp348 and Gln537 in stabilization or membrane anchor release from the protein seems 
unlikely.  
Similar results as previously shown for variant I554G are also observed for the other variants (L565A/G, 
I554A/G, 2G, W570G) that are supposed to be involved in hydrophobic membrane anchor binding. 
Those variants show an increased activation rate of pyruvate-reduced enzyme compared to EcPOX wt. 
One can speculate that due to removal of hydrophobic contacts in those variants the SR II:SR III 
equilibrium is shifted towards the SR III-state which resembles membrane anchor release from the protein 
surface. Further, an indirect proportionality of the resting-state kcat and the half-life of digestion is 
observed (figure 27). As seen in steady-state kinetics, Gly substitutions with a minimal hydrophobic 
character show a higher activity than the corresponding Ala variants. 
figure 27: Correlation of resting-state 
activity with observed half-life of Δ23 
generation determined by SDS-PAGE. kcat 
of the resting-state enzyme was calculated 
from Q0 steady-state assay using Michaelis-
Menten equation (table 8). t1/2 of proteolytic 
digestion with pyruvate-reduced enzyme was 





 emarkably, variants L565A G, I554A G, 2G and W570G are also truncated to activated Δ23 in the 
absence of pyruvate as seen by SDS-PAGE (table 11). In those variants already in the resting state a 
conformation is present in which the Δ23 cleavage site and accordingly the membrane anchor is exposed. 
Therefore, the minimal model of different EcPOX conformation needs to be further extended.  
Second extension of the minimal model 
The R-state was hitherto described by a conformation showing an exposed Δ101 cleavage site, while the 
Δ23 restriction site is protected (later termed   I). The new conformation   III represents now an EcPOX 
structure with hidden Δ101 cleavage site and accessible Δ23 restriction locus. As described above for 
conformations SR II and SR III (figure 24) the structural conversion between R I and R III might proceed 
with the help of a third conformation where both cleavage sites are protected (R II). One can assume that 




























































Since no formation of Δ23 is observed for the resting state of the wt enzyme, the position of the R-state 
equilibrium is strongly shifted towards R I and R II. The thermodynamic barrier for the structural 
transition   II→  III seems to be too high leading to an absence of R III in equilibrium. However, 
variants potentially involved in hydrophobic membrane anchor binding (I554A/G, L565A/G, 2G, 
W570G) show an increased amount of R III in equilibrium. This leads to quantitative formation of 
activated Δ23 also in the absence of pyruvate in the digestion approach. Thus, a decreased stabilization of 
the membrane anchor at the protein surface seems to lower the barrier of the   II→  III transition and 
the membrane anchor is partially released. 
Similar observations can be made if variants which are potentially involved in hydrophobic membrane 
anchor binding are incubated with MAP during proteolysis. Under this condition these variants are 
converted to activated Δ23, while the wt enzyme remains uncleaved. Thus, also enzyme state SB must be 
described as equilibrium of three conformations. The position of this equilibrium is shifted towards state 
SB II in the wt enzyme, while in those variants also state SB III accumulates. 
4.1.5 EcPOX activation by the membrane mimic SDS 
Limited proteolysis was used in chapter 4.1.4 to investigate the activation process of EcPOX. Both applied 
assays required an established equilibrium of conformations SR II and SR III of the enzyme to generate 
activated EcPOX Δ23. Given that the proteolysis assay is an artificial system, the results previously 
observed were validated by stimulations of EcPOX with SDS. This activation system is probably more 
native-like since SDS mimics the cell membrane. 
The activation model of SDS 
It was reported that EcPOX shows an increased activity if detergents or lipids are present in in vitro assays 
[34]. The molecular mechanism of interaction of the enzyme with such amphiphiles is still uncertain due 
to the fact that no structures of EcPOX in complex with detergents or lipids are available. However, 
interactions of those amphiphilic molecules with the enzyme are supposed to be restricted to the 
membrane anchor, since activity of the proteolytically activated Δ23 variant failed to be further accelerated 
by addition of amphiphiles [18].  One could speculate that lipids or detergents stabilize the exposed 
membrane anchor of pyruvate-reduced EcPOX similar to the native membrane by induction of a helical 
structure.  
A similar mode of activation was proposed for SDS-stimulation and proteolysis for EcPOX ( figure 28). 
The enzyme is reduced with pyruvate leading to equilibrium of enzyme forms SR II and SR III. While the 
membrane anchor is still attached to the protein surface in SR II, possible interactions with SDS are 
supposed to maintain resting-state activity. Remarkably, only conformation SR III resembles a released 
membrane anchor which could be stabilized by SDS contacts leading to accelerated activity. The increase 
in activity can be directly correlated to the amount of SR III in equilibrium.  
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figure 28: Supposed model of SDS-mediated EcPOX activation. In the resting state (R) the Δ101 cleavage site is accessible 
whereas the Δ23 restriction site is protected. The substrate-bound state (SB) is induced by formation of covalent ThDP-
intermediates, while FAD remains unaffected. Both protease cleavage sites are shielded. The substrate-reduced state (SR) is 
formed due to pyruvate-induced reduction of FAD. Equilibrium of two forms is established: SR II represents an enzyme species 
where the flavin cofactor is already reduced, but the Δ23 cleavage site is still protected. SR III resembles the enzyme after the 
second conformational change with an exposed Δ23 cleavage site and a released membrane anchor. Only state III is competent to 
be activated by SDS leading to helix formation of the membrane anchor. The functional tetramer of EcPOX is simplified 
illustrated as monomer for better visualization. Note that the alpha-peptide is displayed separately from the beta-peptide, although 
the alpha-peptide resembles the C-terminal part of the beta-peptide. Different conformations of the R- and SB-state as previously 
determined by proteolysis experiments (chapter 4.1.4) were omitted for reasons of clarity.     
 
However, activation of EcPOX with SDS illustrates not only the transition S  II→S  III but also the 
property of the membrane anchor to form an amphipathic helix. One can assumes that only a properly 
folded helix can be stabilized by SDS resulting in the desired activity acceleration. Therefore, this method 
additionally allows analysis of the intrinsic helix propensity of the membrane anchor which might be 
altered due to amino acid substitutions in variants I554A/G, L565A/G, 2G and W570G. 
SDS-mediated activation assay 
To study the influence of different amino acid residues on the activation in a native-like system EcPOX is 
stimulated with SDS in an assay constructed similar to the proteolysis experiments. The enzyme is pre-
incubated with pyruvate to establish SR II:SR III equilibrium. Addition of SDS leads preferentially to 
stabilization of the SR III-state which is therefore gradually removed from equilibrium.  
After initiation of the activation process by addition of different amounts of SDS, the increase in activity 
is determined after distinct time points using the Q0 steady-state assay (figure 29 A and B). Afterwards, 
obtained activities are displayed in dependence of the SDS concentration (figure 29 C). Although this 
figure is not time-resolved, for one specific SDS concentration the lowest activity corresponds to an SDS 
incubation time of approximately one minute and the final activity to enzyme stimulated for 30 min with 
SDS. To compare the different variants the final activity is converted to relative activity by adjusting the 
SDS
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maximum activity to 100 %. Activation studied with different amounts of SDS allows determination of 
SDS0.5, the SDS concentration where 50 % of the protein is activated after half of the measuring time 
(figure 29 D). SDS0.5 describes the affinity of EcPOX for SDS molecules and was used as a measure to 
compare the different variants. Thus, an increase of SDS0.5 with respect to the wt enzyme can indicate a 
smaller amount of SR III in equilibrium or a disturbed helix formation.  
SDS-mediated activation of EcPOX variants 
EcPOX wt: 
Kinetics of SDS-mediated activation of EcPOX wt and variant L565A are exemplary shown in figure 29 A 
and B. Data of other variants are illustrated in the appendix (chapter 8.4) and summarized in figure 29 D. 
The wt enzyme is completely activated in the presence of 100 µM SDS. At this concentration the 
activation process is already finished within the dead time of the assay (approximately one minute). 
Intermediary activation is observed if 20-70 µM SDS are added. In those cases the activity is increased 
with longer SDS incubation time. SDS0.5 was determined to be 50 µM.  
Putative signal transfer variants F465A, Y278F, Y549A and F260A: 
Variant F465A is not activated by SDS which resembles results observed in the proteolysis reactions. 
Since both assays rely on exposition of the membrane anchor in state SR III based on functional FAD 
reduction, the observed effects can be correlated to an impaired electron transfer to the flavin cofactor 
due to the substitution of Ala for Phe.  
EcPOX Y278F shows nearly no activation if assayed with 30 µM SDS and complete activation only at 150 
µM detergent. In comparison to the wt enzyme Y278F needs an approximately 1.5fold higher SDS 
amount to reach a similar activation level (EcPOX wt: SDS0.5 = 50 µM, Y278F: SDS0.5 = 70 µM). Since the 
amino acid sequence of the membrane-anchor is not altered in this variant, the observed results only 
correspond to a shift of the SR II:SR III equilibrium towards the SR II-state. The same effect was 
observed for proteolytic activation (chapter 4.1.4). Both experiments imply an important role of Tyr278 
on the activation process starting from the reduced flavin cofactor.   
A approximately 1.7fold decreased SDS0.5 is detected for Y549A. Although the exchanged residue of this 
variant is located at the N-terminal end of the membrane anchor an influence on helix formation cannot 
be excluded. However, it seems more likely that the lowered SDS0.5 is caused by a shift of the SR II:SR III 
equilibrium towards the membrane binding competent species SR III in the variant.  
Wt-like activation is observed for EcPOX F260A with a SDS0.5 of 50 µM. As already indicated in 
proteolysis reaction Phe260 does not seem to play a central role in release of the membrane anchor and 





figure 29: SDS-mediated activation of EcPOX variants. 160 nM EcPOX were pre-incubated with 200 mM pyruvate. The 
activation process was initiated by addition of different SDS amounts and activity was monitored by Q0 steady-state assay. A: 
Kinetics of EcPOX wt activation. B: Kinetics of EcPOX L565A activation. C: Comparison of SDS-mediated activation of EcPOX 
wt and L565A in dependence of the desired SDS concentration. Each ensemble of data points at a given SDS concentration 
resembles one curve of A and B. The gray dashed line highlights SDS0.5. D: Comparison of SDS0.5 values of EcPOX variants. 
SDS0.5 values are displayed as bar plot and by white numbers. Red color indicates a SDS0.5 smaller than wt whereas black color 
illustrates a SDS0.5 higher than wt. (* F465 was not activated with SDS. # EcPOX 2G was already completely activated without 
SDS)  
 
Potential alpha-peptide binding variants 3x, I554A/G, L565A/G, 2G, W570G: 
Variants supposed to be involved in hydrophobic stabilization of the membrane anchor (I554A, 
L565A/G, 2G) show a decreased SDS0.5 value compared with the wt enzyme. The most pronounced 
effect is observed for EcPOX 2G which is already completely activated in the resting state. Thus, one can 
suggest that the equilibrium between SR II and SR III is shifted towards the SDS-binding competent 
SR III-state in those variants. These findings are in line with proteolysis experiments and foster the idea 
that the membrane anchor is stabilized at the protein surface by hydrophobic interactions. 
A similar observation can be made for variant EcPOX 3x which lacks the prominent electrostatic 
interactions and hydrogen bonds of the membrane anchor to the protein core. Compared to EcPOX wt 
the determined SDS0.5 value is 1.7fold decreased which reveals accumulation of state SR III in equilibrium. 
However, this result is in contrast to proteolytic digestion approaches which show a wt-like equilibrium 
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interactions contrary to the protein surface. Thus, SDS could increase the amount of the exposed form of 
the membrane anchor which leads to accelerated activity compared to the wt enzyme. 
An opposite effect is observed for EcPOX I554G and W570G. For both variants a SDS0.5 of 70 µM is 
determined. These findings are in contrast to proteolysis experiments where the equilibrium of SR II and 
SR III is shifted towards the SR III-state and a partially released membrane in the resting state is detected. 
Therefore, the decreased SDS0.5 value is most likely caused by a disturbed helix formation due to the 
amino acid exchanges in both variants which leads to a decreased affinity for SDS molecules. One could 
propose that the SDS0.5 would be even lower but that the accumulation of SDS-binding competent SR III 
in equilibrium counteracts disturbed generation of the helix.  
4.1.6 Temperature-induced unfolding of EcPOX  
It was previously reported that the full-length enzyme of EcPOX is significantly stable, since it resists a 
heat precipitation step during purification [15]. Contrary, pyruvate-reduced enzyme tends to aggregate 
[18]. Thus, it was suggested that the reduced enzyme resembles the membrane-bound EcPOX protein, 
while oxidized EcPOX corresponds to a typical cytosolic enzyme [111]. Temperature-labile behavior is 
also observed for the proteolytically activated EcPOX Δ23, which aggregates at conditions where the full-
length enzyme is particular stable. 
Analysis of the resting-state conformations by thermal unfolding 
Stability of full-length EcPOX, proteolytically activated Δ23 and several variants was investigated by 
temperature-induced inactivation. Unfolding was monitored by far-UV CD spectroscopy at 208 nm. At 
this area mainly alpha-helical parts of the protein produce a negative signal, which disappears due to 
unfolding at higher temperatures (figure 30). 
Temperature-dependent unfolding of the EcPOX protein is an irreversible process since refolding trials of 
the unfolded protein by stepwise decrease in temperature did not generate a functional enzyme (data not 
shown). Nevertheless, an apparent melting temperature was determined with the equation of Pace [87] 
which is typically used to examine melting temperatures of reversible unfolding processes. Thus, only an 
apparent Tm was obtained with this method. Since the experiments were performed under identical 
conditions the determined Tm could be used for qualitative comparison of different variants.  
The different EcPOX variants were only examined in the absence of substrate which exclusively allows 
statements concerning the resting state of the enzyme. The obtained results should therefore correlated to 
proteolysis experiments of resting-state EcPOX in the absence of pyruvate and MAP. In this regard, a 
decreased melting temperature indicates a partly released membrane anchor from the protein surface. 
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Thermal unfolding of EcPOX variants 
EcPOX wt and activat d Δ23: 
Compared to full-lenght EcPOX wt activated Δ23 shows a by 15 °C decreased apparent Tm (figure 30 B 
and table 12). However, it is astonishing that such an enormous difference is caused by deletion of 23 
amino acids which resemble only a surface-attached membrane anchor of the protein. Thus, a stabilizing 
effect of this membrane anchor to the entire protein structure besides membrane binding is suggested.  
 
figure 30: Thermal unfolding of EcPOX wt and selected variants. A: CD spectra of native (20 °C) and unfolded (95 °C) 
EcPOX wt (0.1 mg/mL, path lenght 1 mm). The signal at 208 nm (grey line) was used for temperature-dependent denaturation. 
B: Temperature-dependent unfolding of EcPOX wt and selected variants at 208 nm. Progress curves were used to calculate the 
apparent melting temperature Tm by equation 6. The shift of the observed melting temperature Tm for the variants is indicated by 
an arrow. Unfolding curves of other variants are displayed in the appendix (chapter 8.3) and calculated Tm are presented in 
table 12. 
Putative signal transfer variants Y549A and F260A: 
The observed Tm of EcPOX F260A is only slightly decreased compared to the wt enzyme. Thus, the 
membrane anchor is still attached to the protein in the variant which is in good agreement to proteolytic 
digestion experiments of the resting-state enzyme.  
Contrary, variant Y549A shows a significantly by 5 °C decreased Tm. As already indicated by proteolysis 
reactions the membrane anchor of EcPOX Y549A seems to be destabilized leading to a partial release and 
thus to an enhanced thermal unfolding similar to EcPOX Δ23.  
Potential alpha-peptide binding variants 3x, I554A/G, L565A/G, 2G, W570G: 
Variant EcPOX 3x lacking three prominent electrostatic interactions and hydrogen bonds to the 
membrane anchor shows similar unfolding like the wt protein. One can conclude that this mutant reflects 
the wt enzyme with a membrane anchor clamped to the protein. This finding is in line with previous 
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table 12: Apparent melting temperatures of EcPOX variants. Apparent Tm was calculated from unfolding curves (figure 
30 B) using equation 6. (n. d. = not determined)  
EcPOX variant app. Tm (°C) 
wt 78.4 
wt Δ23 63.8 
F465A n. d. 
Y278F n. d. 
Y549A 73.0 
F260A 76.7 





L565G, I554G (EcPOX 2G) 67.8 
W570G 76.1 
 
Almost all variants supposed to be involved in hydrophobic membrane anchor binding show a decreased 
Tm value compared with EcPOX wt. Gly variants with a minimal hydrophobic character compared to the 
native Leu or Ile unfold at lower temperatures similar to activated EcPOX Δ23. This finding also 
correlates with an increased kcat of the resting state analyzed by Q0 steady-state assay (figure 31). However, 
in both assays substitutions of Ala for Ile and Leu lead to results less pronounced. Therefore, Ala mutants 
show still wt-like properties, while the Gly variants are more similar to Δ23.  
figure 31: Correlation of resting-state activity with 
the apparent melting temperature of EcPOX 
variants. kcat of the resting-state enzyme was 
determined by Q0 steady-state assay (table 8). 
Apparent Tm was obtained from thermal unfolding 


















































4.1.7 EcPOX structure determination by X-ray crystallography 
The crystal structures of full-length and proteolytically activated EcPOX revealed only minor structural 
changes [35]. A prominent difference within the active site was repositioning of Phe465 between both 
cofactors upon activation, which was interpreted to facilitate electron transfer between the thiamine and 
flavin cofactors. Due to truncation of the membrane anchor, a reorganization of the residual membrane 
binding domain was also observed in Δ23 which results in improved accessibility of the active site.  
Crystal structures of EcPOX variants in the resting state were generated and analyzed focusing both on 
differences within the active site and on the polypeptide chain conformation of the membrane anchor and 
its relative orientation to the remaining part of the molecule. The determined resting-state structures were 
compared to the structure of the full-length protein or activated Δ23, respectively (pdb: 3EY9 and 3EYA, 
[35]). Results should be related to proteolysis and thermal unfolding experiments of the resting state of 
each variant. 
Crystal structures of EcPOX variants 
Crystallization of several variants was performed similar to the wt enzyme [82] and bright yellow crystals 
grew typically within one week. After cryo-protection, the crystals were measured at different 
synchrotrons resulting in datasets within 3.24 to 2.8 Å resolution range (table 7 and table 13). 
All EcPOX variant crystals are isomorphous with wt enzyme which crystallized in tetragonal space group 
P43212 with two molecules of EcPOX per asymmetric unit. The final structures were solved by using the 
full-length structure of EcPOX wt as initial model and further refinements (chapter 3.25). Data collection 
and final refinement statistics are summarized in the appendix (chapter 8.7) and root-mean-square 
deviations (r.m.s.d.) compared to the wt structure are displayed table 13. Due the low resolution of the 
crystal structures one should be aware that minor but important changes of central amino acids were 
potentially not resolved in the calculated electron density maps. 
Putative signal transfer variants Y278F, Y549A and F260A: 
Variant Y278F is investigated with special focus on the interaction of the substituted amino acid with the 
flavin cofactor and on the architecture of the active site. Comparison of the obtained Y278F structure 
with the wt enzyme reveals neither deviations of the overall structural organization of the protein nor 
rearrangements within the active site (figure 32 A and table 13). Additionally, the position and 
conformation of Phe278 side chain in the variant was not changed significantly to Tyr278 in the wt 
enzyme. Noteworthy, for the six ring atoms of Phe278 the occupancy was refined to 70 %. This 
implicates an important role of the proposed hydrogen bond to the N5-atom of the flavin in stabilizing 
the conformation of Tyr278. If this interaction is disrupted by deletion of the hydroxyl function in the 
variant, the side chain seems to be more flexible and the position shows an increased uncertainty in the 
crystal. Nevertheless, this minor change could not explain the significant differences of Y278F compared 
to the wt observed in proteolysis and flavin reduction experiments. 
Results 68 
table 13: R.m.s.d. values of variant structures of EcPOX and LpPOX. R.m.s.d. values were calculated based on the position 
of the Cα-atoms with the program lsqman [112] using the EcPOX wt structure (pdb: 3EY9), EcPOX Δ23 (pdb: 3 YA) and 
LpPOX wt structure (unpublished high-resolution at 1.09 Å structure of LpPOX wt was friendly provided by Dr. Danilo Meyer, 
Department of Bioanalytics, Göttingen). All amino acids were included in the model. Amino acid residues which deviate more 
than 3 Å from the models were excluded from r.m.s.d. calculations and are listed in the table. All excluded residues were mainly 
located in highly flexible loop regions. A, B and I-J in the table indicate different chains in the structures. (n. c. = no crystals were 
obtained, n. d. = not determined, a= only the tetramer composed of subunits I-L was used for r.m.s.d. calculations) 
variants final resolution (Å) r. m. s. d. (Å) excluded amino acid residues  
F465A n. c. n. c. - 
Y278F 2.96 0.195 B: Lys2, Leu476 
Y549A 2.79 0.120 B: Lys2 
F260A 3.08 0.125 B: Lys2 
D328A, D348A, Q537A (EcPOX 3x) 3.20 0.162 B: Lys2 
L565A 3.24 0.204 A: Gly474, B: Lys2 
L565G n. c. n. c. - 
I554A 3.02 0.183 A: Gly474, B: Lys2 
I554G 2.90 0.190 A: Leu476, B: Trp475, Leu476 
L565G, I554G (EcPOX 2G) n. d. n. d. - 
W570G n. d. n. d. - 
EcPOX Δ23:Q0 3.20 0.140a I/J/K/L: Met1, Gly479a 
LpPOX F289Y 1.43 0.061 B: Thr9 
 
Variants Y549A and F260A were also analyzed concerning rearrangements within the active site and 
potential release of the membrane anchor from the monomer surface. Both variants show no significant 
structural deviations to the wt enzyme (table 13). Active site residue Phe465 reveals identical 
conformation as observed in the non-activated EcPOX structure and points away from both cofactors 
(figure 32 B). Further, the membrane anchor is still bound at the protein and reveals no elevated flexibility. 
For variant F260A these findings are in agreement to previous results obtained from proteolysis and 
thermal unfolding experiments which predict Phe260 to play no central role in membrane anchor 
stabilization or in the signal transfer from FADH2 to the membrane anchor. Contrary, analysis of variant 
Y549A clearly indicated a partially released membrane anchor already in the resting state which cannot be 
observed in the crystal. This phenomenon is also observed for variants supposed to be involved in 
hydrophobic membrane anchor binding.  
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figure 32: Comparison of the crystal structures of EcPOX variants Y278F and Y549A with EcPOX wt. A: Comparison of 
EcPOX Y278F (blue) with the full-length enzyme (wt) of EcPOX (white). No significant structural changes are detected within 
the active site in the variant. B: Comparison of EcPOX Y549A (blue) with the full-length enzyme (wt) of EcPOX (white). Phe465 
and Ala549 occupy an identical position in the variant as in the wt enzyme. 
Although crystals of F465A were measured, structure determination of this variant failed. All crystals 
constituted of multiple layers and were not usable to determine the structure. Several attempts to improve 
the crystal properties, including screening of buffer conditions, were applied but failed.    
Potential alpha-peptide binding variants 3x, I554A/G, L565A: 
EcPOX 3x which lacks electrostatic interactions and hydrogen bonds to the membrane anchor shows a 
wt-like structure (table 13). This is in agreement with other experiments like proteolysis and temperature-
induced unfolding. 
No significant structural changes compared to the wt enzyme can be detected for variants I554A/G and 
L565A presumably involved in hydrophobic membrane anchor binding (table 13 and chapter 8.9). 
Although proteolytic digestion and thermal unfolding experiments reveal a partially released membrane 
anchor already in the resting state, this part is found attached to the protein surface in all three crystal 
structures (chapter 8.9). Thus, the obtained structures reflect species   I where the Δ23 cleavage site is 
protected, while the Δ101 restriction site is accessible. 
To exclude that the obtained crystal structures suffered from model bias since the full-length structure was 
used as initial model a simulated annealing omit map as calculated with CNS was generated for variant 
EcPOX I554G. The obtained electron density mFo-DFc omit map shows that the protein backbone and 
amino acid side chains of the membrane anchor are defined up to residue 572, which argues against a 










figure 33: Crystal structure of variant EcPOX I554G. A: Simulated annealing omit map for EcPOX I554G. The protein-
attached membrane anchor (residues M550-R572) is presented in green whereas the protein core is shown as white cartoon. The 
obtained mFo-DFc omit map for the membrane anchor (simulated annealing omit map was calculated with CNS) is shown as 
orange mesh countered at  4 σ. The position of the exchanged residue I554G is indicated by a blue arrow. B: Crystal contacts of 
two subunits of EcPOX I554G. Potential interactions of two subunits within the crystal are shown as green dashed lines. Residues 
of the membrane anchor are presented as blue sticks whereas interacting side chains of the other subunit are depicted in red.  
However, it seems reasonable that the obtained crystal structures of variants I554A/G and L565A do not 
reflect the solution state of the enzyme. Due to contacts of the subunits within the crystal the membrane 
anchor could be forced into this fixed conformation although it is more relaxed in solution (figure 33 B). 
Additionally, although equilibrium of three different R-states is supposed to be established it seems 
possible that only conformation R I with a protein-bound membrane anchor tends to crystallize under the 
given conditions. 
4.2 Structural analysis of the membrane-associated membrane anchor 
Analysis of the EcPOX-bound membrane anchor (alpha-peptide) indicates formation of two beta-strands 
and unstructured loops [35]. However, secondary structure predictions of the amino acid sequence of the 
isolated alpha-peptide reveal formation of a helix [29]. Indeed, it could be shown that the isolated peptide 
adopts a helical structure in the presence of the surface-active agent SDS, while in the absence of lipids or 
detergents the structure of the alpha-peptide is characterized by an increased amount of random-coil 
parts [35].  
The influence of alpha-peptide sequence on stabilization to the protein surface of EcPOX was earlier 
described in chapter 4.1. This part focusses on the impact of membranes and mimics thereof on helix 
formation of the alpha-peptide and subsequent membrane binding. Similar to membrane anchor 
stabilization at the protein surface also the primary sequence of the alpha-peptide can affect intrinsic helix 
propensity. Further, properties of the membrane like surface charge and tension or lipid composition 
might improve or inhibit helix formation and concomitant bilayer association. For analysis of these 
different conditions only the isolated membrane anchor instead of the entire protein was used as 














conformation, while liquid-state NMR studies reveal information about the three-dimensional structure on 
the atomic level. Therefore, labeling of the alpha-peptide with the heavy atoms 15N and 13C was necessary. 
4.2.1 Preparation of the alpha-peptide 
Heavy-atom labeling of the peptide is possible in two different ways. On the one hand the peptide can be 
chemically synthesized from labeled amino acids. However, not all labeled amino acids are commercially 
available and some amino acids are composed of labeled and non-labeled N- and C-atoms. Synthesized 
peptide samples derived from those amino acids would consist of several incompletely labeled species. On 
the other hand recombinant expression of the alpha-peptide in 15N- and 13C-containing media can be 
applied. Thereby, heavy atoms are introduced in the peptide during expression in the bacterial cell. This 
method was chosen for alpha-peptide labeling within this thesis. Since the final amount of pure peptide 
after expression was typically low due to numerous purification steps, optimization of the expression and 
purification procedures had to be performed. 
Expression and purification of non-labeled alpha-peptide 
The non-labeled alpha-peptide was recombinantly expressed as SUMO-alpha fusion construct in E. coli in 
rich media (figure 34 A). The SUMO-protein, which is N-terminal fused to the alpha-peptide (23 amino 
acids), exhibits a polyhistidine-tag which allowed purification by Ni affinity columns. The SUMO-protein 
was cleaved off by specific digestion with SUMO-protease which selectively recognizes the three-
dimensional fold of SUMO [113]. Finally, both the protease and the SUMO-protein were removed from 
the peptide by a second Ni-affinity column since the peptide was untagged after cleavage. 
 
 
figure 34: A: Purification scheme of the SUMO-alpha fusion construct. The alpha-peptide is expressed as SUMO-fusion 
construct with an N-terminal polyhistidine-tag (His6) and purified by Ni-affinity column. The SUMO-protein is cleaved by the 
SUMO-protease which also contains a polyhistidine-tag. Protease and SUMO-protein are removed from the alpha-peptide by a 
second Ni-affinity column and the alpha-peptide is found in the flow through. B: Reversed-phase HPLC analysis of the 
obtained alpha-peptide fraction. The alpha-peptide fraction from a standard purification was loaded on a C18 column and 
eluted with the analytical gradient (chapter 3.17). Fractions of peak I and II were collected and analyzed by mass spectrometry. 
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Reversed-phase HPLC analysis of the obtained peptide revealed that beside the full-length alpha-peptide 
also shorter fragments are generated (figure 34 B). Those species were identified by mass spectrometry as 
C-terminal truncated fragments of the entire alpha-peptide. To avoid these impurities in the peptide 
fraction expression and purification procedure were optimized (data not shown). While temperature 
changes did not lead to accumulation of the entire alpha-peptide, decreased expression time after 
induction showed a higher amount of the alpha-peptide compared to the unfavored fragments. Further, 
protease inhibitors were added during purification. However, no effect compared to untreated SUMO-
alpha purification was detected. Thus, it is reasonable to conclude that degradation of the alpha-peptide 
already occurs during expression in E. coli cells and cannot be prevented. To remove truncated peptide 
fragments the obtained peptide solution was purified by reversed-phase HPLC. 
Expression and purification of heavy-atom labeled alpha-peptide 
Expression of labeled alpha-peptide was performed in M9 minimal media relying on the method of 
Marley and co-workers [84]. According to their procedure high cell mass is generated in rich media 
followed by exchange to media containing the labeled nutrients. During this step cells are dissolved in a 
smaller volume to generate a high cell density, which provides higher yields with respect to the applied 
cultivation volume. Finally, a short recovery period allows clearance of unlabeled substances followed by 
induction of protein expression. Purification of the alpha-peptide was similar to non-labeled peptide 
samples. 
Prior to labeling several optimization trials were either performed in unlabeled media or with cells derived 
from expression in unlabeled media. With regard to the highest yield the following expression and 
purification parameters were optimized: 
 cell density after media exchange 
 expression time and temperature 
 cell amount used for purification 
 desalting step for imidazole removal prior to digestion 
 removal of SUMO-protein and -protease after digestion 
The final expression and purification procedure is detailed described in chapters 3.14 and 3.15. With this 
procedure 1.3 mg pure labeled alpha-peptide were obtained from 250 mL labeled media. 
Determination of 13C- and 15N-incorporation rate  
To investigate the amount of incorporated 15N- and 13C-atoms into the labeled alpha-peptide the HPLC-
purified peptide was subjected to mass spectrometry analysis. A molecular weight difference of 151 g/mol 
calculated from non-labeled (2639 g/mol) and labeled (2790 g/mol) alpha-peptide corresponds to 
complete incorporation of 13C and 15N. Mass spectrometry analysis of the non-labeled peptide revealed 
the expected molecular weight of 2640.45 g/mol (figure 35 A). For samples of the labeled peptide a mass 
shift to 2766.68 - 2791.74 g/mol is detected (figure 35 B) which correspond to 84 – 100 % enrichment of 
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15N and 13C. Remarkably, the peak with the highest intensity (2789.74 g/mol) indicates 99 % successful 
heavy-atom incorporation 
  
figure 35: Mass spectrometry analysis of non-labeled (A) and labeled (B) alpha-peptide. HPLC purified peptide samples 
were analyzed by electro spray ionization mass spectrometry performed by Dr. Holm Frauendorf (Department Zentrale Analytik 
und Massenspektrometrie, Göttingen). Spectra were deconvoluted prior to use. Molecular weight of the non-labeled peptide was 
determined to be 2640.45 g/mol and molecular weights of the labeled peptide were determined between 2766.68-2793.74 g/mol. 
The enrichment of more than 84 % heavy atoms and the amount of labeled alpha-peptide were sufficient 
for structural studies by liquid-state NMR. Since a successful heavy-atom incorporation method is the 
base to examine the alpha-peptide structure in the presence of diverse lipids, extensive analysis with 
various membrane-like systems and varying lipid compositions are now possible. 
4.2.2 Analysis of the alpha-peptide structure by far-UV CD spectroscopy 
Analysis of the secondary structure of peptides and proteins by far-UV CD spectroscopy reveals insights 
into the overall fold [114] [115]. Deconvolution of obtained spectra can further examine the contribution 
of secondary structure elements to the global conformation. Here, CD spectroscopy was used to analyze 
the influence of detergent micelles (applied as membrane mimics) on helix formation of the alpha-peptide. 
Therefore, the peptide was reconstituted with 50 mM SDS or 50 mM DPC in buffer (figure 36). Both 
detergent concentrations were set at 20 x the CMC to ensure formation of micelles. Prior to the 
measurement the CMC was determined in the corresponding buffer system by ITC (chapter 8.1). Besides 
detergents also trifluoroethanol was added to the peptide to induce a distinct helical structure [95]. 
Afterwards, all spectra were deconvoluted with the implemented chirascan software CDNN [96]. 
  
A: non-labeled alpha-peptide B: labeled alpha-peptide
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figure 36: Far-UV CD spectra of the alpha-peptide in 
detergents. 0.1 mg/mL alpha-peptide was examined by far-
UV CD spectroscopy in a 1 mm cuvette at 20 °C. 
Measurements were performed in buffer (50 mM NaH2PO4 
pH 6.0) supplemented with SDS (50 mM), DPC (50 mM) or 





The alpha peptide adopts a random-coiled structure in the absence of detergents (figure 36 and table 14). 
Remarkably, the addition of SDS or DPC micelles leads to induction of a structure containing 41 % and 
46 % helical motifs. Similar observations can be made for the alpha-peptide in the presence of 
trifuoroethanol (33 % helix). These results are in good agreement to the work of Weidner who reported 
47 % helix amount due to SDS addition [45].  
table 14: Secondary structure content of the alpha-peptide in the presence of detergent micelles. Percentage of secondary 
structure elements was calculated with the program CDNN [96] from spectra of figure 36. 
 alpha-helix (%) beta-sheet (%) turn (%) coil (%) 
alpha-peptide in buffer 5 25 26 44 
alpha-peptide + 50 mM SDS 41 16 18 25 
alpha-peptide + 50 mM DPC 46 13 17 24 
alpha-peptide + 50 % (v/v) trifluoroethanol 33 16 21 30 
 
Noteworthy, the zwitterionic detergent DPC leads to a slightly increased helix amount compared to the 
anionic SDS, which raises the question if the peptide conformation is different in both detergents. Since 
solution-state NMR studies of the SDS-bound peptide revealed an extended helix [45], it seems reasonable 
that the DPC-attached alpha-peptide forms a more compressed helical motif. Comparison of the structure 
of both detergents indicates that especially the head group of DPC is more related to the native 
phospholipids phosphatidylglycerol and phosphatidylethanolamine found in the E. coli membranes (figure 
37). Thus, one can assume that the conformation induced by DPC reflects more likely the native 
membrane-bound alpha-peptide. In this regard, NMR-studies of the peptide:DPC complex could reveal 
further insights.  
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figure 37: Structural comparison of E. coli phospholipids and detergents. A: phosphatidylglycerol 
B: phosphatidylethanolamine, C: SDS, D: DPC. (R1 and R2 represent fatty acid tails) 
Although it is demonstrated that the amphiphiles SDS and DPC mediate formation of a helical structure 
of the hitherto unstructured alpha-peptide it remains unclear how strong curvature and surface tension 
enhance this conformation. Since detergents are known to induce helices in peptides and proteins [116] it 
seems questionable if the observed alpha-peptide conformation is only related to properties of the used 
membrane mimic. It needs to be proven if membrane-like systems like bicelles and vesicles also lead to 
formation of an amphipathic helix of the alpha-peptide. In contrast to micelles lipid vesicles or bicelles 
better resemble the lipid bilayer due to the flat surface which severely reduced surface curvature and 
tension [46] (figure 38).  
figure 38: Schematic representation of membrane mimics. A: 
Micelles formed from detergent molecules exhibit high curvature and 
surface tension. B: Bicelles are binary assemblies of long-chain lipids 
and detergents or short-chain lipids. Due to their planar bilayer 
formed of long-chain lipids surface tension and curvature are severely 
reduced. C. Liposomes resemble the native cell with a bilayer 
entrapped volume. Depending on their size curvature and surface 
tension may vary. D: Membranes are composed of lipid bilayers with 
almost no surface tension and curvature.  
 
4.2.3 NMR structure determination in the presence of DPC micelles 
Secondary structure analysis of the alpha-peptide in the presence of DPC micelles revealed a slight 
increase of the helical amount compared to incubation with SDS. It is suggested that the increased 
percentage of the helix motif is reflected in a partly altered structure of the peptide. Since the alpha-
peptide helix determined in complex with SDS indicates an extended conformation it can be assumed that 
the DPC-induced helix is more compressed. 
To investigate this hypothesis in a preliminary experiment the heavy atom-labeled alpha-peptide was 





























































Piotr Wysoczanski and Prof. Dr. Markus Zweckstetter at the Department of Structure Determination of 
Proteins Using NMR (Max Planck Institute for Biophysical Chemistry, Göttingen).  
Unfortunately, until the end of this thesis only a preliminary structure was available which revealed alpha-
helix formation of the alpha-peptide in the presence of DPC micelles. Further, it was indicated that Arg of 
the peptide are involved in the interaction with the polar head groups of DPC. Few indications were 
obtained which opens speculation that hydrophobic Val13, Ile14 and Leu17 might be embedded into the 
core of micelles. Further analysis need to be performed to assign solve the structure of the entire peptide 
and positions of amino acid side chains. 
The preliminary results are consistent with the previous structure of the alpha-peptide determined in the 
presence of SDS micelles (figure 10). Similar to the DPC-reconstituted peptide structure also the presence 
of SDS induces formation of an alpha-helix with Val13, Ile14 and Leu17 constituting the core of this 
helical motif [45]. Also the electrostatic interactions between positively charged Arg with the phosphate 
moieties of DPC are expected. It was shown for membrane binding of other amphipathic helices that 
these interactions are necessary to attract the peptide from the bulk solvent to the membrane surface [56] 
[58] [59]. However, an interesting point that needs to be studied is release of the membrane anchor from 
the membrane to ensure reversibility of binding. Therefore, variants of the alpha-peptide should be 
generated where several positively or negatively charged and hydrophobic amino acids are exchanged to 
Ala to study the impact of the desired amino acid on membrane binding and release of the alpha-peptide.  
 
4.3 Investigations of the electron transfer from EcPOX to Q8 
A fundamental step in EcPOX catalysis is the electron transfer from the reduced flavin cofactor to the 
membrane-bound Q8 leading to the regenerated enzyme and reduced Q8 [17]. This energy-conserving step 
depends on translocation of EcPOX from the cytosol to the cell membrane to get access to the 
membrane-dissolved substrate Q8. However, how the electrons are shuffled from the active site into the 
membrane remains open. One could speculate that the head group of ubiquinone can partly leave the 
membrane and penetrates the active site. This mechanism could allow electron tunneling between cofactor 
and substrate within a short distance of 14 Å [67]. On the other hand it can be proposed that electrons 
hop with the help of the protein backbone and side chains to Q8. In this case, ubiquinone could remain 
located at the membrane interface. Both electron transfer mechanism and substrate interaction modes 
seem possible and need to be further investigated. 
The reaction of reduced EcPOX with the substrate Q8 can be simply described as followed: 
EcPOX-FADH2  +  Q8   →   EcPOX-FAD  +  Q8H2 
Reduced pyruvate oxidase transfers two electrons to Q8, which is subsequently reduced yielding Q8H2 and 
the regenerated enzyme. However, mandatory translocation of EcPOX to the membrane, which harbors 
Q8, is missing in this scheme. In order to analyze the interaction of the enzyme with its substrate in more 
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detail a reconstitution of Q8 into membranes or vesicles would be essential. To simplify analysis, the 
water-soluble analog Q0, which lacks the isoprenoid tails, was used as Q8 substitute. Importantly, it was 
assumed that binding and electron transfer of Q0 and Q8 proceed similar.   
4.3.1 Proteolysis under steady-state conditions 
Limited proteolysis was already applied to investigate conformational changes during the catalytic cycle. It 
was shown that formation of covalent ThDP intermediates reveals a non-cleaved enzyme, while 
truncation of EcPOX by 23 amino acids is only observed if the flavin cofactor is reduced [35]. Thus, 
formation of EcPOX Δ23 can be directly correlated to the flavin cofactor redox state.  
This finding was used to analyze the flavin redox state under steady-state conditions where both pyruvate 
and Q0 are present in saturating amounts to allow continuous turnover. A modified proteolysis assay was 
established as described earlier for analysis of EcPOX activation (chapter 4.1.4). Here, the enzyme was 
pre-reduced with pyruvate (which typically reveals formation of EcPOX Δ23 after proteolytic cleavage) 
but turnover was initiated by addition of Q0. After 30 seconds steady state was established and alpha-
chymotrypsin was added. On the one hand Q0 conversion was monitored by UV-Vis spectroscopy. 
Additionally, samples were prepared after distinct time points to study EcPOX digestion to Δ23 by SDS-
Page. Since higher protein concentrations were required for SDS-Page analysis compared to steady-state 
activity assays (chapter 3.19), Q0 concentration was also increased to 10.4 mM (typical steady-state assay: 
500 µM Q0). Thus, absorbance had to be measured apart from the maximum Q0 at 500 nm. As reference 
experiments EcPOX was subjected to digestion both in the absence of pyruvate or Q0. Additionally, Q0 
conversion was also monitored by UV-Vis spectroscopy without proteolytic cleavage. The combination of 
proteolytic patterns and Q0 conversion curves are displayed in figure 39.  
Analysis of Q0 conversion in the absence of alpha-chymotrypsin shows complete depletion within 10 
minutes (figure 39 A top). However, if the protease is added after steady state is established, the reaction is 
only slightly enhanced with a total reaction time of 7 minutes. This minor difference indicates that only a 
small amount of Δ23 is generated during proteolysis. In fact, this conclusion is supported SDS-PAGE 
analysis (figure 39 A bottom). Only traces of Δ23 are formed if pyruvate and Q0 are present in the 
digestion approach and the major amount of EcPOX remains uncleaved. Once Q0 is completely depleted 
(after 7 minutes) and the excess of pyruvate results in complete reduction of EcPOX, the proteolysis 
reaction proceeds rapidly leading to quantitative Δ23 formation within two minutes. The reference 
experiments show that in the absence of Q0 Δ23 is formed with a half-life of two minutes (figure 39 B). If 
pyruvate is omitted, 50 % of the full-length enzyme is cleaved to Δ101 after 20 minutes (figure 39 C). 
These experiments illustrate that under turnover conditions EcPOX remains intact and the Δ101 and Δ23 
cleavage sites are protected. Shielding of both restriction sites is caused by formation of covalent ThDP 
intermediates from pyruvate. Therefore, the flavin cofactor needs to be mainly oxidized in steady state. 
The only way this can be ensured is that flavin reoxidation by Q0 is faster than all steps leading to FAD 
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reduction. In other words, once FADH2 is present electrons are rapidly shuffled to Q0 which ensures a 
mainly oxidized flavin.  
 
figure 39: Limited proteolysis of EcPOX under steady-state conditions. A: top: Q0 conversion by EcPOX in the absence 
and presence of alpha-chymotrypsin (top) and the corresponding SDS-PAGE analysis of EcPOX digestion in under steady-state 
conditions (bottom). 0.186 mg/mL EcPOX were pre-reduced with 200 mM pyruvate and turnover was initiated by addition of 
10.4 mM Q0. After 30 seconds 20 µg/mL alpha-chymotrypsin were added to start proteolysis. Q0 conversion was monitored at 
500 nm and 20°C. Simultaneously, gel samples were prepared after distinct time points. B. Proteolytic digestion of EcPOX in the 
absence of Q0. Digestion was performed similar to A but 10.4 mM Q0 were omitted. C. Proteolytic digestion of EcPOX in the 
absence of pyruvate. Digestion was performed similar to A but pyruvate was omitted. 
 
These observations are in line with previous investigations of microscopic kinetic events in EcPOX 
catalysis. Kinetic analysis of single catalytic steps revealed that covalent binding of pyruvate to the 
thiamine cofactor is the rate limiting step [45]. In combination with data from proteolysis under turnover 
conditions one can suggest that this is also the case during steady state.  
4.3.2 Crystal structure of an EcPOX:Q complex 
To analyze whether the active site of EcPOX can directly interact with Q8 X-ray crystallography was 
applied. Therefore, crystal structures of proteolytically activated EcPOX Δ23 in complex with Q0, the 
water-soluble analog of Q8, should be generated. If Q0 could be detected in the active site of EcPOX, 
direct electron tunneling between the flavin and Q8 can be suggested.  
EcPOX Δ23 was co-crystallized with varying concentrations of Q0 at 20 °C similar to EcPOX Δ23. 
Crystals appeared within a few weeks in the presence of 10 molar equivalents Q0 and were directly flash-
cooled in a liquid nitrogen without further cryo-protections. Data collection was performed at the in-
house source of the Department of Molecular Structural Biology and a final resolution of 3.2 Å was 
obtained for the best crystal. EcPOX Δ23:Q0 complex crystallized in space group P212121 with three 
tetramers per asymmetric unit. The structure was solved by using activated EcPOX as initial model and 
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performing further refinements. Data collection and preliminary refinement statistics are summarized in 
the appendix (chapter 8.7).  
After initial rigid body refinement additional electron density and positive difference density is detected in 
all 12 subunits between both cofactors in the active site. It seems unlikely that side chain residues of the 
protein matrix are positioned in this area. Thus, in preliminary trials the substrate Q0 was fitted into this 
density and one additional refinement cycle was performed. The obtained model and densities indicate 
that Q0 could occupy this position in the active site (figure 40). Hydrogen bonding between amino acid 
side chains and the peptide backbone could stabilize Q0. Additionally, the orientation of refined Q0 could 
imply that native Q8 potentially binds in the same manner with the isoprenoid anchor sticking out of the 
active site towards the membrane (figure 40). However, it was observed that occupancy and the position 
of Q0 seem to vary between the subunits. Therefore, crystal quality and resolution should be improved to 
obtain a more detailed interaction model. 
It was tried to obtain crystals of better quality by soaking of existing EcPOX Δ23 crystals in soaking 
solutions supplemented with different concentrations of Q0 and for varying periods of time. 
Unfortunately, in most cases crystals cracked in the given soaking solution or the final resolution was even 
worse than observed for unsoaked crystals or crystals obtained using co-crystallization. Further 
optimizations should be performed by screening of buffer conditions and Q0 concentrations for both co-
crystallization and soaking approaches. Additionally, the Q8-analogs Q1 and Q2 could be applied. It seems 
possible that a more fixed orientation of the benzoquinone ring can be observed due to one or two 
isoprenoid units attached in Q1 and Q2 which might interact with the protein surface near the active site 
and thus stabilize the position of 6-membered ring. 
  
figure 40: Structure of an EcPOX Δ23:Q0 complex. Q0 is presented as orange stick model and the blue sphere indicates 
postion of a potential isoprenoid tail. The protein core is presented as white surface and selected amino acids are highlighted as 
green sticks. The cofactors ThDP (yellow) and FAD (rose) are depicted as sticks or lines. A: Electron density representation of 
bound Q0 in the active site of EcPOX. Gray 2mFo-Fc density is countered at 1.2 σ and green mFo-DFc density is countered at 
 3 σ. B: Q0 is bound at the active site of EcPOX by hydrogen bonds (black dashed lines) to side chains and the protein backbone. 















Due to poor resolution of the best crystal no final conclusion should be drawn from this preliminary 
structure. However, it could be speculated that Q0 can bind in the active site with an orientation also 
suitable for native Q8. Thus, it seems possible that Q8 could partially leave the lipid bilayer to enter the 
active site and receive electrons from reduced flavin. In this case, no further participation of amino acid 
side chains or the protein would be necessary which would argue for electron tunneling rather that 
hopping.    
4.4 Analysis of oxygen reactivity of EcPOX and LpPOX 
Analysis of the artificial oxidative half-reaction revealed that Tyr278 is involved in suppression of 
unfavored oxygen reactivity in EcPOX. Due to its interactions with the N5-flavin atom as well as with the 
neighboring C4a-atom (figure 14) one can suggested that the hydroxyl moiety of Tyr278 represses binding 
of oxygen and thus determines EcPOX to act as dehydrogenase rather than as oxidase. This hypothesis 
was proved by mutational analysis of pyruvate oxidase from Lactobacullis plantarum which harbors Phe289 
at the same position. The EcPOX-related enzyme LpPOX is known to be a real oxidase which converts 
molecular oxygen as native substrate [75]. It is supposed that Phe289 promotes increased reactivity 
towards oxygen in LpPOX whereas Tyr278 in EcPOX inhibits this reaction. Therefore, vice versa 
substitutions of LpPOX and EcPOX were performed leading to the variants LpPOX F289Y, which shall 
resemble EcPOX wt, and EcPOX Y278F, which may mimic LpPOX wt. 
4.4.1 The catalytic cycle of LpPOX  
Although both flavoenzymes are classified into different groups according to their oxygen reactivity, the 
catalytic cycle of LpPOX is similar to that of EcPOX [74] (figure 41). As observed in EcPOX pyruvate 
conversion yields HE-ThDP after decarboxylation. Subsequently, a single electron transfer step leads to 
formation of a flavin radical species. The second electron transfer to the flavin is coupled to 
phosphorolytic cleavage yielding acetyl phosphate. Finally, flavin regeneration is mediated by reoxidation 
with molecular oxygen.  
As described for EcPOX, the redox state of the flavin cofactor is used to assign reductive and oxidative 
half-reaction for LpPOX [24]. Thus, the derived rate constants kred and kreoxi are not related to microscopic 
rates of individual reactions of the catalytic cycle but are mixed constants including several catalytic 
processes. Although kred and kreoxi resemble different steps of the enzymatic pathway they were used to 




figure 41: Catalytic 
cycle of LpPOX. After 
activation of ThDP (not 
shown) pyruvate is 
bound yielding L-ThDP. 
Subsequently, decarboxy-
lation leads to formation 
of HE-ThDP interme-
diate. Single electron 
transfer to FAD results 
in HE-ThDP radical 
intermediate. Phosphoro-
lytic cleavage is coupled 
to the second electron 
transfer step. FADH2 is 
regenerated with mole-
cular oxygen yielding hy-
drogen peroxide. Figure 
was taken from Meyer 
[80] and slightly modi-
fied. (R1 = aminopyrimi-
dine moiety, R2 = 
diphosphate anchor). 
 
4.4.2 Flavin reduction at aerobic and anaerobic conditions 
To determine the rate constants kred and kreoxi a similar experimental setup as described for EcPOX 
(chapters 4.1.2 and 4.1.3). Pre-steady-state kinetics with single turnover conditions for FAD were applied 
to analyze pyruvate-induced flavin reduction in the absence of electron acceptors. Additionally, steady-
state conditions allowed calculation of the rate constant of the flavin reoxidation by molecular oxygen. 
Results of EcPOX Y278F were detailed described in chapters 4.1.2 and 4.1.3. 
Upon pyruvate-induced flavin reduction in the absence of oxygen a lag-phase is observed, which 
resembles initial catalytic steps like pyruvate binding and decarboxylation (figure 42 A). Although this 
phase reflects only a small part of the overall amplitude (<10 %), kinetic traces were fitted with a double-
exponential equation including the lag-phase and FAD reduction. In contrast to EcPOX Y278F the 
reductive half-reaction is significantly altered in LpPOX F289Y (figure 42 and table 15). kred is 6.7fold 
decreased in the variants (16 ± 0.029 s-1) relative to the wt enzyme (107 ± 0.689 s-1) indicating that FAD 
reduction or previous catalytic steps are severely impaired.  
Remarkably, no oxidized FAD is observed in the steady state for variant LpPOX F289Y at aerobic 
conditions, while 56 % of the flavin cofactor is oxidized in the wt (figure 42 B and table 15). The rate 
constants of the reoxidation were calculated for the wt enzyme (kreoxi = 136 ± 0.877 s-1) and for the F289Y 
variant (kreoxi = 0.84 ± 0.002 s-1) according to equation 10. Therefore, 5 % of oxidized FAD was estimated 
in the steady state, which corresponds to the threshold of the applied method. However, the rate constant 



















As detailed described earlier, flavin reduction is not affected in EcPOX variant Y278F but a 2fold 
increased reoxidation rate is observed compared to EcPOX wt enzyme (table 15). 
 
figure 42: Anaerobic (A) and aerobic (B) flavin reduction of LpPOX wt and F289Y. 2 mg/mL of LpPOX were rapidly 
mixed with 100 mM pyruvate. Flavin reduction was monitored at 457 nm and 25 °C. Progress curves were converted to relative 
amount of oxidized flavin. A: Anaerobic flavin reduction. The rate constants of the lag-phase and the main phase were 
determined by a double-exponential equation (fit not shown). Inset: FAD reduction within the first 30 milliseconds. The lag-
phase (apparently 2-4 milliseconds) is highlighted by an arrow. B: Aerobic flavin reduction. The position of the steady state is 
indicated by an arrow. Inset: FAD reduction within the first 200 milliseconds. The dashed line highlights the amount of oxidized 
FAD in the steady state for LpPOX wt (56 %). For F289Y variant a maximum amount of 5 % oxidized FAD was estimated.  
The obtained results implicate that flavin reoxidation is dramatically decreased in LpPOX F289Y due to 
the substitution of Phe by Tyr. In combination with the observed effects of EcPOX Y278F this finding 
fosters the idea that solely Tyr can efficiently prevent oxygen attack to the reduced state of the flavin at 
positions N5 and C4a. However, it is yet unclear, how Tyr ensures this function, since the only difference 
to Phe is a single hydroxyl moiety. One could speculate that the Tyr-OH suppresses oxygen attack by a 
steric hindrance or by disturbing correct positioning of oxygen to FAD.  
table 15: Overview of rate constants of reductive and oxidative half-reaction for LpPOX wt, EcPOX wt and selected 
variants. For EcPOX kred was determined using a single-exponential equation from progress curves of the reductive half-reaction 
(table 9). For LpPOX kred was determined using a double-exponential equation including a lag-phase from progress curves of the 
reductive half-reaction (figure 42 A). kreoxi was calculated from progress curves of flavin reduction at steady-state conditions 
(figure 42 B and figure 21) using equation 10. (a = a maximal amount of oxidized flavin was estimated to be 5 % in the steady 
state) 
enzyme kred (s-1) kreoxi (s-1) FAD : FADH2 (%) 
LpPOX wt 107 (± 0.689) 136 (± 0.877) 56 : 44 
LpPOX F289Y 16 (± 0.029) (<) 0.84 (± 0.002) (<) 5 : 95 a 
EcPOX wt 1.94 (± 0.001) 0.58 (± 0.0003) 22 : 78 
EcPOX Y278F 2.1 (± 0.002) 1.11 (± 0.001) 35 : 65 
 
To exclude that active site rearrangements caused the observed effects of the EcPOX and LpPOX variant 
the structure of both variants was solved by X-ray crystallography. Results of EcPOX Y278F are described 
in chapter 4.1.7. 
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4.4.3 Crystal structure of LpPOX F289Y  
The variant LpPOX F289Y crystallized like wt in space group C2221 with half of the tetramer per 
asymmetric unit and a final resolution of 1.43 Å was obtained. To solve the structure of the variant a 
structure of the wt in the ground state (unpublished high-resolution structure at 1.09 Å of LpPOX wt was 
friendly provided by Dr. Danilo Meyer, Department of Bioanalytics, Göttingen) was used as initial model 
and further refined. Data collection and final refinement statistics are summarized in the appendix 
(chapter 8.7) and r.m.s.d. values compared to the wt structure are presented in table 13. 
The crystal structure of LpPOX F289Y was analyzed with particular attention to deviations near the flavin 
cofactor due to the substitution of Tyr for Phe289. No significant differences of the overall structure or 
within the active site can be detected (figure 43) which is also reflected in the low r.m.s.d. value (table 13). 
Thus, it can be concluded that the decreased reduction and reoxidation rate of the flavin cofactor (chapter 
4.4.2) are not caused by detectable structural reorganizations within the enzyme due to the exchange of 
Phe289 to Tyr.  
figure 43: Comparison of the crystal structures of LpPOX 
variant F289Y with LpPOX wt. The wt enzyme is depicted 
in blue whereas the variant is shown in green. The thiamine 
and flavin cofactors and the exchanged amino acid F/Y289 
are highlighted by stick. Surrounding amino acids of the 
active site are indicated by lines. No significant changes of the 
exchanged side chain or other amino acids within the active 






5. Discussions  
5.1 Signal perception and information transfer from the active site to the protein 
surface  
The activation process of EcPOX is initiated by reduction of the flavin cofactor with pyruvate [35]. This 
change of the flavin redox state triggers membrane anchor release from the protein, which subsequently 
leads to membrane association [12] and manifold enhancement of the catalytic activity of EcPOX [13]. 
This thesis shows how the protein matrix senses the FAD redox state and how the information is 
transferred from the active site to the membrane anchor clamped to the protein surface.  
5.1.1 Tyr278 senses the flavin redox state 
The OH-moiety of Tyr278 is located in 3.2 Å proximity to FAD and forms a hydrogen bond to the redox 
active flavin-N5-atom (figure 44). It is supposed that Tyr278 utilizes this interaction to sense the redox 
state of the flavin and thus plays a central role in initiating membrane anchor release. This hypothesis was 
investigated by the substitution of Phe for Tyr278 where hydrophobicity and space are similar but 
hydrogen bonding is impaired.  
figure 44: Orientation of Tyr278 to the flavin and thiamine 
cofactors. In full-length EcPOX Tyr278 (blue) is located within the 
active site in close proximity to both cofactors and interacts with the 







Both, the steady-state activity of non-activated enzyme and reduction of the flavin cofactor were only 
slightly affected in variant EcPOX Y278F. However, analysis by limited proteolysis and SDS-mediated 
activation revealed that the activation process was significantly altered in Y278F. Since both assays are 
based on the amount of species SR III (showing a released membrane anchor) in equilibrium it is 
suggested that this equilibrium is shifted in Y278F towards the membrane anchor-attached conformation 
SR II compared to the wt enzyme. This can be explained by a defective sensing and communicating 
mechanism from the active site to the membrane anchor in the variant.  
A significant role of the hydrogen bond between Tyr278 and the flavin-N5 was deciphered by X-ray 
crystallography. The orientation of Phe in the crystal was similar to Tyr278 in the wt enzyme structure. 






seems to be important for correct positioning of the sensor which might be relevant for efficient signal 
transfer.   
Concluding, Tyr278 is the initial actor of a cascade which senses the flavin redox state and transfers this 
information to mediate membrane anchor release. However, further amino acid residues seem to be 
involved in this cascade since exchange of Tyr278 does not lead to a complete loss of activation. 
A similar redox switch mechanism as observed for EcPOX is also described for the peripheral membrane 
protein proline utilization A (PutA) from E. coli [117]. It was shown that due to proline-induced reduction 
of the flavin cofactor conformational changes occur which lead to exposure of a membrane anchor and 
subsequently to membrane attachment [118]. Although little is known about the membrane binding 
domain of PutA it was speculated that the C-terminus of PutA might be involved in membrane 
association [117]. Additionally, it was demonstrated that Arg431 plays an important role in reductive 
activation of this enzyme. Arg431 is located near the flavin cofactor and forms a hydrogen bond to the 
flavin-N5 (figure 45) similar to Tyr278 in EcPOX. Although the exchange of Arg431 to Met does not 
affect proline-triggered reduction the PutA variant is not able to bind lipids anymore [118]. Therefore, the 
authors speculated that the hydrogen bond between Arg431 and the N5-locus of the flavin has a profound 
impact on the redox switching mechanism of PutA. However, the question remained open how the signal 
is further transmitted from Arg431 to the protein surface.  
figure 45: Position of Arg431 to the flavin cofactor in PutA from E. coli. 
Green sticks represent oxidized PutA whereas white sticks highlight dithionite-







5.1.2 Phe465 and Tyr549 do not cooperate during activation 
Comparison of the crystal structure of full-length EcPOX with the proteolytically activated Δ23 structure 
indicated that Phe465 and Tyr549 are involved in the information transfer from the active site to the 
membrane anchor. In the activated enzyme Phe465 swings between both cofactors upon proteolytic 
activation and might clash with Tyr549 which is located at the N-terminal edge of the membrane anchor 
(figure 46). Accordingly, Tyr549 is displaced from the catalytic center due to repulsion which subsequently 
leads to destabilization of the protein-bound membrane anchor. In this regard, a cooperating action of 
both amino acids would be suggested. However, it seems possible that also a more competitive action of 
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Tyr549 and Phe465 initiates EcPOX activation. Tyr549 might occupy the position of Phe465 in the resting 
state and could inhibit rearrangement of Phe465. Thus, activation and repositioning of Phe465 would only 
occur after Tyr549 removal. To decipher which mode promotes membrane anchor release of EcPOX 
both residues were exchanged by Ala.  
figure 46: Interaction of Phe465 and Tyr549 upon activation. 
Phe465 swings between ThDP (yellow) and FAD (green) upon 
activation and Tyr549 is displaced from the active site. Side chains of 
full-length EcPOX are shown in green, while amino acid residues of 
activated enzyme are represented as blue sticks EcPOX Δ23. 
Structural rearrangements upon proteolytic activation are highlighted 





Phe465 is involved in flavin reduction and the first conformational change 
The substitution of Ala for Phe465 led to 70fold decreased steady-state activity compared with the wt 
enzyme. Additionally, variant F465A was not activated by proteolysis or with SDS. However, these effects 
could be related to an impaired electron transfer from the thiamine to the flavin cofactor due to the 
exchange of Ala for Phe465. In fact, analysis of flavin reduction showed a 100fold decreased kred. These 
results confirm previous investigations of EcPOX F465A which deciphered Phe465 to facilitate the 
electron transfer reaction from ThDP to FAD [45]. Exchange of the corresponding Phe479 to Trp or Tyr  
in EcPOX-related LpPOX shows also a significantly impaired flavin reduction rate [119]. Unfortunately, 
no suitable crystals of EcPOX F465A could be generated to elucidate how the substitution of Phe465 
influences the active site architecture. 
Limited proteolysis of F465A revealed that independently of the addition of pyruvate or MAP in all cases 
quantitative formation of non-active EcPOX Δ101 was observed. Therefore, the first conformational 
transition  →SB, which leads to protection of the Δ101 cleavage site and is typically induced by pyruvate 
binding to ThDP, is disturbed in F465A. Also the second structural change SR II→S  III is impaired in 
the variant. However, this is expected as in F465 reduction of the flavin cofactor, which is the mandatory 
signal for this second transition, is dramatically disturbed. 
In summary, vital roles of Phe465 on reduction of the flavin cofactor and on the first structural transition 
leading to the protection of the Δ101 cleavage site are observed. However, no conclusions concerning the 






Phe465 and Tyr549 do not interact during activation 
Analysis of variant Y549A showed a partially activated enzyme already in the resting state. Also 
investigations of the activation process by proteolysis and SDS-stimulated activity measurements revealed 
rather improved than disturbed activation due to the substitution of Ala. These results argue against a 
steric clash of Phe465 and Tyr549 which promotes membrane anchor release. Beside cooperating action 
of Phe465 and Tyr549 also a competitive action of Tyr549 was possible. However, the crystal structure of 
Y549A showed that Phe465 is still located in the non-activated position which argues against an inhibiting 
role of Tyr549. 
The obtained results reveal no obvious interaction of Phe465 and Tyr549 during activation. Instead, data 
indicate that Tyr549 stabilizes the membrane anchor in the protein-bound form. This function is 
discussed later (chapter 5.2.4).  
5.1.3 Phe260 is not involved in the signal transfer process 
Phe260 is located on the protein surface near membrane anchor residues Ile554 and Leu565 (figure 47). 
Crystal structure analysis of the full-length protein (where the membrane anchor is protein-bound) and 
EcPOX Δ23 (where the membrane anchor is removed) indicate alternative conformations of Phe260. 
Interconversion between both orientations would lead to a steric clash with Ile554 and Leu565 which 
might trigger membrane anchor exposure. This assumption was examined by substitution of Ala for 
Phe260. 
figure 47: Clash of Phe260 with Ile554 and 
Leu565 upon activation. Interconversion of 
Phe260 between the non-activated (green) 
and activated (blue) conformation upon 
activation leads to a clash with Ile554 and 
Leu565 (gray lines). The cofactors ThDP 
(yellow) and FAD (green) indicate the 
position of the catalytic center. Structural 
rearrangements upon proteolytic activation 




Results of different experiments revealed no specific role of Phe260 on the signal transfer from the active 
site to the membrane anchor of EcPOX. Wt-like activity was observed in the steady-state activity assay or 
if EcPOX F260A was activated by limited proteolysis and with SDS. These results disprove the hypothesis 











5.2 Stabilization of the membrane anchor at the protein surface 
The membrane anchor of EcPOX is bound at the protein surface by a four-stranded half-barrel motif and 
several electrostatic, polar and non-polar interactions [35]. However, it was shown that the same 
polypeptide sequence forms an amphipathic helix in the presence of SDS micelles which were applied as 
membrane mimic [45]. The question arises how these two conformations of the membrane anchor are 
stabilized in the particular environment. 
5.2.1 Electrostatic interactions and hydrogen bonds play a minor role in membrane anchor 
binding to EcPOX 
Analysis of the crystal structure of full-length EcPOX reveals two prominent electrostatic contacts (D328-
R572 and D348-R558) and one hydrogen bond (Q537-E564) between the membrane anchor and the 
protein surface (figure 48) [35]. Since these interactions bind both ends of the anchor as well as the center 
they may facilitate association of the membrane anchor to the protein. To investigate the impact of these 
contacts the triple mutant EcPOX 3x (D328A, D348A, Q537A) was generated where the amino acids of 
the protein part were exchanged to Ala. Note that the primary sequence of the membrane anchor was not 
affected in this variant. 
figure 48: Membrane anchor stabilization of 
resting-state EcPOX by electrostatic 
interactions and hydrogen bonds. Prominent 
electrostatic interactions and hydrogen bonds of 
the membrane anchor (yellow sticks) to the protein 
surface (green sticks) are shown as red dashed 
lines. The protein core is shown as white cartoon 
and cofactors ThDP and FAD are depicted as 
spheres and highlight the position of the active site. 
The membrane anchor is displayed in yellow 
cartoon, while the linker region is indicated in blue 
cartoon format. In the triple mutant amino acids 
shown as green sticks were exchanged to Ala 
within this thesis. 
 
Steady-state activity, thermal unfolding and limited proteolysis in the absence of pyruvate revealed that the 
membrane anchor is still clamped to the protein in the resting state of EcPOX 3x. This finding was 
further supported by the crystal structure which showed a protein-bound lipid binding domain. Also 
proteolytic digestion of the pyruvate-reduced enzyme confirmed that the conformational transition SR 
II→S  III is not affected in the triple variant. This implies a similar activation process as in the wt 
enzyme. Only experiments with SDS demonstrated that a smaller amount of the detergent was necessary 
to activate the variant to a similar level like EcPOX wt. 
Summarizing the obtained results, an influence of electrostatic interactions and hydrogen bonds on 
membrane anchor association to the protein seems unlikely. Consequently, the major forces which 










5.2.2 Hydrophobic interactions of Ile554, Leu565 and W570 mainly contribute to membrane 
anchor association to EcPOX 
Besides electrostatic contacts and hydrogen bonds the protein-bound membrane anchor interacts with the 
protein core via hydrophobic areas. A prominent hydrophobic patch is formed between Phe260 (which 
was also predicted to act as conformational switch), Ile554 and Leu565 (figure 49 A). Additionally, Trp570 
sticks into a pocket composed of different amino acids of the protein surface at the protein surface. While 
Phe260, Ile554 and Leu565 seem to stabilize the center of the membrane anchor, Trp570 binds the C-
terminal edge to the protein core. However, analysis of the binding cavity of Trp570 reveals no obvious 
hydrophobic contacts but rather two counterparts perfectly fitting to each other (figure 49 B).  
 
figure 49: Hydrophobic interactions of the membrane anchor with the protein surface. A: The membrane anchor (yellow) 
is attached to the protein core (white) by hydrophobic interactions. Central amino acids exchanged within this thesis are shown as 
green (resting-state EcPOX) and blue (Δ23) sticks. The cofactors ThDP and FAD are depicted as white spheres and highlight the 
position of the active site. The red arrow indicates conformational changes upon proteolytic activation. The linker region is shown 
in blue. B: The pocket which stabilizes W570 (green sticks) at the protein surface is composed of charged, polar and hydrophobic 
residues (gray lines). 
The impact of these hydrophobic interactions was investigated by variants I554A/G, L565A/G, 
W570A/G and the double variant 2G (I554G, L565G). Hydrophobic amino acids were replaced by Ala 
and Gly which are still nonpolar but show decreased hydrophobicity. Note that all amino acid exchanges 
alter the primary sequence of the membrane anchor.  
Hydrophobic interactions stabilize the attached membrane anchor 
Analyses of the steady-state activity and thermal unfolding already implied a partial released membrane 
anchor in the resting state of all variants. Remarkably, the double variant 2G was completely activated in 
the resting state and showed similar catalytic efficiency as observed for EcPOX Δ23. These findings were 
further supported by proteolytic digestion experiments revealing that activated Δ23 was generated 
quantitatively in the absence of pyruvate. Thus, the resting-state equilibrium in the variants is significantly 
shifted towards species R III which is characterized by exposure of the membrane anchor and removal of 


















are in line with the previous findings since improved accessibility to the active sites is observed for the 
variants which argues for a partly exposed membrane anchor.  
However, in all determined crystal structures of the variants the membrane anchor was found attached to 
the protein core resembling state R I. It can be speculated that although in solution equilibrium of several 
EcPOX conformers exists only one particular species crystallizes under the given conditions. Therefore, 
X-ray crystallography cannot be used to decipher the conformational equilibrium and cannot determine 
the activation process on a molecular level.     
Additionally, also the SR II:SR III equilibrium is shifted significantly towards state SR III in all variants 
which was demonstrated by a decreased half-life for proteolytic digestion with pyruvate-reduced enzymes. 
These results were supported by decreased SDS0.5 values for variants I554A, L565A/G and 2G.  
Also the beta-half-barrel motif is involved in membrane anchor binding 
The obtained results foster the idea that hydrophobic interactions mainly stabilize the membrane anchor 
at the protein and thus play a central role in the activation process. However, also the structural 
organization of the membrane anchor seems to contribute to protein association. Both Leu565 and Ile554 
are located in two beta-strands which are involved in formation of the four-stranded half-barrel that 
stabilizes main parts of the membrane anchor at the protein.  
Exchanges of Leu565 and Ile554 seem to disturb formation of this structural element leading to 
membrane anchor release already in the absence of reduced flavin. This assumption is supported by 
differentiated results for Ala and Gly mutants. While activation in the resting state is less pronounced if 
Ala is substituted for Ile554 and Leu565, exchanges to Gly lead to EcPOX Δ23-like activities. According 
to Chou an Fasman [120] it can be speculated that Ala is still able to form the beta-strand whereas Gly 
acts as breaker and causes severe disorder of the membrane anchor structure.   
A central role of half-barrel structure on membrane anchor stabilization was also observed by Bertagnolli 
and Hager [121] who analyzed C-terminal deletion variants of EcPOX. They elucidated by proteolysis 
studies that a deletion of 7 residues (EcPOX Δ566-572) produces an enzyme with wt-like activity. 
Surprisingly, if 8 or 11 C-terminal amino acids are cleaved off (EcPOX Δ565-572 Δ562-572) constitutively 
activated EcPOX is generated. Similar to exchanges of Ile554 and Leu565 truncation of the C-terminal 
edge of the membrane anchor leads to removal of one strand of the half-barrel motif (residues 560-565) 
which seems to destabilize the entire lipid binding domain resulting in EcPOX Δ23-like activity.  
5.2.3 Phe260 does not participate in membrane anchor stabilization  
In chapter 5.1.3 it was shown that Phe260 plays no central role in the information transfer from the active 
site to the protein surface. However, Phe260 is supposed to form a hydrophobic patch in combination 
with Ile554 and Leu565 and thus might fix the membrane anchor to the protein core. To analyze this 
hypothesis also variant F260A was examined.  
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Contrary to I554A/G and L565A/G for variant F260A no improved membrane anchor release was 
detected. Similar to the wt enzyme digestion of F260A in the absence of pyruvate did not lead to 
formation of EcPOX Δ23. Also no significant decrease in the apparent melting temperature was observed. 
These findings were supported by the crystal structure of F260A where the membrane binding domain is 
found bound to the protein surface. These results argue against increased accessibility of the active site 
and indicate a completely attached membrane anchor in the resting state. Only an increased flavin 
reduction and slightly enhanced reoxidation rate might imply that the membrane anchor is exposed to 
some extent. In summary, similar to studies of the signal transfer process Phe260 has no central function 
in membrane anchor stabilization. 
5.2.4 Tyr549 stabilizes the membrane anchor at the protein by interactions with the active site 
Tyr549, which is located at the N-terminal end of the membrane anchor, was supposed to interact with 
Phe465 leading to displacement of the lipid binding domain upon activation. However, analysis of Y549A 
could not confirm this hypothesis. The obtained results rather revealed that Tyr549 might stabilize the 
membrane anchor at the protein surface. 
The exchange Tyr549 to Ala generated an activated enzyme with a released membrane anchor already in 
the resting state. This was demonstrated by steady-state activity, thermal unfolding and limited proteolysis 
in the absence of pyruvate. Analysis of flavin reduction and artificial reoxidation revealed increased 
accessibility of the active site when compared to the wt enzyme and thus support the idea of improved 
membrane anchor release. These findings are in line with activation by SDS which implied a shift of the 
SR II:SR III equilibrium towards SR III in the variant. However, the crystal structure argued against an 
exposed membrane anchor. 
figure 50: Active site interactions of Tyr549 in full-length 
EcPOX. Tyr549 is represented in rose sticks whereas 
surrounding amino acids of the active site are shown as gray 
sticks and lines. The cofactors ThDP (yellow) and FAD (green) 
are shown as lines. No obvious interaction partners of Tyr549 






In summary, most results support the hypothesis that Tyr549 stabilizes the membrane anchor at the 
protein by interactions with the active site of full-length EcPOX. It can be assumed that either a hydrogen 







phenyl ring might be responsible for Tyr549 association to the active site. However, analysis of the crystal 
structure revealed no obvious interaction partners for Tyr549 (figure 50).  
Concluding, it can be speculated that Tyr549 might be the final amino acid of the signal transfer cascade 
initiated from the flavin cofactor. Induced by formation of FADH2 Tyr549 could be released from the 
active site leading to exposure of the entire membrane anchor.  
5.3 Stabilization of the membrane anchor at the membrane 
Besides the half-barrel structure composed of the protein-attached membrane a helical structure of the 
membrane anchor was predicted from the primary amino acid sequence [29]. In fact, Neumann and 
Weidner et al. could show that the isolated membrane anchor forms an amphipathic helix in the presence 
of artificial SDS micelles which were applied as membrane mimics  [45] [35]. To investigate which factors 
influence membrane binding properties of the peptide anchor modulations of the membrane anchor 
sequence were exploited. 
5.3.1 Helix formation of the membrane anchor is disturbed in EcPOX I554G and W570G 
The previously discussed variants Ile554G/A, Leu565G/A, 2G and W570G were investigated concerning 
their properties of membrane anchor attachment to the protein core. Notably, in those variants also the 
primary sequence of the membrane anchor is altered which might influence the intrinsic helix propensity 
and concomitant bilayer association. This hypothesis was analyzed by activity measurements stimulated by 
SDS which served as model of the EcPOX membrane. 
Ile554 and W570 influence the intrinsic helix propensity of the membrane anchor 
Improved SDS-mediated activation compared to the wt enzyme was observed for variants Ile554A, 
Leu565G/A and 2G. Remarkably, the Gly variants of Ile554 and W570 showed impaired activation by the 
detergent demonstrated by an increased SDS0.5 value. A disturbed S  II→S  III transition could be 
excluded since proteolytic activation was substantially increased for I554G and W570G. Consequently, 
affinity to the amphiphile was decreased in both variants indicating disturbed helix formation. These 
observations are consistent with secondary structure analysis by Chou and Fasman [120] who predicted 
that Ala is a strong alpha-helix former whereas Gly acts as helix breaker. Remarkably, the exchange of 
Leu565 to Gly did not alter the intrinsic helix propensity of the membrane anchor. Since Leu565 is 
located in the center of the putative helix it seems likely that neighboring residues stabilize the entire 
helical fold. On contrast, no stabilization is possible for Ile554 and W570 since they are positioned at the 
N- and C-terminal edges of the helix revealing a central role of both residues on helix formation and 
EcPOX membrane binding. Nevertheless, the behavior observed for the entire protein should be 
additionally verified with similar variants of the isolated membrane anchor and analyzed by liquid-state 
NMR. 
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Other amino acids affect helix formation and membrane binding 
In former studies also other amino acids of the membrane anchor were shown to be crucial for membrane 
binding of EcPOX. Significant alterations of the lipid-binding ability were observed when the acidic 
Glu564 and hydrophobic Leu 565 are replaced by Pro [122]. However, exchanges to Pro severely interfere 
with both, the protein- and membrane-bound conformation of the anchor peptide, and results are hard to 
interpret. Minor effects were detected for variants A553V and R572G [122] which are located at the helix 
edges similar to Ile554 and Trp570. While Ile554 and Trp570 were shown in this thesis to be crucial for 
helix formation, Ala553 and Arg572 seem to be of less importance. 
Besides the influence of single amino acids also the length of the peptide, that is mandatory for efficient 
membrane binding, was examined before. The deletion of three residues from the C-terminal part 
(EcPOX Δ570-572) results in defective lipid association [122]. An additional mutant lacking 9 C-terminal 
residues shows even more pronounced effects. Therefore, a membrane anchor of at least 21 amino acids 
seems to be essential to efficiently form the helical structure and bind to lipids or detergents. 
5.4 Electron transfer to Q8 
Electron transfer from FADH2 to Q8 confronts EcPOX with a challenging task since substrate and 
enzyme are localized in two different compartments. To solve this problem EcPOX binds peripherally to 
the lipid bilayer [18]. However, the molecular mechanism of electron transfer remains unclear. One can 
speculate that electrons hop with the help of the protein matrix to Q8 or that the ubiquinone partly leaves 
the membrane and enters the active site to accept the reducing equivalents directly from the flavin via 
tunneling. 
5.4.1 The crystal structure of an EcPOX Δ23:Q0 complex indicates Q0 interactions within the 
active site 
To investigate whether ubiquinone sticks into the active site to regenerate the flavin cofactor a crystal 
structure of activated EcPOX Δ23 with an accessible active site in complex with Q0 was solved. After 
initial refinements additional electron density and positive difference density were observed in the active 
sites of the 12 subunits in the asymmetric unit. Preliminary trials to fit Q0 into this density succeeded and 
potential hydrogen bonds with Tyr278, Ser28, Gln113 and Asp27 were detected. Also the orientation of 
Q0 suggests that the native substrate Q8 might bind similar with the isoprenoid tail sticking out of the 
active site towards the membrane. Although an out-of-the membrane binding of Q8 was indicated by 
these results final conclusions should be drawn from an interaction model received from crystals of better 
quality and higher resolution. 
Out-of-the-membrane binding of ubiquinones 
The mechanism of Q8 desorption out of the membrane into the active site of EcPOX was first described 
by Schloss et al. in 1988 [123]. The authors analyzed inhibitors of the thiamine diphosphate-dependent 
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flavoenzyme acetohydroxyacid synthase. They found that Q0 and Q1 inhibit this enzyme although both 
molecules obviously share no similarities to the substrate pyruvate or to the allosteric effectors Val, Leu 
and Ile. In combination with the high sequence similarity of acetohydroxyacid synthase with EcPOX [123] 
the authors concluded that both enzymes have the same ancestor and that a ubiquinone binding site exists 
in both enzymes. However, until now no structural evidence were available which support this proposal. 
Remarkably, only recently it turned out that desorption of a ubiquinone out-of the-membrane into a 
cytosol-localized active site is not a unique feature of EcPOX catalysis. Several crystal structures of 
subunits or the entire respiratory chain complex I were solved and an ubiquinone binding site was 
identified [124] [125] [126]. Complex I catalyzes the electron transfer from NADH to ubiquinone which is 
coupled to  translocation of four protons across the membrane [127]. In all structures of complex I the 
ubiquinone binding site is located in the cytosolic part of the complex (figure 51 A) revealing a distance of 
15-60 Å from the benzoquinone head group to the membrane surface [128] [129] [125] [124]. Although 
the distances determined from different crystal structures vary it is obvious that ubiquinone has to move 
out of the membrane to accept the electrons. Therefore, the entire complex provides a narrow channel to 
stabilize the isoprenoid tail [124]. 
 
figure 51: Ubiquinone binding in respiratory chain complex I. A: Schematic drawing of the out-of-the-membrane binding 
mechanism of ubiquinone. Ubiquinone (dark red) has to enter the Q-binding site in the 49 kDa-domain of mitochondrial 
complex I localized 35 Å away from the membrane surface in the peripheral arm to accept electrons. Movement of ubiquinone 
out of the membrane is indicated by a red arrow. Figure was taken from Zickermann et al. [129] and slightly modified. B: 
Ubiquinone interactions within Q-site found at the interface of three subunits (colored orange, green and pink) of complex I from 
Thermus thermophilus. Blue 2mFo–DFc density (countered at 1 σ) assigns the position of decylubiquinone (ubiquinone analog, blue 
sticks). The keto groups of the ubiquinone head group interact with Tyr87 and His38 (green sticks) of the protein. Both residues 
are essential for reductase activity of complex I and are predicted to protonate electron-reduced Q2-. Here, ubiquinone 
presumably has to move 15 Å away from the membrane to get reduced. Figure was taken from Baradaran et al. [124]. 
The ubiquinone binding site of EcPOX is similar to other enzymes 
Comparison of the interaction mode of Q0 in EcPOX with other ubiquinone-reducing enzymes reveals 
several similarities. The FAD-Q0 distance in the EcPOX Δ23: Q0 complex is approximately 8 Å which is 
consistent with spaces of 7-12 Å between electron donor and ubiquinone observed in other enzymes [124]  
[130]  [131]. Additionally, coordination of ubiquinone by active site residues is similar in ubiquinone-
A B
Discussions 95 
reducing enzymes. In EcPOX Q0 is presumably bound via hydrogen bonds to Tyr278, Ser28, Gln113 and 
the N-backbone atom of Asp27 (figure 40 B). Also Zhang et al. reported that hydrogen bonding to the 
backbone nitrogen and carbonyl group of Gly272 and Gly273 with the keto functions of ubiquinone is 
observed in the electron transfer flavoprotein-ubiquinone oxidoreductase [130]. Further, in multiple 
enzymes interactions of the keto moiety with Tyr is detected (figure 51 B) [130] [124] [126]. It was 
reported that these Tyr residues are pivotal for enzymatic activity [132] [128] and are proposed to 
protonate electron-reduced Q2-. Baradaran and coworkers even suggested that either formation of anionic 
Q2- or deprotonation of Tyr87 might initiate a conformational transition of the enzyme [124] inducing the 
proton translocation across the membrane in complex I. 
A similar mechanism can be proposed for EcPOX. Reduction of Q8 should consequently lead to removal 
of the enzyme from the membrane to enable access to cytosolic pyruvate which initiates the next cycle of 
substrate conversion and membrane binding. So far it is unclear how release of membrane-bound EcPOX 
is promoted. Analysis of available crystal structures of EcPOX reveals that Ser28 and Tyr278 could 
participate in this process (figure 40 B). However, the exchange of Tyr278 to Phe, which is defective in 
proton donation, does not lead to a complete loss of activity (chapter 4.1.1) which argues against an 
essential role of Tyr278 as proton donor. Whether Ser28 is involved in protonation of Q8 and potential 
membrane release of EcPOX needs to be explored.  
Ubiquinone binds to the active site of EcPOX and allows direct tunneling of electrons 
Since the crystal structure of an EcPOX Δ23:Q0 complex reveals an interaction of Q0 with the active site it 
can be proposed that electrons are directly transferred from reduced flavin to Q8 via tunneling rather than 
hopping. The determined distance of approximately 8 Å between Q0 and the flavin is consistent with 
typical tunneling distances of 14 Å in biological systems [67]. Additionally, entering of Q8 seems 
reasonable with regard to the physiological function of EcPOX. Direct tunneling of electrons ensures that 
energy in form of reducing equivalents is conserved. Contrary, hopping of electrons could lead to 
unfavored reduction of other electron acceptors within the bilayer. In that case, pyruvate-derived energy 
could be lost and the catalytic reaction of EcPOX would be wasteful.  
5.5 Inhibition of the artificial reoxidation reaction in EcPOX  
The final step in EcPOX catalysis is regeneration of the flavin by electron transfer to membrane-bound Q8 
[17]. Interestingly, the EcPOX-related enzyme LpPOX, which also catalyzes oxidative decarboxylation of 
pyruvate, utilizes molecular oxygen for flavin reoxidation [73]. However, such a reaction needs to be 
inhibited in EcPOX by the protein matrix to conserve the pyruvate-derived energy. Inspired by the crystal 
structure Tyr278 was predicted to prevent EcPOX from unfavored oxygen reactivity since it is located in 
3.2 Å vicinity to the reactive N5- and C4a-locus of the flavin. Noteworthy, LpPOX contains Phe289 at 
this position which might promote oxidase activity. This hypothesis was studied by reciprocal amino acid 
substitutions in both enzymes.   
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5.5.1 Tyr278 inhibits unpreferred oxidase activity in EcPOX 
Analysis of pyruvate-induced flavin reduction and reoxidation by molecular oxygen revealed that the 
substitution of Phe for Tyr278 in EcPOX leads to an increased reactivity towards oxygen whereas the 
exchange of Phe289 by Tyr in LpPOX prevents oxygen-mediated reoxidation. These results confirm the 
assumption that Tyr near the flavin cofactor suppresses unpreferred oxidase activity, while Phe supports 
it. It can be speculated that the hydroxyl function of Tyr inhibits the reaction of FADH2 with oxygen due 
to decreased accessibility of the flavin-N5 and -C4a. 
Could other factors cause the altered oxygen reactivity? 
To elucidate whether active site rearrangements caused the observed kinetic differences, crystal structures 
of both variants were determined in the absence of substrates. Since no structural differences could be 
detected upon comparison with the corresponding wt enzymes the observed alterations can be directly 
related to the mutations.  
Another explanation for the kinetic differences upon amino acid exchange close to the flavin could be the 
modulation of the flavin cofactor redox potential. Analysis of the protein-bound flavin redox potential by 
titration with redox active dyes could prove this suggestion [133]. However, it was shown for L-galactono-
γ-lactone dehydrogenase that an exchange of the N5-flavin-interacting Ala for Gly yields a catalytically 
competent oxidase [134]. In this regard only a slight modulation of the flavin redox potential was 
observed for the variant compared to the wt enzyme. Thus, the significant oxidase activity could not be 
explained by this minor effect.  
Do oxygen channels within the enzyme determine oxygen reactivity? 
Although the reoxidation rate was 2fold increased for variant EcPOX Y278F the enzyme was not 
converted into a real oxidase. Its reoxidation rate is still far away from typical oxidases with rate constants 
up to 1.5 x 106 M-1s-1 as reported for glucose oxidase [135]. One can suggest that other factors like oxygen 
channels and cavities, which facilitate oxygen binding and migration to the active site rather than catalysis, 
might be suboptimal designed in EcPOX. It was shown for other monooxygenases and oxidases that 
these tunnels and niches provided by the protein mainly harbor hydrophobic residues, which comprise an 
ideal environment to store gaseous oxygen and guide it from the solvent into the reactive centers [136]. 
Since oxygen travelling through an enzyme is hard to investigate, the PyMol plugin MOLE [137] was used 
to simulate oxygen channels within the protein structure of EcPOX and LpPOX wt and variants by a 
search algorithm. The resulting oxygen pathways are displayed in figure 52. Surprisingly the oxygen 
molecule seems to attack the flavin cofactor from the si site opposite to the Phe/Tyr residue in both 
enzymes. This would argue against a steric interference of the Tyr-OH moiety. Noteworthy, in LpPOX 
oxygen seems to migrate from two directions into the active site to the flavin, while in EcPOX only 
tunnels leading to the si site of the flavin were found. A disturbed oxygen migration in EcPOX could 
explain the observation that the substitution of Phe for Tyr278 did not convert EcPOX into a real 
oxidase. 
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figure 52: Potential oxygen 
channels in EcPOX and 
LpPOX. Oxygen channels 
(blue) were simulated in 
structures of full-length 
EcPOX wt (A and B) and 
LpPOX wt (C and D) 
(unpublished high-resolution 
structure of LpPOX wt was 
friendly provided by Dr. 
Danilo Meyer, Department 
of Bioanalytics, Göttingen) 
by a search algorithm of the 
program MOLE [137]. 
Similar results were obtained 
when the corresponding 
variant structures of EcPOX 
and LpPOX were used for 






However, the static structures determined by X-ray crystallography lack protein movements during 
catalysis which could expose alternative oxygen channels. For example, it was reported for toluene/o-
xylene monooxygenase hydroxylase that slight protein motions are mandatory for oxygen passing the di-
iron active site [138]. Similar scenarios seem possible for LpPOX and EcPOX, since both proteins are 
supposed to undergo conformational changes due to pyruvate binding [45]  which could provide further 
oxygen tunnels (unpublished data of Dr. Danilo Meyer, Department of Bioanalytics, Göttingen). Notably, 
the active site of activated  cPOX Δ23 is completely accessible to oxygen. To prove whether the 
simulated channels have a functional role in solution amino acid substitutions of small side chains to 
bulkier residues should decrease oxidase activity in both enzymes.  
Tyr and Phe also determine oxygen reactivity in other pyruvate-converting oxidases and dehydrogenases 
To examine whether regulation of oxygen reactivity by Tyr and Phe is a general principle, alignments of 
the protein sequences of EcPOX and LpPOX with selected pyruvate-converting oxidases and 
dehydrogenases from several organisms were performed with the program ClustalW2 [139]. Remarkably, 
all proteins classified as pyruvate dehydrogenases contain a Tyr at this particular position, while 
categorized oxidases harbor Phe (table 16). This is an unexpected observation since in most cases the 
proteins share only a sequence identity of 30-50 % to EcPOX or LpPOX. Thus, pyruvate-depending 
oxidases seem to require Phe near the flavin, whereas dehydrogenases suppress oxygen reactivity by a Tyr. 









extensive generalizations should be made since this finding only corresponds to pyruvate-converting 
oxidases and dehydrogenases. 
table 16: Sequence alignment of selected pyruvate-converting oxidases and dehydrogenases from different organisms. 
Enzymes classified as dehydrogenases were aligned with the EcPOX sequence, while assigned oxidases were compared to 











p. oxidase E. coli K-12 P07003 MMNADTLVLLGTQFPYRAFYPTDAKII-289 100 % 572 








NP_630260 THECDLLLLIGTDFPYNAFLPDDVKIA-290 52 % 580 




ZP_05569937 IEKSDLIIFLGTIFPYTQFLKNVDNIQ-284 30 % 549 












Q54970 VFEADTVLFLGSNFPFAEVYEAFKNTE-294 48 % 591 








YP_006545209 VLESDLVIACG--ASFSDLTGIPE-DK-294 31 % 539 
 
The local environment of flavin-N5 and -C4a plays an important role in oxygen reactivity of flavoenzymes  
Oxidase activity controlled by the environment near the reactive flavin atoms is not a unique principle 
only observed for pyruvate oxidases and dehydrogenases but is also detected in other flavoenzymes. 
However, in these cases other amino acids than Tyr and Phe are involved. It was shown that lactate 
monooxygenase is converted into an oxidase by exchanging Gly99 for Ala, which is located near the N5-
C4a locus of FAD [77]. This result is further supported by the finding that glycolate oxidase, which has an 
analogous active site to lactate monooxygenase, also contains an Ala at the desired position [78]. Thus, it 
can be speculated that an increased space near the reactive centers of the flavin cofactor ensures higher 
oxygen reactivity. Contrary to this in aryl-alcohol oxidase the exchange of a Phe near the N5-atom for a 
bulkier Trp results in a 2fold increased oxidation rate [140]. Here the results are interpreted in a way that a 
more hydrophobic environment due to Trp replacement facilitates the electron transfer reaction and that 
Trp is involved in correct positioning of oxygen prior to reduction.  
Although no general conclusion concerning the different oxygen reactivities of flavoenzymes should be 
drawn, results of this thesis highlight the important role of an interaction of the flavin cofactor with the 




6.1 The molecular mechanism of activation and membrane binding of EcPOX 
The peripheral membrane protein pyruvate oxidase from E. coli is activated at elevated concentrations of 
pyruvate. This leads to reduction of protein-bound flavin which is the initial signal for cytosolic exposure 
of the hitherto protein-associated membrane anchor and subsequently triggers membrane binding. 
Association to the lipid bilayer promotes accessibility to Q8 and enhances the catalytic activity of EcPOX 
by several orders of magnitude. Aim of this thesis was to elucidate the molecular mechanism which 
controls activation and membrane binding in EcPOX. Therefore, variants of Tyr278, Phe465, Y549, 
Phe260, Ile554, Leu565, Trp570, Asp328, Asp348 and Gln537 were investigated.  
Taken together the results obtained in this thesis, a molecular activation and membrane binding model of 
EcPOX can be proposed (figure 53). This scheme is an extension of the minimal model presented in the 
introduction (figure 5) but comprises additional EcPOX conformations found in various variants of 
EcPOX.  
In the cytosolic resting state (R) an equilibrium of two EcPOX conformations is established. While state 
R I represents a conformation where the beta-peptide segment is partly released from the protein, species 
R II resembles a compact enzyme structure with both alpha- and beta-peptide parts clamped to the 
protein core. Since R I is characterized by a more accessible active site compared to R II it is suggested 
that this protein conformation is competent to bind the substrate pyruvate. 
Binding of pyruvate to state R I and concomitant formation of covalent ThDP intermediates initiates 
formation of the substrate-bound species (SB) of EcPOX. Immediately after pyruvate binding a first 
conformational transition from SB I to the compact SB II-state is induced leading to quantitative 
formation of SB II. Interconversion between SB I and SB II is promoted by Phe465 which swings 
between the thiamine and flavin cofactor in SB II and thus mediates protein association of the beta-
peptide segment.  
Formation of SB II also enables the electron transfer between the thiamine and flavin cofactor, which is 
facilitated by Phe465, yielding the reduced flavin in the substrate-reduced state (SR). Reduced flavin 
initiates the second conformational change from SR II to SR III. The latter species resembles the EcPOX 
conformation with a released membrane anchor (alpha-peptide) competent for membrane binding. 
Several amino acids are involved in this structural rearrangement. Tyr278 senses the flavin redox state and 
might initiate the signal transfer cascade from the flavin to the membrane anchor. Tyr549 could be the 
final receptor for this signal and seems to play an important role in membrane anchor stabilization at the 
protein surface. Similar functions are attributed to Ile554, Leu565 and Trp570 which fix the membrane 
binding domain at the protein via hydrophobic interactions. Electrostatic contacts (Asp328-Arg572 and 
Asp348-Arg558) and hydrogen bonds (Glu564-Gln537) play only a minor role. Additionally, no 
involvement of Phe260 is observed.  
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Once the membrane anchor is exposed the presence of membranes induces the third conformational 
change. This change seems to be restricted to the membrane anchor which folds into an amphipathic 
helical structure at the lipid bilayer and mediates membrane association of EcPOX. Crucial amino acid 
residues that control helix formation and membrane binding are Ile554 and Trp570 which are positioned 
at the N- and C-terminal helix edge, respectively. Additionally, bilayer association of the membrane anchor 
removes an autoinhibitory part of the membrane binding domain from the protein core which enhances 
the enzymatic activity by several orders of magnitude. 
Attached to the membrane EcPOX catalysis is completed by electron shuffling to Q8. Therefore, the 
ubiquinone moves out of the membrane into the active site of EcPOX to accept the electrons. In this 
regard Try278 and/or Ser28 might protonate the anionic reduced Q82- and hypothetically initiate another 
conformational switch which promotes subsequent membrane dissociation of the enzyme. Besides this 
potential function Tyr278 was also deciphered to prevent the flavin cofactor from wasteful reoxidation by 
molecular oxygen. 
6.2 Conclusions 
In this thesis the activation and membrane binding mechanism of pyruvate oxidase from E.coli was 
investigated. EcPOX is a peripheral membrane protein and was used as well-suited model system to 
analyze the impact of multiple amino acids on an enzymes activation mechanism and eventual bilayer 
association. Intensive kinetic and thermodynamic studies were performed in combination with X-ray 
crystallography. The results allowed the creation of a molecular activation model and give insights into a 
close coupling mechanism of catalysis and compartmentalization of an occasionally active enzyme. 
It was shown that amino acids within the active site mediate pyruvate-induced reduction of the protein-
bound flavin cofactor. The flavin redox state is also sensed by specific amino acids. Thus, the flavin acts as 
redox switch and a signal transfer cascade starting from the reduced flavin leads to exposure of the 
hitherto protein-bound membrane anchor. This membrane anchor is attached to the protein surface by 
hydrophobic interactions with the protein core. Upon activation these contacts are disturbed by 
conformational changes of the protein and the lipid binding domain to ensure membrane anchor 
exposure. Concomitant to release of the membrane anchor also an autoinhibitory helix is removed from 
the protein which leads to a great enhancement of the catalytic activity of EcPOX. Finally, the membrane 
anchor undergoes a last conformational transition in the presence of membranes. Bilayer association of 
the enzyme is thereby promoted by the formation of an amphipathic helix from the membrane anchor. 
Similar to the stabilization at the protein the membrane anchor is also bound to the membrane by 
hydrophobic contacts. Attached to the bilayer EcPOX has then access to its substrate Q8 and can 
complete its catalytic cycle. Initial results suggest that Q8 leaves the membrane and penetrates the active 
site of EcPOX according to an out-of-the membrane mechanism. 
 
Summary 101 
Knowing the impact of particular amino acids on specific steps of EcPOX activation allowed to track the 
pathway of activation. It remains to be studied whether the observations made for EcPOX can be 
assigned to other peripheral membrane binding enzymes. However, since the mechanisms of EcPOX 
activation are based on general principles (like protein association of the membrane anchor being of 
hydrophobic nature) it can be suggested that similar processes also govern the behavior of other enzymes 
and proteins.  
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figure 53:  Molecular mechanism of activation and membrane binding of EcPOX. Green boxes highlight the prominent 
species of EcPOX in equilibrium and indicate the suggested activation pathway. Final electron transfer of membrane-attached 
EcPOX to Q8 is omitted for reasons of clarity. The functional tetramer of EcPOX is simplified illustrated as monomer for better 
visualization. Note that the alpha-peptide is presented separately from the beta-peptide, although the alpha-peptide resembles the 
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8.1 Determination of the critical micelle concentration of SDS and DPC by ITC 
ITC was used to determine the CMC of the detergents SDS and DPC in water and 50 mM NaH2PO4 
pH 6.0 (buffer) according to [104]. As example a thermogram of the CMC determination of SDS in water 
is shown. Negative peaks at the beginning of the titration correspond to demicellization events whereas 
positive peaks at the end of the measurement indicate micelles dilution [141]. The point of inflection in 
the lower figure corresponds to the CMC which was calculated according to [106]. The determined CMCs 




table 17: CMC of SDS and DPC. 
detergent  in water/buffer CMC (mM) 
SDS in water 8.6 (± 0.4) 
SDS in buffer 1.9 (± 0.1) 
DPC in water 1.6 (± 0.1) 
DPC in buffer 1.3 (± 0.1) 
 
time (min)





































CMC = 8.65 mM
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8.2 Steady-state activity of EcPOX variants 
Steady-state activity of EcPOX variants in dependence of the pyruvate concentration. Data (dots) were 
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8.3 Temperature-induced unfolding of EcPOX variants 
Temperature-dependent unfolding of EcPOX wt and selected variants (0.1 mg/mL) was observed at 
208 nm by CD spectroscopy. Progress curves were used to calculate the apparent melting temperature Tm 
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8.4 SDS-mediated activation of EcPOX variants 
EcPOX activity stimulated by different amounts of SDS was analyzed by Q0 steady-state assay. Therefore, 
160 nM EcPOX were pre-incubated with 200 mM pyruvate. Activation was initiated by addition of SDS 
and activity was monitored by Q0 steady-state assay. A: Kinetics of EcPOX activation. B: Comparison of 
SDS-mediated activation of EcPOX wt and the examined variant in dependence of the desired SDS 
concentration. Each ensemble of data points at a given SDS concentration resembles one curve of A. 
SDS0.5 (highlighted by gray dashed lines) resembles the SDS concentration at which approximately 50 % 
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8.5 Aerobic and anaerobic flavin reduction of EcPOX variants 
Anaerobic (A) and aerobic (B) flavin reduction of EcPOX variants was determined at 438 nm with a path 
length of 1 cm and at 20 °C. 2 mg/mL of EcPOX were rapidly mixed with 200 mM pyruvate in the 
absence or presence of oxygen. Progress curves were converted to relative amount of oxidized flavin prior 
to use. A: Anaerobic flavin reduction. The rate constant of flavin reduction was determined by a single-
exponential equation (fit not shown). B: Aerobic flavin reduction. Position of the steady state, at which 
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8.6 Limited proteolysis of EcPOX variants 
Proteolytic activation of EcPOX variants was monitored by SDS-PAGE (A-C) and Q0 steady-state assay 
(D). 48.4 µM of EcPOX was digested at room temperature by 0.4 µm alpha-chymotrypsin. A-C: Gel 
samples were prepared after distinct time points and 0.6 µg of proteolyzed EcPOX were analyzed by SDS-
PAGE. A: EcPOX was pre-reduced with 200 mM pyruvate for 10 min prior to protease addition. B: 
EcPOX was digested in the absence of substrate. C: EcPOX was incubated with 20 mM MAP for 10 min 
prior to protease addition. The different protein bands are indicated as followed: FL = full-length protein, 
Δ23 = EcPOX Δ550-572, Δ101 = EcPOX Δ471-572. Half-life of the digestion reaction (t1/2), where half 
of the full-length protein is cleaved to Δ23, is highlighted (). D: Proteolytic digestion was performed 
similar to the SDS-PAGE experiments but activated enzyme was examined by Q0 steady-state assay after 
distinct time points. Increase in activity (dots) due to Δ23 formation was analyzed by a single exponential 
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8.7 Data collection and refinements statistics of crystal structures 
table 18: Statistics of crystal structures of EcPOX and LpPOX variants and the EcPOX Δ23:Q0 complex. Values in 
parentheses refer to the highest resolution shell. 








data collection      
wavelength, Å 1.541790 0.918410 0.918410 0.918410 0.918410 
space group P212121 C2221 P43212 P43212 P43212 
cell parameters: a, Å 204.051 119.480 152.014 152.496 150.290 
                         b, Å 205.915 154.330 152.014 152.496 150.290 
                         c, Å 214.627 165.440 153.789 154.206 152.970 
                         α, β, γ, ° 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 
monomers per asymmetric 
unit 
12 2 2 2 2 




























































refinement      










Wilson B, Å2 70.83 9.27 81.07 81.07 80.08 




















no. of nonhydrogen atoms     
protein 49007 11307 8841 8841 8735 
water 0 1612 0 0 0 
sulfate, phosphate, glycerol, 
Q0 
144 54 0 0 0 
FAD, ThDP, Mg2+ 936 160 158 158 158 
r.m.s.d. from ideality      
bond lengths, Å 0.003 0.013 0.014 0.017 0.006 
bond angles, ° 0.798 1.541 1.628 1.834 1.102 
average B-factors, Å2      
protein atoms 72.44 82.14 80.99 80.99 87.67 
water - 85.79 - - - 
sulfate, phosphate, glycerol, 
Q0 
60.28 74.36 - - - 
FAD, ThDP, Mg2+ 65.34 71.90 70.26 75.12 69.98 
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Extension of table 18. 







data collection     
wavelength, Å 1.239530 1.239530 0.918410 0.8 
space group P43212 P43212 P43212 P43212 
cell parameters: a, Å 151.692 150.730 149.966 151.710 
                         b, Å 151.692 150.730 149.966 151.710 
                         c, Å 156.369 151.880 151.436 151.650 
                         α, β, γ, ° 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 
monomers per asymmetric 
unit 
2 2 2 2 
















































refinement     








Wilson B, Å2 81.07 81.06 81.06 80.91 
















no. of nonhydrogen atoms    
protein 8834 8836 8836 8821 
water 0 0 0 0 
sulfate, phosphate, glycerol, 
Q0 
0 0 0 0 
FAD, ThDP, Mg2+ 158 158 158 158 
r.m.s.d. from ideality     
bond lengths, Å 0.017 0.015 0.014 0.014 
bond angles, ° 1.863 1.748 1.618 1.656 
average B-factors, Å2     
protein atoms 81.00 82.14 87.67 82.76 
water - - - - 
sulfate, phosphate, glycerol, 
Q0 
- - - - 




8.8 Amino acid sequence alignments 
The primary amino acid sequence of EcPOX, LpPOX and the catalytic subunit of acetohydroxyacid 
synthase (AHAS) from yeast were aligned with ClustalW2 [139]. 
 
EcPOX           --------------------------MKQT------VAAYIAKTLESAGVKRIWGVTGDS 28 
LpPOX           ------------------------MVMKQTKQTNILAGAAVIKVLEAWGVDHLYGIPGGS 36 
AHAS            APSFNVDPLEQPAEPSKLAKKLRAEPDMDTSFVGLTGGQIFNEMMSRQNVDTVFGYPGGA 60 
                                            :*       .  . : :.  .*. ::* .*.: 
 
EcPOX           LNGLSDSLNRMG-TIEWMSTRHEEVAAFAAGAEAQLSGELAVCAGSCGPGNLHLINGLFD 87 
LpPOX           INSIMDALSAERDRIHYIQVRHEEVGAMAAAADAKLTGKIGVCFGSAGPGGTHLMNGLYD 96 
AHAS            ILPVYDAIHNSD-KFNFVLPKHEQGAGHMAEGYARASGKPGVVLVTSGPGATNVVTPMAD 119 
                :  : *::      :.::  :**: ..  * . *: :*: .*   :.***  :::. : * 
 
EcPOX           CHRNHVPVLAIAAHIPSSEIGSGYFQETHPQELFRECSHYCELVSSPEQIPQVLAIAMRK 147 
LpPOX           AREDHVPVLALIGQFGTTGMNMDTFQEMNENPIYADVADYNVTAVNAATLPHVIDEAIRR 156 
AHAS            AFADGIPMVVFTGQVPTSAIGTDAFQEADVVGISRSCTKWNVMVKSVEELPLRINEAFEI 179 
                .  : :*::.: .:. :: :. . *** .   :  . :.:   . .   :*  :  *:.  
 
EcPOX           AVLNR-GVSVVVLPGDVA----LKPAPEGATMHW--YHAPQPVVTPEE--EELRKLAQLL 198 
LpPOX           AYAHQ-GVAVVQIPVDLP----WQQIPAEDWYAS--ANSYQTPLLPEPDVQAVTRLTQTL 209 
AHAS            ATSGRPGPVLVDLPKDVTAAILRNPIPTKTTLPSNALNQLTSRAQDEFVMQSINKAADLI 239 
                *   : *  :* :* *:.     :  *          :   .    *   : : : :: : 
 
EcPOX           RYSSNIALMCGSGCAGAH---KELVEFAGKIKAPIVHALRGKEHVEYDNPYDVGMTGLIG 255 
LpPOX           LAAERPLIYYGIGARKAG---KELEQLSKTLKIPLMSTYPAKGIVADRYPAYLGSANRVA 266 
AHAS            NLAKKPVLYVGAGILNHADGPRLLKELSDRAQIPVTTTLQGLGSFDQEDPKSLDMLGMHG 299 
                  :..  :  * *        : * :::   : *:  :  .   .    *  :.  .  . 
 
EcPOX           FSSGFHTMMNADTLVLLGTQFPYRAF--------------YPTDAKIIQIDINPASIGAH 301 
LpPOX           QKPANEALAQADVVLFVGNNYPFAEVS-----------KAFKNTRYFLQIDIDPAKLGKR 315 
AHAS            CATANLAVQNADLIIAVGARFDDRVTGNISKFAPEARRAAAEGRGGIIHFEVSPKNINKV 359 
                  ..  :: :** :: :* .:                         ::::::.* .:.   
 
EcPOX           SKVDMALVGDIKSTLRALLPLVEEKADRKFLDKALEDYRDARKGLDDLAKPSEKAIHPQY 361 
LpPOX           HKTDIAVLADAQKTLAAILAQVSERESTPWWQANLANVKNWRAYLASLEDKQEGPLQAYQ 375 
AHAS            VQTQIAVEGDATTNLGKMMSKIFPVKERSEWFAQINKWKKEYP-YAYMEETPGSKIKPQT 418 
                 :.::*: .*  ..*  ::. :    .       : . :.       : .     ::.   
 
EcPOX           LAHEISHFAADD---AIFTCDVGTPTVWAARYLKMNGKRRLLGSFNHGSMANAMPHGVGA 418 
LpPOX           VLRAVNKIAEPD---AIYSIDVGDINLNANRHLKLTPSNRHITSNLFATMGVGIPGAIAA 432 
AHAS            VIKKLSKVANDTGRHVIVTTGVGQHQMWAAQHWTWRNPHTFITSGGLGTMGYGLPAAIGA 478 
                : : :.:.*      .* : .**   : * :: .    .  : *   .:*. .:* .:.* 
 
EcPOX           QATEPERQVVAMCGDGGFSMLMGDFLSVVQMKLPVKIVVFNNSVLGFVAMEMKAGG-YLT 477 
LpPOX           KLNYPERQVFNLAGDGGASMTMQDLATQVQYHLPVINVVFTNCQYGFIKDEQEDTNQNDF 492 
AHAS            QVAKPESLVIDIDGDASFNMTLTELSSAVQAGTPVKILILNNEEQGMVTQWQSLFYEHRY 538 
                :   **  *. : **.. .* : :: : **   **  :::.*   *::    .        
 
EcPOX           DGTELHDTNFARIAEACGITGIRVEKASEVDEALQRAFSIDG--PVLVDVVVAKEELAIP 535 
LpPOX           IGVEFNDIDFSKIADGVHMQAFRVNKIEQLPDVFEQAKAIAQHEPVLIDAVITGDRPLPA 552 
AHAS            SHTHQLNPDFIKLAEAMGLKGLRVKKQEELDAKLKEFVSTKG--PVLLEVEVDKKVPVLP 596 
                  ..  : :* ::*:.  : .:**:* .::   ::.  :     ***::. :  .    . 
 
EcPOX           PQIKLEQAKGFSLYMLRAIISGRGDEVIELAKTNWLR-------------- 572 
LpPOX           EKLRLDSATSSAADIEAFKQRYEAQDLQPLSTYLKQFGLDDLQHQIGQGGF 603 
AHAS            ---MVAGGSGLDEFINFDPEVERQQTELRHKRTGGKH-------------- 630 
                    :  ...    :       . :                           
 
Sequence identity to EcPOX:  LpPOX = 28 % 
    AHAS = 23 % 
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8.9 Comparison of the crystal structures of EcPOX I554G with full-length 
EcPOX wt 
The crystal structure of EcPOX I554G is shown as example since it is identical to structures of variants 
F260A, I554A, L565A and EcPOX 3x. The full-length enzyme is depicted in orange whereas the variant 
I554G is shown in green. The position of the exchanged amino acid (Ile/Gly554) in the variant is 
highlighted by a blue sphere. The membrane anchor is detected completely attached to the protein core  
(A) an all variants and no significant structural changes of the overall structure or within the active site (B) 
are observed. 
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